Developing Inorganic Approaches to Polymerization and Bioconjugation by Messina, Marco Stefano
UCLA
UCLA Electronic Theses and Dissertations
Title
Developing Inorganic Approaches to Polymerization and Bioconjugation
Permalink
https://escholarship.org/uc/item/4082939v
Author
Messina, Marco Stefano
Publication Date
2019
 
Peer reviewed|Thesis/dissertation
eScholarship.org Powered by the California Digital Library
University of California
 
 
UNIVERSITY OF CALIFORNIA 
Los Angeles 
 
 
 
Developing Inorganic Approaches to 
Polymerization and Bioconjugation 
 
 
 
A dissertation submitted in partial satisfaction of the 
requirements for the degree Doctor of Philosophy 
in Chemistry 
 
by 
 
Marco Stefano Messina 
 
 
2019 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by 
Marco Stefano Messina 
2019 
ii 
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  Multi-disciplinary approaches to problem solving are needed given the increasing 
complexity of fundamental scientific questions. This dissertation undertakes a holistic approach to 
research and tackles challenges spanning the biology, chemistry, and materials interface. The 
central theme for most projects involves applying inorganic and main group chemistry to develop 
new bioconjugation strategies or polymerization methodologies to access novel materials. Chapter 
One provides an overview of the dissertation projects and provides insight on the project 
inceptions. 
Chapter Two describes efforts in understanding the effects of trehalose polymers towards 
protein stabilization. The stabilization capability of polymers made from a set of styrenyl-based 
trehalose monomer regioisomers were studied. Polymers of each trehalose monomer regioisomer 
iii 
 
and one polymer which contained all three isomers combined were synthesized. All polymer 
regioisomers stabilized insulin to a similar degree towards agitation and heat stress. 
Chapter Three details the initial discovery that icosahedral boron-rich cluster compounds 
of the type B12(OR12)—where “R” can be any alkyl or aryl group— could be utilized as strong 
one-electron photooxidants thereby initiating the polymerization of olefins. The perfunctionalized 
clusters are able to initiate polymerization of a range of styrene substrates under blue LED 
irradiation. Also demonstrated, is the visible light initiated, metal free cationic polymerization of 
isobutylene into poly(isobutylene). 
Chapter Four introduces carborane-based chain-transfer agents (CTA’s) to be used in 
reversible addition-fragmentation chain-transfer (RAFT) polymerization. The CTA’s mediate the 
controlled polymerization of olefin-based monomers to produce monodisperse carborane 
terminated polymers. The carborane-based scaffold serves as a general 1H NMR spectroscopic 
handle used to elucidate polymer molecular weight. Binding of carborane into the hydrophobic 
cavity of β-cyclodextrin was demonstrated by isothermal titration calorimetry thereby validating 
its potential use as an affinity label. The carborane RAFT agents also act as Raman active probes. 
Chapter Five explores the reactivity of gold(III) organometallic complexes in the context 
of bioconjugation chemistry. The gold(III) organometallic complexes mediated the conjugation of 
small molecule substrates which included heterocycles, an anti-cancer drug, biotin, and low 
molecular weight PEG to cysteine residues on biomolecules. The bioconjugation reactions 
proceeded rapidly, with high efficiency, and in a broad pH range.  
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Chapter 1   
 
General Introduction 
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 1.1 General Overview  
The general need for multi-disciplinary strategies to tackle challenges at the interface of 
multiple fields has shaped my PhD studies and this dissertation. Against this backdrop, I have 
spent my dissertation studies bridging the research themes of two groups by developing main-
group and organometallic-based systems for polymerization and bioconjugation. The broad theme 
throughout each project is in the development of new materials or in the development of 
methodologies to access specific materials, and the foundation of each project lies in chemical 
synthesis.  
The first project consists of synthesizing styrenyl trehalose-based polymers for protein 
stabilization, the ultimate goal of which was to determine if the modification site of the styrene 
substituent on the trehalose monomers would affect the overall ability of the polymers to stabilize 
a therapeutically relevant protein to agitation and heat stress.1 The Maynard group has previously 
shown that trehalose-based polymers are able to stabilize an array of proteins to heat stress and 
have also studied the effect that different polymer backbones have on the stabilization of proteins.2-
4 However, we had yet to understand if different monomer regioisomers would have a significant 
effect on the overall stabilization capability of the polymers. During the synthesis of the styrenyl-
based trehalose monomer, we observed the formation of four regioisomeric products in which 
styrene was substituted at either the 2-O, 3-O, 4-O, or 6-O position of trehalose. This led to a study 
where we isolated each of the trehalose monomer regioisomers, with the exception of the 3-O 
substituted product due to <1% yield, and polymerized each one using free-radical polymerization. 
Additionally, we prepared a polymer containing all of the monomer regioisomers. Ultimately, we 
found that all polymers were able to stabilize the protein insulin to agitation and minor heat stress, 
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indicating that the regioisomers could be pooled together in order to increase the overall yield of 
the monomer synthesis thus avoiding tedious purification techniques.1  
Through the course of these studies I had encountered difficulties in polymer 
characterization. GPC analysis of the trehalose-based polymers consistently produced low 
molecular weight readings as all of the polymer samples were eluting from the column late into 
the method.1,5 Additionally, calculation of the polymer molecular weight by 1H NMR of controlled 
polymerization reactions did not match the polymer molecular weight by GPC and in all cases the 
trehalose polymers again eluted close to the solvent elution on the GPC spectra. Ultimately, 
because the hydroxyl groups on trehalose can interact with the GPC columns thereby introducing 
inaccurate results, we acetyl protected the trehalose polymers in order to determine polymer 
molecular weight through back-calculation by GPC.  
 This problem inspired a strategy to address an idea which had been passed around the 
Maynard laboratory for some time. This idea was to develop a polymer initiator which could also 
act as a spectroscopic probe in order to determine polymer molecular weight by end-group analysis 
using 1H NMR. This type of initiator would need to be substituted with a motif which exhibited a 
shift in the 1H NMR spectrum significantly different from most commonly used polymer materials 
and was also strong enough in intensity for accurate integration. This strategy could then be used 
to determine the molecular weight of polymer materials which were not amenable to traditional 
GPC techniques. Having become familiar with the carborane-based research projects in the 
Spokoyny group, the idea of using a carborane-based scaffold to incorporate on the polymer chain-
end took shape and ultimately led to the third chapter of the dissertation. 
 We opted to develop an ortho-carborane-based chain-transfer agent to be used in RAFT 
polymerization processes.6 The o-carborane scaffold is highly tunable, as the boron vertices can 
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be easily functionalized using reported techniques. O-carborane also has unique electronic 
properties. Carbon atoms attached to the boron vertices most distal to the carbon vertices (B(9) 
and B(12)) encounter a shielding effect which results in a resonance that appears far upfield 
(methyl C-H ≈ 0.2 ppm) in the 1H NMR spectrum. Carborane is also able to bind into hydrophobic 
pockets within proteins, a characteristic which could play a role in affinity labeling processes.7-9 
Additionally, the B-H vibration resonates at ~2350-2600 cm-1 which is a typically silent region in 
the Raman spectrum of biological samples and is also unique amongst other commonly used 
Raman probes which rely on the vibration signal of alkynes and nitriles.10 All of these 
characteristics would make carborane-based RAFT agents unique amongst other commonly used 
RAFT agents and would bridge the themes of main-group chemistry with controlled radical 
polymerization techniques.6  
 We were able to synthesize a set of carborane RAFT agents in an efficient manner using 
straight-forward synthetic techniques. The carborane RAFT agents were proficient in mediating 
the RAFT polymerization of styrene, acrylate, and acrylamide based monomers producing 
polymers of controlled molecular weights. In all cases, the 1H resonances from the methyl 
substituents on the B(9) and B(12) vertices of carborane were sufficiently upfield from any of the 
1H resonances exhibited by the polymers themselves, which made for facile determination of 
polymer molecular weight through end-group analysis using 1H NMR spectroscopy. The polymer 
molecular weight determined by end-group analysis matched closely with the molecular weight 
determined by GPC across a range of polymers. We performed ITC to measure the extent of 
binding of the ortho-carborane terminated polymers to β-cyclodextran as a model system and 
found 2:1 binding of ortho-carborane to β-cyclodextran with strong binding affinity (Ka = 9.37 x 
104 M-1) which is advantageous for its use in affinity labeling applications.6 Additionally, the 
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carborane terminated polymers exhibited a Raman signal at 2549 cm-1, a silent region in the Raman 
spectra of biological samples, indicating that the carborane RAFT agents could also serve as 
Raman active probes.6  
 The second chapter of this dissertation was a project that spawned out of the Spokoyny 
group, but again allowed me the ability to bridge the research themes of inorganic cluster-based 
chemistry with polymerization techniques. This project involved our initial discovery that 
persubstituted boron-rich clusters of the type B12(OCH2Ar) (where Ar = C6H5 (1) or C6F5 (2)) could 
act as powerful one-electron photooxidants for the initiation and subsequent polymerization of 
olefins.11 We found the formation of polymer upon leaving a solution of 4-methoxystyrene in the 
presence of 1 under ambient laboratory lighting. Ultimately this initial observation led to us 
performing control experiments which determined that polymerization occurs only in the presence 
of both visible light and the cluster compounds. Because both of the boron-rich cluster derivatives 
absorb at 450 nm, we performed all polymerization reactions under blue LED irradiation. After 
observing low polymer yields in the presence of 1, we hypothesized that addition of electron-
withdrawing groups on the periphery of the cluster would increase the oxidation potential of the 
compound to generate a more reactive species and synthesized 2 under this hypothesis. Due to the 
higher oxidation potential of exhibited by 2 (0.5V higher than 1 vs SCE), we were able to 
polymerize a large array of electron-rich or -poor styrene substrates with varying functionality. 
Additionally, we were able to demonstrate the first example of a visible-light initiated and metal 
free polymerization of the completely unactivated olefin monomer isobutylene into highly 
branched poly(isobutylene) using 2.11  
 The final chapter of this dissertation involves the use of organometallic gold(III) reagents 
for the modification of cysteine amino acid residues on peptides and proteins.12 The goal was to 
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broaden the scope of transition-metal based complexes able to carry out the chemoselective 
modification of biomolecules in biologically relevant conditions. Moreover, I saw this as an 
opportunity to develop an organometallic-based approach for the construction of protein-polymer 
conjugates thereby harnessing the expertise of both the Maynard and Spokoyny groups. The 
hypothesis at the beginning of the project was that the thiophilicity and electrophilicity exhibited 
by gold(III) oxidative addition complexes should enable for chemoselectivity towards cysteine 
amino acid residues and facilitate reductive elimination to transfer aryl-containing molecules to 
cysteine, a process termed cysteine arylation. We began this project using carborane stabilized 
gold(III) oxidative addition complexes harboring small molecule aryl groups and found them 
successful in undergoing cysteine arylation on peptides. However, we observed decreased product 
yields upon higher fractions of water in the reaction media.12 This posed a challenge as it is 
essential for new biomolecule modification strategies to exhibit high efficiency in biologically 
relevant solvent conditions. After multiple failed attempts to modify the ligand system on our 
caborane stabilized gold(III) oxidative addition complexes, we turned to a commercially available 
gold(I) precursor stabilized by an Me-Dalphos ligand framework. Using a modified synthetic 
approach developed by the Bourissou group, we were able to synthesize an array of gold(III) 
organometallic reagents harboring pharmaceutically relevant aryl substrates, which included 
heterocycles, an anti-cancer drug, a short-chain PEG, and a fluorescent dye. The MeDalphos 
stabilized gold(III) reagents were able to efficiently modify a range of unprotected peptide and 
protein substrates in a variety of conditions. The bioconjugation reactions proceeded rapidly (<5 
min) in a large pH window (0.5-14), at ambient temperature, and in low micromolar 
concentrations. Using this methodology we were able to generate peptide macrocycles, transfer 
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pharmaceutically relevant molecules onto the surface of peptides and proteins, and transfer a short-
chain PEG onto a therapeutically relevant protein in completely aqueous conditions.12 
 Future work in this area is focused on using gold(III) chemistry as a platform to develop 
protein-polymer conjugates by either grafting-to or grafting-from. This includes taking advantage 
of the chemoselectivity of the gold(I)-based reagents to undergo oxidative addition across Aryl-I 
bonds in the presence of other Csp2/3-X bonds. This characteristic will enable us to develop 
gold(III) oxidative addition complexes harboring prototypical ATRP initiators which we can then 
transfer to cysteine amino acid residues on proteins in order to build a polymer from the protein 
surface. Additionally, we can develop gold(III) oxidative addition complexes modified with 
polymers in order to efficiently transfer polymers directly to proteins. 
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Chapter 2 
Effect of Trehalose Polymer Regioisomers on Protein Stabilization 
 
Reproduced with permission from: Messina, M. S.; Ko, J. H.; Yang, Z.; Strouse, M. J.; Houk, K. 
N.; Maynard, H. D. “Effect of trehalose polymer regioisomers on protein stabilization.” Polym. 
Chem. 2017, 8, 4781-4788. Copyright 2017 Royal Society of Chemistry. 
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2.1 Introduction 
Proteins are widely used as therapeutics in the pharmaceutical industry, feed-stock 
additives in the agricultural industry, and biochemical reagents in the laboratory setting. However, 
many proteins are prone to inactivation when exposed to outside stressors such as heat,1 pH 
changes,2 agitation,3 and desiccation,4 and their instability during the production, storage, and 
transport increases their cost.5 To prevent denaturation and thereby prolong protein activity, 
excipients such as sugars and polymers are often added to protein formulations.6  
Trehalose, a non-reducing disaccharide formed by α,α-1,1-linked glucose units,7 is 
upregulated in lower-level organisms such as tardigrades during long periods of desiccation.8,9 
This increase in trehalose concentration imparts stability to the organism by protecting the cell 
membrane and proteins.10 The mechanism of trehalose protein stabilization is under debate and 
there exist several different hypotheses.11-13 The three main hypotheses include water 
replacement,13 mechanical entrapment (vitrification),10 and water entrapment.14 In the water 
replacement theory, trehalose forms direct hydrogen bonds with the protein, effectively replacing 
water molecules and acting as the protein hydration shell. The mechanical entrapment hypothesis 
suggests that trehalose forms a glassy matrix around the protein, thereby reducing the mobility of 
the protein and allowing it to retain its tertiary structure. The water entrapment theory states that 
trehalose molecules trap water molecules around the protein to form a water hydration layer 
between the protein and trehalose. While the exact mechanism, or the combination of multiple 
mechanisms, responsible for the stabilization of proteins by trehalose remains to be fully 
determined,15 the stability that trehalose imparts on proteins remains clear. It is this feature that 
has enabled its use as an excipient in a range of protein therapeutic formulations such as 
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Herceptin®, Avastin®, and Advate®.16 Trehalose has also been effective as an excipient for the 
stabilization of reverse transcriptase,17 as an embedding medium for preserving protein structure 
during electron crystallography,18 and as an additive to improve shelf-life of food/ 
pharmaceutical/cosmetic products.16  
Motivated by these features of trehalose, we developed polymeric materials based on 
trehalose that stabilize proteins ranging from enzymes,19-21 growth factors,22,23 hormones,24 and 
antibodies22,25
 
to various stressors including heat, lyophilization, agitation, and direct electron 
beam irradiation. Other groups have also used trehalose containing polymers in the prevention of 
amyloid beta (Aβ) aggregation26 and small interfering RNA (siRNA) and plasmid DNA (pDNA) 
delivery.27,28
 
Previously, we have explored the effect of the polymer back- bone identity on the 
overall stabilization properties of trehalose glycopolymers by comparing polystyrene and 
polymethacrylate backbones as excipients to stabilize horseradish peroxidase (HRP) to heat and 
β-galactosidase (β-Gal) to lyophilization.20 Slight differences in stabilizing effect were observed 
for different polymer backbones at low equivalents of the polymer, but at higher equivalents all of 
the polymers stabilized the proteins, regardless of polymer backbone.  
We were thus motivated to systematically investigate the effect of the point of linkage on 
trehalose while keeping the polymer backbone the same. To study possible differences between 
trehalose regioisomers on protein stabilization, we prepared styrenyl trehalose monomers with 
trehalose modified at the 2-O, 3-O, 4-O, or 6-O positions (Scheme 2-1). The resulting polymers, 
as well as a polymer containing all of the regioisomers, were then tested as excipients for the 
stabilization of the model protein insulin to mechanical agitation. The results are described herein.  
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Scheme 2-1. Synthesis of trehalose monomer regioisomers.  
2.2 Results and Discussion 
The styrenyl trehalose monomers were synthesized using a single-step Williamson 
etherification. While the synthetic route does not require protecting group strategies, it does result 
in four regioisomeric monomers O2, O3, O4, and O6. Fortunately, the isomers exhibited 
significantly different retention times on the HPLC (Table 2-1, top), which allowed us to separate 
the monomers.  
Table 2-1. HPLC trace and yields for trehalose monomer regioisomers. 
 
Monomer Isolated Yield 
O2 11% 
O3 <1% 
O4 39% 
O6 13% 
OA 64% 
 
14 
 
The identity of each regioisomer was assigned after extensive characterization by NMR 
spectroscopy (COSY, HMBC, and HSQC) (Figure A1–A20). Although the regioisomers were 
expected to exhibit very similar characteristics, the coupling of the geminal benzyl protons in the 
1H NMR spectra varied significantly, with O4 exhibiting strong coupling (10.8 Hz) indicative of 
nonequivalent geminal protons in significantly different environments and large Δδ (0.16 ppm; 
Figure 2-1 B) and O2 and O6 exhibiting similarly strong coupling (Figure 2-1 A and C), while O3 
did not show any benzyl proton coupling (Figure A6). This spectroscopic data gave us an 
indication that each monomer likely adopts a different conformation in solution. Direct NMR 
observation of through-space correlation in aqueous environment was not possible due to the 
broadening of the trehalose hydroxyl proton signals in water. Therefore, we computationally 
explored the differences in the aqueous conformation of the regioisomers.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2-1. Benzyl region of 1H NMR for monomers O2, O4, and O6, and their corresponding 
lowest energy conformations in aqueous solution. 
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Briefly, for each isomer a conformational search was con- ducted using Maestro 10.4 and 
select conformers were optimized by density functional theory (DFT) calculation at B3LYP-D3/6-
31G(d) level of theory in Gaussian 09.29 As shown by the lowest energy conformers for each 
isomer (Figure 2-1 D–F), all of the isomers retain the so-called clam shell conformation, in which 
the disaccharide is bent at the anomeric position, bringing the two glucose rings in close proximity 
that is characteristic for trehalose.30,31 All of the stable conformations (defined prior to the 
calculations as within 2 kcal mol-1 energy with respect to the most stable conformation) retain the 
clam shell conformation (Figure A52) as opposed to the higher energy more open conformation 
(Figure A53). However, O6 has a single most stable conformation within 4 kcal mol-1 (i.e., 99.9% 
of the population will be in this conformation at any given time according to Boltzmann 
distribution), and O4 has two stable conformations within 2 kcal mol-1 that only differ by 0.1 kcal 
mol-1 in energy. O2 has multiple stable conformations within 2 kcal mol-1. These results suggest 
that O6 and O4 have a relatively rigid conformation while other regioisomers are more flexible 
and fluctuate among the multiple low energy conformations. This result is reasonable, since O2 
substitution would cause the most steric hindrance to the opposite ring due to the spatial proximity 
of the vinyl benzyl unit, while O6 would cause the least hindrance. Furthermore, both of the 
lowest-energy conformations of O4 show that one of the benzyl protons is proximal to the oxygen 
of the adjacent hydroxyl on C3 (2.41 and 1.92 Å for the two lowest energy conformers, (Figure 2-
1E)), which would explain the exceptionally large Δδ of O4 benzyl protons in the 1H NMR 
spectrum (Figure 2-1B).  
The yields for all of the regioisomers are provided in Table 2-1; OA denotes the combined 
yield of all of the monomer regioisomers. Interestingly, O4 was the most favored product. This 
observed regioselectivity was unexpected, as the primary hydroxyl (O6) would be anticipated as 
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the major product in a simple SN2 reaction such as Williamson etherification. Based on literature 
reports of metal-trehalose ionic complexation,32,33 we hypothesized that ionic complexation of 
sodium with trehalose may be responsible for the reduced nucleophilicity of the primary hydroxyl. 
It has been reported that sugars complex with cations in the following order: Ca2+
 
> Mg2+
 
> Na+
 
> 
K+,32 and the crystal structure of Ca2+
 
with trehalose indicates that 2-O, 3-O, and 6-O chelate the 
cation.33 One would therefore expect that the use of potassium hydroxide in place of sodium 
hydroxide would result in a relatively looser ion pairing at 6-O and increased modification at the 
primary hydroxyl due to its intrinsically higher nucleophilicity, if ionic complexation were 
responsible for the unusual selectivity. Indeed, the yield of O6 relative to O4 was increased when 
potassium hydroxide was used as the base or when less sodium hydroxide was used than in the 
reaction (Table A1). This was further supported by the increased relative yield of O6 at higher 
temperature or in water, both of which would attenuate the effect of ionic complexation (Table 
A2). In water O6 was the major product as expected. However, the absolute yield of the monomers 
in water was low even in the presence of a phase transfer catalyst, which was likely due to the 
hydrolysis of the vinylbenzyl chloride.  
Modulation of sugar hydroxyl reactivity by intramolecular hydrogen bonds34 and metal 
ions35 has been previously observed. Benzoylation of methyl α-D-glucopyranoside in pyridine 
showed that hydroxyl reactivity followed the order 6-OH > 2-OH > 3-OH > 4-OH.34 However, 
different reaction conditions changed the reactivity, sometimes even favoring the secondary 
alcohol 2-OH over the primary 6-OH when mannose was methylated in the presence of silver 
oxide.34 Miller et al. leveraged the calcium complexation of fructose to selectively modify the 3′-
OH secondary hydroxyl of the fructose unit in a glycosyl acceptor in the presence of four primary 
hydroxyls in the donor and the acceptor.35 Our observation on the interesting chemical reactivity 
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of trehalose adds to the body of work on regioselectivity of sugars.  
With the monomer regioisomers assigned, we then targeted polymers made from each 
regioisomer monomer separately (P2, P4, and P6) and also one containing all regioisomers 
together (PA) (Figure 2-2). The polymer containing all of the monomer regioisomers was 
synthesized by pooling the mixture purified from HPLC (OA). The polymer from O3 was not 
pursued due to the low yield of the monomer. The polymers were all synthesized using free radical 
polymerization with AIBN as the initiator in DMF and water mixtures at 90 °C.  
 
Figure 2-2. Polymer structures of P2, P4, P6, and PA. GPC traces with corresponding molecular 
weight and dispersity for acetyl protected (black) and unprotected (red) polymers. The molecular 
weights for the unprotected polymers are provided above the GPC traces. For P2, P6, and PA these 
were calculated from the GPC of the acetylated polymers. 
Polymerization of O2, O6, and OA resulted in polymers (P2, P6, and PA), which ran close 
to the solvent elution on the GPC spectra, initially suggesting that the Mn of polymers were very 
small (<2 kDa; Figure 2-2). We have previously observed that trehalose polymers with free 
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hydroxyl groups can interact with GPC columns in DMF giving erroneous results.23 Thus, to better 
characterize the molecular weight, we acetylated each polymer (P2-OAc, P4-OAc, P6-OAc, and 
PA-OAc). This was accomplished by treating a small portion of the polymer in solution with 
excess acetic anhydride in dry pyridine and stirring at room temperature for 48 hours. The 
motivation was that by increasing the hydrophobicity of the polymer, the polymers from different 
regioisomers would be similarly solvated by the organic mobile phase (DMF) for accurate GPC 
analysis. Indeed, acetyl protected polymers showed larger Mn (15.4–24.8 kDa, Figure 2), which 
allowed us to back-calculate the original polymer molecular weight. Since P4 did not give 
erroneous GPC readings as the other polymers, we used this polymer as a control to test the 
accuracy of estimating Mn in this manner. The Mn for P4-OAc was 24.8 kDa, which gives a 
calculated weight for P4 of 15.1 kDa. This result is very close to the 14.8 kDa Mn determined by 
GPC of P4 prior to acetylation (Figure 2-2). This method provided us molecular weights between 
9.4–14.8 kDa for all the polymers. We also tested to see if the mixture of monomers could be 
acetylated first and then polymerized. Indeed, the polymerization proceeded smoothly to yield PA-
OAc that was subsequently deprotected as PA (see Appendix A for details).  
We then utilized the polymers to prevent aggregation of a protein during heating to body 
temperature and agitation, since this is one way therapeutic proteins are degraded. Insulin was 
employed as the model protein, since it is an important and widely used therapeutic protein for the 
treatment of diabetes. Insulin solutions are prone to aggregation when agitated, which makes 
transportation and storage difficult.3 Inactivation of insulin, even in small amounts, poses a risk to 
patients due to improper insulin dosage.36  
Samples were prepared of insulin and polymer at 1 and 10 weight equivalents (wt equiv.) 
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in DPBS in 1.5 mL screw-top dram vials. The protein samples were stressed at 37 °C with 250 
rpm agitation for 3 hours. Using this method, large insoluble insulin aggregates were visually 
observed (Figure A50). In order to quantify the amount of intact (non-aggregated) insulin, we 
utilized HPLC. HPLC has been frequently employed to separate degradation products from the 
protein thereby enabling accurate quantification of intact insulin.37 After stress, samples were 
filtered through 0.2 μm syringe filters to ensure removal of insulin aggregates and analyzed via 
HPLC.  
 
Figure 2-3. Stabilization of insulin using 10 wt equiv. of polymer. Samples were heated to 37 °C 
with 250 rpm agitation for 3 hours. Intact insulin quantified by HPLC. There is no statistical 
difference between polymers (n = 3). Note that DPBS and trehalose have zero intact insulin %. 
None of the polymers prevented aggregation at 1 wt. equiv. (Figure A51). However, all of 
the polymers prevented aggregation of insulin similarly (97–100%) at 10 wt. equiv., whereas 
samples of insulin stressed without added polymer or with 10 wt. equiv. of trehalose aggregated 
completely (Figure 2-3) meaning that zero percent intact insulin was observed by HPLC. This 
agrees with previous observations that trehalose in polymeric form is a better stabilizer than 
trehalose.19,20,26 Since there were no statistical differences in stabilization between polymers at 10 
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wt equiv., we conclude that the trehalose monomer regioisomers can be combined to achieve 
higher monomer yield, and all polymers can be utilized interchangeably, at least with the protein 
insulin.  
The computational studies have shown that while there seem to be differences in 
conformational flexibility between the monomer regioisomers, all of the stable conformations still 
possess the clam shell conformation of trehalose (Figure A52), and it is mostly the vinyl benzyl 
substituent that moves in the conformations for each isomer. Studies have pointed to the axial α,α-
(1→1) linkage that results in the clam shell conformation as being important for the protective 
ability of trehalose.30,31 Indeed, we have observed that trehalose polymers have superior protein 
stabilizing ability over polymers from other sugars such as lactose that have more open 
conformations.23 More thorough investigation is needed in the future to conclusively decouple the 
effects of conformational rigidity and the clam shell conformation on protein stabilization; in other 
words, more work will need to be done to determine if it is the clam shell conformation and the 
spatial arrangement of the hydroxyl groups itself or the molecular rigidity that results from the 
clam shell that is responsible for the stabilization. Nonetheless, we observe that the site of 
attachment of the trehalose to the polymer backbone does not have significant influence on the 
stabilizing ability. It should also be noted that the trehalose polymer stabilizes better than trehalose, 
likely due to the cluster glycoside effect from increased local concentration23,28 and/or the nonionic 
surfactant character of the hydrophilic sugar side chain attached to the hydrophobic backbone.20,23 
Together, our findings offer an interesting view on the synthesis of trehalose monomers and 
provide us with data suggesting that monomer regioisomers can be pooled to increase trehalose 
polymer yields without reducing protein stabilization ability.  
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2.3 Conclusions 
In conclusion, we synthesized four trehalose regioisomers containing an ether-linked 
styrene moiety positioned at the 2-O, 3-O, 4-O, or 6-O position of trehalose. The substitution 
position of each monomer was rigorously identified via NMR spectroscopy. NMR data suggested 
that each regioisomer adopted a distinct conformation in solution and computational methods were 
employed to explore this. Calculations gave insight into the relative rigidity of the trehalose 
regioisomers in solution, with monomers O6 and O4 being the least flexible with only one or two 
stable conformations, and monomer O2 showing multiple stable conformations suggesting that it 
is conformationally flexible. Despite the differences in conformational flexibility, all monomer 
regioisomers retained the native clam shell conformation of trehalose. We then probed the 
stabilization capability of each trehalose regioisomer in polymeric form. Polymers containing each 
monomer separately and one containing all monomer regioisomers together were synthesized via 
free radical polymerization. The stabilization capability of the polymers as excipients against 
mechanical agitation with moderate heating was then tested using insulin as a model protein. There 
was no substantial difference in the stabilization capability between each polymer; the different 
polymers prevented protein aggregation (>97%) while there was no intact insulin with trehalose 
itself or free protein. We conclude that different regioisomers may be combined to achieve higher 
yields of the polymer material while being able to effectively stabilize proteins, at least insulin, to 
mechanical stress.  
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2.5 Appendix A 
 
2.5.1 Materials  
Trehalose was purchased from The Healthy Essential Management Corporation (Houston, TX), 
dried with ethanol, and stored under vacuum. Azobisisobutyronitrile (AIBN) (98%) was purchased 
from Sigma-Aldrich and recrystallized from acetone before using. 4-Vinylbenzyl chloride (90%) 
was purchased from Sigma-Aldrich. Insulin, human recombinant (Cat. No. 91077C; Lot No. 
15L255-D) was purchased from Sigma Aldrich. Sodium hydroxide (≥97%, Pellets/Certified ACS), 
N,N- dimethylformamide (DMF) (≥99.8%, Certified ACS), dimethyl sulfoxide (DMSO) (≥99.9%, 
Certified ACS), Eppendorf LoBind® microcentrifuge tubes (0.5 mL and 1.5 mL), and pyridine 
(≥99%, Certified ACS) were purchased from Fisher Scientific. Pyridine was dried via distillation 
over calcium hydride and stored over 3 Å molecular sieves. Spectra/Por® 3 dialysis membrane 
standard RC tubing (MWCO: 3.5 kDa) was used for dialysis of polymers. Deuterated solvents 
(Cambridge Isotope Laboratories) for NMR spectroscopic analyses were used as received.  
2.5.2 Analytical techniques  
NMR spectra were recorded on Bruker AV 400, 500, or DRX 500 MHz spectrometers. Chemical 
shifts are reported in ppm relative to the residual signal of the solvent (D2O: δ 4.79 ppm, CDCl3: 
δ 7.26 ppm, or (CD3)2SO: δ 2.50 ppm). 1H NMR spectra are reported as follows: chemical shift (δ 
ppm), multiplicity (t = triplet, d = doublet, dd = doublet of doublets, m = multiplet), coupling 
constant (Hz), and integration. 1H NMR spectra were acquired with a relaxation of 2 s for small 
molecules and 30 s for polymers with an acquisition time of 3.27 s and 30° pulse angle. Gel 
permeation chromatography (GPC) was conducted on a Shimadzu high performance liquid 
chromatography (HPLC) system with a refractive index RID-10A, one Polymer Laboratories 
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PLgel guard column, and two Polymer Laboratories PLgel 5 μm mixed D columns. Eluent was 
DMF with LiBr (0.1 M) at 50 °C (flow rate: 0.80 mL min-1). Calibration was performed using 
near-monodisperse pMMA standards from Polymer Laboratories. HPLC purification of trehalose 
monomers was performed on a Shimadzu HPLC system with a refractive index and UV detector 
RID-10A monitoring at λ = 254 and 220 nm, and one Luna 5 μm C18(2) 100 Å LC column (250 
× 21.2 mm) with 40% MeOH and 60% H2O isocratic eluent mixture at a flow rate of 20 mL min
-
1. The same HPLC system, equipped with an analytical Luna 5 μm C18(2) 100 Å column (250 × 
460 mm), was utilized for detection of insulin with a gradient solvent system (water: acetonitrile 
= 30:70 to 40:60 + 0.1% trifluoroacetic acid over 15 min at 1 mL min-1). Thermogravimetric 
analysis (TGA) was performed on a PerkinElmer Diamond TG/DTA instrument with a ramping 
rate of 10 °C per minute. Infrared (IR) spectra were obtained with a PerkinElmer Spectrum One 
instrument equipped with a universal ATR assembly; spectra are reported in wavenumbers (ṽ). 
Mass spectra were acquired on a Waters Acquity Ultra Performance Liquid Chromatography 
(UPLC) connected to a Waters LCT-Premier XE Time of Flight Instrument controlled by 
MassLynx 4.1 software. The mass spectrometer was equipped with a Multi-Mode Source operated 
in the electrospray mode. Trehalose samples were separated using an Acquity BEH C18 1.7 μm 
column (2.1 × 50 mm) and were eluted with a gradient of 5–50% or 10–45% solvent B over 6 min 
(solvent A: water, solvent B: acetonitrile, both with 0.2% formic acid (vol/vol)). Mass spectra were 
recorded in the negative ion mode in the m/z range of 70–2000 with leucine enkephalin (Sigma 
L9133) as the lock mass standard. Mass spectra were also collected on a Thermo Scientific 
Exactive Plus mass spectrometer with IonSense Direct Analysis in Real Time (DART-MS) ID-
CUBE. Samples of insulin were stressed in a New Brunswick Scientific Excella E24 Incubator 
Shaker.  
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2.5.3 Computational methods  
Conformers for regioisomer O2, O4, and O6 were searched by using Maestro 9.4 with OPLS_2015 
force field in implicit water. For each regioisomer, the ensemble of conformers con sists of those 
whose energies are within 10 kcal mol-1 from the lowest one. This ensemble typically includes 
∼400 structures. The structures were then clustered to 25 representative structures for O2, 33 for 
O4, and 42 for O6 using the chemical informatics tool in Maestro 9.4. These structures were then 
optimized using B3LYP/6-31 g(d) with SMD water model in Gaussian 09.29 Frequency analysis 
was conducted to confirm that the structures are stationary points on the potential energy surface 
with no imaginary frequency. Thermal energies are calculated by using simple harmonic oscillator 
model. The reported energies are Gibbs free energies at 298.15 K and 1 bar.  
2.5.4 Synthesis of Trehalose Regioisomers 
6-O-(4-Vinylbenzyl ether)-α,α-trehalose (O6), 4-O-(4-vinyl- benzyl ether)-α,α-trehalose (O4), 3-
O-(4-vinylbenzyl ether)- α,α-trehalose (O3), 2-O-(4-vinylbenzyl ether)-α,α-trehalose (O2). NaOH 
(4.44 g, 1.14 × 10-1 mol) was added to DMSO (100 mL) and stirred for 5 min. Trehalose (4.86 g, 
1.42 × 10-2 mol) was then added to the reaction flask. Once trehalose dissolved, 4-vinylbenzyl 
chloride (0.4 mL, 2.55 × 10-3 mol) was added dropwise and reaction turned yellow. The reaction 
was stirred for 12 hours at 25 °C and was then precipitated in a mixture of cold hexanes (1.6 L) 
and dichloromethane (400 mL). Precipitate was collected via filtration and dried under reduced 
pressure to afford a yellow-white solid. The solid was dissolved in H2O (50 mL) and neutralized 
with 12 N hydrochloric acid (HCl). Once neutralized, MeOH (50 mL) was added and the solution 
mixed. The solution was then filtered through a 0.45 μm cellulose acetate filter and purified via 
preparative HPLC (40% MeOH in H2O). MeOH was removed under reduced pressure and water 
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was removed via lyophilization to afford compounds O2, O3, O4, and O6 in 11%, <1%, 39%, and 
13% yield, respectively, as fluffy white powders. The combined yield for all the regioisomers was 
64%.  
O2: HPLC retention time (peak intensity): 10.3 minutes. 1H NMR (500 MHz in D2O, 298 K): δ = 
7.47–7.45 (m, 2H), 7.35–7.33 (m, 2H), 6.77–6.71 (m, 1H), 5.84–5.80 (d, J = 17.69 Hz, 1H), 5.30–
5.28 (d, J = 11.42 Hz, 1H), 5.23–5.22 (d, J = 3.68 Hz, 1H), 5.14–5.13 (d, J = 4.05 Hz, 1H), 4.69–
4.61 (m, 2H), 3.91–3.51 (m, 10H), 3.45–3.39 (m, 2H); 13C NMR (125 MHz in D2O, 298 K): δ = 
137.5, 136.6, 136.2, 128.9, 126.4, 114.7, 93.5, 91.4, 78.7, 73.2, 72.4, 72.2, 72.0, 72.0, 71.0, 69.8, 
69.2, 60.6, 60.1; IR ṽ (cm-1): 3294 (br), 2923, 1635, 1362, 1043, 988, 827, 803; LC-MS (±1.0) 
observed (predicted): [M+HCOO]- 503.1762 (503.1765).  
O3: HPLC retention time (peak intensity): 11.7 minutes. 1H NMR (500 MHz in D2O, 298 K): δ = 
7.53–7.45 (q, 4H), 6.83–6.78 (dd, 1H), 5.88–5.85 (d, J = 17.86 Hz, 1H), 5.33–5.31 (d, J = 11.02 
Hz, 1H), 5.20–5.19 (m, 2H), 4.86 (s, 2H), 3.91–3.82 (m, 6H), 3.78–3.73 (m, 3H), 3.67–3.64 (m, 
1H), 3.57–3.53 (t, J = 9.63 Hz, 1H), 3.47–3.43 (t, J = 9.63 Hz, 1H); 13C NMR (125 MHz in D2O, 
298 K): δ = 137.3, 136.2, 128.9, 126.2, 114.4, 93.2, 93.0, 81.3, 74.8, 72.4, 72.2, 72.1, 70.9, 70.8, 
69.6, 69.3, 60.4, 60.3. IR ṽ (cm-1): 3301 (br), 2932, 1628, 1512, 1406, 1358, 1285, 1259, 1216, 
1146, 1105, 1080, 1027, 986, 943, 910, 827, 802; DART-MS observed (predicted): [M-H]- 
457.17040 (457.17044).  
O4: HPLC retention time (peak intensity): 14.6 minutes. 1H NMR (500 MHz in D2O, 298 K): δ = 
7.53–7.41 (q, 4H), 6.83–6.78 (dd, 1H), 5.89–5.85 (d, J = 17.73 Hz, 1H), 5.34–5.32 (d, J = 10.97 
Hz, 1H), 5.19–5.16 (m, 2H), 4.89–4.84 (d, J = 10.81 Hz), 4.71–4.69 (d, J = 10.81 Hz, 1H), 3.99–
3.95 (t, J = 9.62, 1H), 3.86–3.79 (m, 5H), 3.76–3.72 (m, 2H), 3.68–3.66 (m, 1H), 3.63–3.59 (m, 
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1H), 3.54–3.50 (t, J = 9.46 Hz, 1H), 3.45–3.41 (t, J = 9.62 Hz, 1H); 13C NMR (125 MHz in D2O, 
298 K): δ = 137.5, 136.6, 136.2, 129.2, 126.3, 114.6, 93.2, 93.0, 77.7, 74.6, 72.6, 72.4, 72.0, 71.1, 
71.1, 70.9, 69.6, 60.4, 60.2; IR ṽ (cm-1): 3234 (br), 2930, 1629, 1360, 1107, 1043, 992, 913, 827, 
805; LC-MS (± 1.0) observed (predicted): [M+HCOO]- 503.1720 (503.1765).  
O6: HPLC retention time (peak intensity): 19.7 minutes. 1H NMR (500 MHz in D2O, 298 K): δ = 
7.52–7.38 (q, 4H), 6.82–6.76 (dd, 1H), 5.87–5.84 (d, J = 17.51 Hz, 1H), 5.32–5.30 (d, J = 11.03 
Hz, 1H), 5.17–5.15 (m, 2H), 4.62–4.56 (q, 2H), 3.97–3.94 (m, 1H), 3.85–3.79 (m, 5H), 3.76–3.70 
(m, 2H), 3.64–3.60 (m, 2H), 3.47–3.41 (q, 2H); 13C NMR (125 MHz in D2O, 298 K): δ = 137.3, 
136.8, 136.2, 128.7, 126.3, 114.5, 93.3, 93.2, 72.6, 72.5, 72.4, 72.1, 70.9, 78.8, 70.7, 69.9, 69.6, 
68.6, 60.5; IR ṽ (cm-1): 3328 (br), 2928, 1630, 1512, 1407, 1365, 1212, 1147, 1105, 1076, 1032, 
987, 942, 909, 826, 805, 718; LC-MS (± 1.0) observed (predicted): [M+HCOO]- 503.1765 
(503.1765).  
2.5.5 Representative free radical polymerization (P4)  
O4 (531 mg, 1.16 mmol, 33 eq.) and AIBN (5.77 mg, 35.1 μmol, 1 eq.) were dissolved in H2O 
(3.63 mL) and DMF (7.27 mL). The mixture was added to a dry Schlenk tube and subjected to 
five freeze–pump–thaw cycles. The polymerization was started by immersing the Schlenk tube in 
a 90 °C oil bath. The polymerization was stopped after 21 hours by cooling with liquid nitrogen 
and exposing the reaction to air. The polymer was purified via dialysis (MWCO = 3.5 kDa) against 
H2O for three days and lyophilized to produce a fluffy white solid.  
P2: Mn = 1.9 kDa (Mn calculated from acetylated polymer, vide infra for details: 9.5 kDa); Mw = 
2.1 kDa; Đ = 1.09; 1H NMR (500 MHz in DMSO) δ: 7.06, 6.38, 5.06, 4.90, 4.51, 4.39, 3.71, 3.51, 
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3.36, 3.21, 2.27–0.43; IR: ṽ (cm-1): 3351, 2950, 1623, 1425, 1400, 1362, 1150, 1080, 991, 804. 
TGA weight loss onset temperature: 263 °C.  
P4: Mn = 14.8 kDa (Mn calculated from acetylated polymer: 15.1 kDa); Mw = 23.2 kDa; Đ = 1.56; 
1H NMR (500 MHz in DMSO) δ: 7.03, 6.40, 5.11, 4.92, 4.85, 4.78, 4.60, 4.41, 3.77, 3.65, 3.58, 
3.49, 3.16, 2.11–0.66; IR: ṽ (cm-1): 3342, 2928, 1637, 1423, 1359, 1148, 1104, 1039, 987, 846, 
803, 706. TGA weight loss onset temperature: 286 °C.  
P6: Mn = 1.8 kDa (Mn calculated from acetylated polymer: 9.4 kDa); Mw = 1.9 kDa; Đ = 1.05; 
1H 
NMR (500 MHz in DMSO) δ: 7.05, 6.47, 4.90, 4.80, 4.68, 4.41, 3.89, 3.69, 3.58, 3.49, 3.17, 2.03–
0.63; IR: ṽ (cm-1): 3344, 2924, 2162, 1636, 1423, 1362, 1147, 1076, 1034, 989, 940, 847, 806, 
706. TGA weight loss onset temperature: 274 °C.  
PA (all isomers mixed): Mn = 4.4 kDa (Mn calculated from acetylated polymer: 14.6 kDa); Mw = 
5.4 kDa; Đ = 1.21; 1H NMR (500 MHz in DMSO) δ: 7.02, 6.42, 5.07, 4.91, 4.82, 4.55, 4.41, 3.88, 
3.58, 3.49, 3.16, 2.49, 2.18–0.66; IR: ṽ (cm-1): 3348, 2922, 1430, 1362, 1041, 990, 804. TGA 
weight loss onset temperature: 284 °C.  
2.5.6 Representative polymer acetylation (P4)  
P4 (11.5 mg, 25.1 μmol, 1 eq.) was dissolved in dry pyridine (1.0 mL) and added to a dry and 
degassed round bottom flask. After five minutes of stirring, acetic anhydride (59.3 μL, 0.627 
mmol, 25 eq.) was added dropwise. The solution stirred at room temperature for 48 hours. After 
48 hours, the polymer was precipitated twice from cold diethyl ether. The precipitate was then 
collected and freeze-dried from benzene to afford product as a white powder. Deacetylated 
polymer molecular weights (provided above) were calculated using the following equation:  
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[MnP-OH] = [MnP-OAc] x ((MW Omonomer) / (MW OAcmonomer)).  
P2-OAc: Mn = 15.7; Mw = 25.0 kDa; Đ = 1.59; 
1H NMR (400 MHz in CDCl3) δ: 6.93, 6.41, 5.43, 
5.28, 5.09, 5.01, 4.89, 4.57, 4.25, 4.07, 3.93, 2.09, 2.08, 2.01, 0.15, 0.14, 0.11, 0.10.  
P4-OAc: Mn = 19.6 kDa; Mw = 31.7 kDa; Đ = 1.62; 
1H NMR (400 MHz in CDCl3) δ: 6.89, 6.36, 
5.52, 5.44, 5.28, 5.23, 5.05, 5.02, 4.99, 4.49, 4.22, 4.05, 3.96, 3.54, 2.07, 2.05, 2.01, 1.26, 1.20.  
P6-OAc: Mn = 15.4 kDa; Mw = 21.2 kDa; Đ = 1.37; 
1H NMR (400 MHz in CDCl3) δ: 6.85, 6.29, 
5.47, 5.30, 5.04, 4.36, 4.25, 4.09, 4.03, 4.00, 3.50, 2.07, 2.05, 2.02, 2.02, 1.91, 1.84.  
PA-OAc: Mn: 24.0 kDa; Mw = 35.0 kDa; Đ = 1.62; 
1H NMR (500 MHz in CDCl3) δ: 7.55–6.03, 
5.07, 4.51–4.15, 3.71, 3.53, 3.32, 2.07–0.50.  
2.5.7 Insulin aggregation studies  
A solution of insulin (1.0 mg mL-1) was prepared by dissolving insulin in Dulbecco’s phosphate-
buffered saline (DPBS, pH 7.4). Aliquots of the insulin solution (100 μL) were mixed with DPBS 
buffer (control, 100 μL) or stock solutions (100 μL) containing 1 or 10 weight equivalents of P2, 
P4, P6, or PA dis- solved in DPBS in 1.5 mL screw-top dram vials. These samples were taped 
horizontally for maximum surface area and stressed at 37 °C in an incubating shaker set to 250 
rpm for 3 hours. After 3 hours, the samples were removed from the shaker and placed in a 4 °C 
refrigerator until analytical HPLC analysis.  
2.5.8 Supplementary Procedures, Figures, and Tables 
2.5.8.1 Synthesis of O2, O3, O4, and O6 using different bases – representative example 
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The reaction was conducted as in the experimental section of the manuscript, with different molar 
equivalents of base (entry 1 corresponds to the original condition). A representative reaction 
condition (entry 2) is detailed as follows: Potassium hydroxide (573 mg, 1.02x10-2 mol) was 
suspended in dry dimethyl sulfoxide (9.5 mL) and stirred at room temperature. Trehalose (437 mg, 
1.28x10-3 mol) was then added and stirred until it dissolved. 4-Vinylbenzyl chloride (40 μL, 
2.55x10-4 mol) was added dropwise. The reaction was stirred for 12 hours at 25 ˚C and was then 
precipitated into a mixture of cold hexanes (160 mL) and dichloromethane (40 mL). The 
precipitate was collected via filtration and dried under reduced pressure, and the resulting solid 
was analyzed by HPLC (40% MeOH in H2O). 
Table A1. Modulation of regioselectivity in monomer synthesis using different hydroxyl bases. 
Entry 
Base 
Regioisomer ratio 
O2 : O3 : O4 : O6a Base used 
Mol. eq. relative 
to trehalose 
1 NaOH 8 1 : 0.21 : 3.38 : 1.42 
2 KOH 8 1 : 0.24 : 1.49 : 1.44 
3 NaOH 1 1 : 0.36 : 1.45 : 1.34 
4 KOH 1 1 : 0.35 : 1.02 : 1.36 
a Ratio calculated from HPLC chromatogram AUC.  
2.5.8.2 Synthesis of O2, O3, O4, and O6 in water or at a higher temperature 
The reaction was conducted as in the experimental section of the manuscript, except at a different 
temperature (50 °C) or in water. Briefly, 8 equivalents of NaOH and 1 equivalent of trehalose were 
dissolved in DMSO (to make 0.15 M trehalose), and 0.2 equivalent of 4-vinylbenzyl chloride was 
added dropwise and the reaction was allowed to stir for 15 to 21 hours at respective temperature. 
The reaction was neutralized with dilute hydrochloric acid, and analyzed by LC-MS. The reactions 
in water was conducted both with (entry 3) and without (entry 2) the phase transfer catalyst 
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(tetrabutylammonium hydrogensulfate) at 0.2 molar equivalents with respect to the added 
trehalose. 
 
Table A2. The effect of solvent and temperature on regioselectivity 
Entry Solvent Temperature Additive 
Regioisomer ratio 
O2 + O3a : O4 : O6b 
1 DMSO 50 °C None 1 : 2.27 : 2.12 
2 Water 23 °C None 1 : 3.78 : 4.61 
3 Water 23 °C 
Tetrabutylammonium 
hydrogensulfate 
1 : 2.01 : 3.34 
a Due to the low overall yield and weak signal, O2 and O3 peaks were overlapping.  
b Ratio calculated from UPLC-MS chromatogram. 
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2.5.8.3 Representative Polymer Acetylation: Acetylation of P4 
 
P4 (11.5 mg, 25.1 μmol, 1 eq.) was dissolved in dry pyridine (1.0 mL) and added to a dry and 
degassed round bottom flask. After five minutes of stirring, acetic anhydride (59.3 μL, 0.627 
mmol, 25 eq.) was added dropwise. The solution stirred at room temperature for 48 hours. After 
48 hours, the polymer was precipitated twice from cold diethyl ether. The precipitate was then 
collected and freeze-dried from benzene to afford product as a white powder.  The polymer was 
characterized by DMF GPC.   
Deacetylated polymer molecular weight was calculated using the following equation: 
[Mn P-OH] = [Mn P-OAc]*((MW Omonomer)/(MW OAcmonomer)). 
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2.5.8.4 Representative Monomer Acetylation: Acetylation of OA (OA-OAc) 
 
OA (199.6 mg, 0.435 mmol, 1 eq.) was dissolved in dry pyridine (1.4 mL) and added to a dry and 
degassed round bottom flask. After five minutes of stirring, acetic anhydride (823 μL, 8.70 mmol, 
20 eq.) was added dropwise. The solution was stirred at room temperature for 48 hours. After 48 
hours, solvent was removed under reduced pressure to yield a white solid. The solid was dissolved 
in dichloromethane (≈10 mL) and washed with H2O (≈10 mL) once. Organic layer was collected 
and washed with brine (≈10 mL) once. The organic layer was collected, dried over MgSO4, and 
filtered. Solvent was removed under reduced pressure and flash chromatography was performed 
(dichloromethane:ethyl acetate; 9:1) to afford product as a white solid. Yield= 72%. 
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2.5.8.5 Free Radical Polymerization of OA-OAc (PA-OAc) 
 
 
OA (690.0 mg, 0.917 mmol, 43 eq.) and AIBN (3.5 mg, 21.0 μmol, 1eq.) were dissolved in DMF 
(3.06 mL). The mixture was added to a dry Schlenk tube and subjected to five freeze-pump-thaw 
cycles. Polymerization was started by immersing the Schlenk tube in a 75 °C oil bath. After 21 
hours, the polymer was precipitated from cold diethyl ether. Crude solid was collected via filtration 
and rinsed with cold diethyl ether to afford the product as a white solid.   
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2.5.8.6 Representative Polymer Acetyl Deprotection: Deprotection of PA-OAc  
PA-OAc (73.4 mg, 97.5 μmol, 1 eq.) was dissolved in CHCl3 (2 mL) and MeOH (2mL). To this 
was added sodium methoxide (27 μL, 0.488 mmol, 5 eq.) dropwise. The solution was stirred at 
room temperature for 2 hours. After two hours, the precipitate was collected via centrifugation and 
dried. Resulting white solid was dissolved in water (~10 mL) and neutralized with 0.1 N HCl. 
Product was purified via dialysis (MWCO= 3,500 Da) for three days. Lyophilization afforded 
product as a fluffy white solid. 
 
 
Figure A1. 1H NMR spectrum of O2 in D2O at 298 K. 
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Figure A2. 13C NMR spectrum of O2 in D2O at 298 K. 
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Figure A3. HMBC spectrum of O2 in D2O at 298 K. 
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Figure A4. HSQC spectrum of O2 in D2O at 298 K. 
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Figure A5. COSY spectrum of O2 in D2O at 298 K. 
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Figure A6. 1H NMR spectrum of O3 in D2O at 298 K. 
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Figure A7. 13C NMR spectrum of O3 in D2O at 298 K. 
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Figure A8. HMBC spectrum of O3 in D2O at 298 K. 
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Figure A9. HSQC spectrum of O3 in D2O at 298 K. 
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Figure A10. COSY spectrum of O3 in D2O at 298 K. 
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Figure A11. 1H NMR spectrum of O4 in D2O at 298 K. 
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Figure A12. 13C NMR spectrum of O4 in D2O at 298 K. 
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Figure A13. HMBC spectrum of O4 in D2O at 298 K. 
 
51 
 
 
 
Figure A14. HSQC spectrum of O4 in D2O at 298 K. 
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Figure A15. COSY spectrum of O4 in D2O at 298 K. 
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Figure A16. 1H NMR spectrum of O6 in D2O at 298 K. 
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Figure A17. 13C NMR spectrum of O6 in D2O at 298 K. 
 
  
 
 
 
 
 
 
d
dd
e
ee
c
cf
f
a
a
b
b
g,h
i,j,k,l,m,n,o,p,q,r
s
s
l
q j
m
g
hn
k
p
o
r
i
55 
 
Figure A18. HMBC spectrum of O6 in D2O at 298 K. 
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Figure A19. HSQC spectrum of O6 in D2O at 298 K. 
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Figure A20. COSY spectrum of O6 in D2O at 298 K. 
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Figure A21. IR spectrum of O2. 
 
 
Figure A22. IR spectrum of O3. 
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Figure A23. IR spectrum of O4. 
 
 
Figure A24. IR spectrum of O6. 
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2.5.8.7 Polymer Characterization 
 
 
Figure A25. 1H NMR spectrum of P2 in DMSO-d6 at 298K. 
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Figure A26. 1H NMR spectrum of P4 in DMSO-d6 at 298K. 
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Figure A27. 1H NMR spectrum of P6 in DMSO-d6 at 298K. 
 
 
 
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
ppm
x
H2O
g,h,I,j,k,l,m,n,o,p,q,r
c,d
e,f
a,b s,t,u
a a
bb
s
t
u
u
e,f
l,n
h,m
g
c
d
q
j
o
p
i
r
k
x
DMSO
63 
 
  
 
Figure A28. 1H NMR spectrum of PA in DMSO-d6 at 298K. 
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Figure A29. 1H NMR spectrum of acetylated P2-OAc in CDCl3 at 298 K. 
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Figure A30. 1H NMR spectrum of acetylated P4-OAc in CDCl3 at 298 K. 
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Figure A31. 1H NMR spectrum of acetylated P6-OAc in CDCl3 at 298 K. 
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Figure A32. 1H NMR spectrum of acetylated PA-OAc in CDCl3 at 298 K. 
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Figure A33. GPC trace of P2. Mn= 1.9 kDa; Mw= 2.1 kDa; Đ= 1.09. 
 
Figure A34. GPC trace of P2-OAc. Mn= 15.7 kDa; Mw= 25.0 kDa; Đ= 1.59. 
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Figure A35. GPC trace of P4. Mn= 14.8 kDa; Mw= 23.2 kDa; Đ= 1.56. 
 
Figure A36. GPC trace of P4-OAc. Mn=19.6 kDa; Mw= 31.7 kDa; Đ= 1.62. 
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Figure A37. GPC trace of P6. Mn=1.8 kDa; Mw= 1.9 kDa; Đ= 1.05. 
 
 
Figure A38. GPC trace of P6-OAc. Mn=15.4 kDa; Mw= 21.2 kDa; Đ= 1.37. 
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Figure A39. GPC trace of PA. Mn=4.4 kDa; Mw= 5.4 kDa; Đ= 1.21. 
 
 
Figure A40. GPC trace of PA-OAc. Mn=19.6 kDa; Mw= 35.0 kDa; Đ= 1.62. 
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Figure A41. IR spectrum of P2. 
 
Figure A42. IR spectrum of P4. 
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Figure A43. IR spectrum of P6. 
 
Figure A44. IR spectrum of PA. 
 
Figure A45. IR spectrum of PA-OAc. 
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Figure A46. TGA of P2. 
 
 
 
 
 
 
Figure A47. TGA of P4. 
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Figure A48. TGA of P6. 
 
Figure A49. TGA of PA. 
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2.5.8.8 Insulin Assay Data 
 
Figure A50. Non-aggregated (left) and aggregated (right) insulin samples. 
 
 
Figure A51. A) Insulin agitation assay using 1 wt. equiv. of polymer shows no stabilization. 
Samples were heated to 37 C with 250 rpm agitation for 3 hours. B) Table of insulin agitation 
assay results using 1 wt. equiv. of polymer shows no intact insulin.  C) Intact insulin quantified by 
HPLC, representative traces for 1 wt equiv polymer assay shown. Insulin data on bottom panel is 
an unstressed insulin stock solution with the protein eluting at 12 minutes. (n=3) 
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2.5.8.9 Computational Methods 
Conformers for regioisomer O2, O4, and O6 were searched by using Maestro 9.4. with 
OPLS_2015 force field in implicit water. For each regioisomer, the ensemble of conformers 
consist of those whose energies are within 10 kcal/mol from the lowest one. This ensemble 
typically include ~400 structures. The structures were then clustered to 25 representatives for O2, 
33 for O4, and 42 for O6 using the chemical informatics tool in Maestro 9.4. These structures were 
then optimized using B3LYP/6-31g(d) with SMD water model in Gaussian 09.  
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Figure A52. Conformers for the regioisomers within 2 kcal/mol of the most stable conformer 
(energy difference in kcal/mol shown below the structures). 
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Figure A53. Example of conformer with disrupted clam shell conformation (O4 conformer with 
2.2 kcal/mol higher energy than the most stable conformation). 
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Chapter 3 
Visible-Light-Induced Olefin Activation Using 3D Aromatic Boron- 
Rich Cluster Photooxidants 
 
Reproduced with permission from:  Messina, M. S.; Axtell, J. C.; Wang, Y.; Chong, P.; Wixtrom, 
A. I.; Kirlikovali, K. O.; Upton, B. M.; Hunter, B. M.; Shafaat, O. S.; Khan, S. I.; Winkler, J. R.; 
Gray, H. B.; Alexandrova, A. N.; Maynard, H. D.; Spokoyny, A. M. “Visible-Light Induced Olefin 
Activation using 3D Aromatic Boron-Rich Cluster Photooxidants” J. Am. Chem. Soc. 2016, 
138, 6952-6955. Copyright 2016 American Chemical Society. 
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3.1 Introduction 
We report a discovery that perfunctionalized icosahedral dodecaborate clusters of the type 
B12(OCH2Ar)12 (Ar = Ph or C6F5) can undergo photo- excitation with visible light, leading to a 
new class of metal-free photooxidants. Excitation in these species occurs as a result of the charge 
transfer between low-lying orbitals located on the benzyl substituents and an unoccupied orbital 
delocalized throughout the boron cluster core. Here we show how these species, photo-excited 
with a benchtop blue LED source, can exhibit excited-state reduction potentials as high as 3 V and 
can participate in electron- transfer processes with a broad range of styrene monomers, initiating 
their polymerization. Initiation is observed in cases of both electron-rich and electron- deficient 
styrene monomers at cluster loadings as low as 0.005 mol%. Furthermore, photo-excitation of 
B12(OCH2-C6F5)12 in the presence of a less activated olefin such as isobutylene results in the 
production of highly branched poly(isobutylene). This work introduces a new class of air- stable, 
metal-free photo-redox reagents capable of mediating chemical transformations.  
Photoredox processes are ubiquitous in chemistry and require a chromophore to absorb a 
photon, triggering the formation of an excited state with a redox potential dramatically different 
than that of the parent ground state. Well-defined molecular chromophores typically possess 
functional groups that are capable of absorbing light, upon which an electron is promoted into a 
higher energy molecular orbital; in many of these cases, these photoexcited species can behave as 
photooxidants or photoreductants. There exist two broad classes of molecular-based chromophores 
capable of undergoing photoredox processes: metal-based complexes and organic dyes.1 Metal-
based chromophores possess excited states with highly tunable lifetimes, as they are able to reach 
triplet states and are also able to delocalize electrons over a number of molecular orbitals.2 On the 
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other hand, the majority of organic chromophores possess relatively short-lived excited states 
featuring π→π* electronic excitations with radicals centered primarily within s or p orbitals.3 
(Figure 3-1). Both classes have been utilized to harness energy from visible light, enabling the 
formation of new chemical bonds in the context of building complex and diverse molecular 
architectures.4  
 
Figure 3-1. Molecular chromophores with photoredox activity include transition-metal complexes 
(e.g., I5) and organic dyes (e.g., pyrylium6 II). This work reports B12(OR)12 clusters as a new class 
of photoredox-active molecular chromophores (III).  
Boron-rich clusters are a class of molecules that can contain characteristics of both metal 
complexes and organic molecules.7-10 Many polyhedral boron clusters are robust and kinetically 
stable, and can undergo facile functionalization chemistry.9-11 In particular, dodecaborate clusters 
feature a unique, 3D aromatic bonding situation in which the skeletal electrons are delocalized in 
three dimensions.11,12 Importantly, unfunctionalized boron-rich clusters containing B−H bonds do 
not absorb light in the visible region and also cannot undergo well-defined redox processes.13 
However, researchers previously demonstrated that several classes of perfunctionalized polyhedral 
boron clusters are capable of undergoing reversible redox processes.11,a,b,f,14-17 For example, 
colorless ether-functionalized [B12(OR)12]
2- clusters can undergo two sequential quasi-reversible 
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one-electron redox processes, leading to [B12(OR)12]-
 and neutral B12(OR)12, respectively, both of 
which exhibit strong visible light absorption bands (Figure 3-2 A−C).15-17 We hypothesized that 
this light absorption can be used to generate reactive photoexcited species, though up to this point 
no such behavior has been realized for this class of boron-rich clusters.18 Here we demonstrate the 
visible light photoredox behavior of B12(OR)12 clusters which interact with olefinic species and 
subsequently initiate their polymerization. Specifically, we show that this process occurs across a 
wide array of both electron-rich and electron-deficient styrene monomers as well as isobutylene. 
The latter process represents the first visible-light-induced metal-free polymerization leading to 
highly branched poly(isobutylene).  
3.2 Results and Discussion 
 We recently developed an improved synthetic method which affords perfunctionalized 
B12(OR)12 clusters with tunable electrochemical properties (Figure 3-2).
17 During the course of our 
synthetic investigations, we discovered that, upon leaving cluster species 1a in the presence of 4-
methoxystyrene (2a) in a dichloromethane (CH2Cl2) solution, a viscous mixture resulted, 
indicating polymerization of 2a (see Appendix B). Interestingly, the same reaction did not produce 
any polymer when left in the dark, suggesting that this process is likely photodriven. We decided 
to investigate this interesting behavior more closely via controlled irradiation of a 2 M solution of 
2a in CH2Cl2 at room temperature under an N2 atmosphere with 0.5 mol% 1a (λmax,abs = 470 
nm) illuminated under blue LED light (450 nm). After 4 h of irradiation, the reaction produced 
polymer in <10% yield (Table 3-1). During the course of our investigations, Nicewicz reported an 
elegant pyrilium-catalyzed (II, Figure 3-1), photomediated polymerization protocol of 2a and 
suggested that the mechanism of the polymerization likely occurs through a cationic route.19 We 
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hypothesized that a similar process might be in operation with the B12(OBn)12 system and, if so, a 
cluster functionalized with more electron-withdrawing substituents would increase the oxidation 
potential of the photoinitiator, thereby providing greater photooxidizing power of these species. 
Therefore, B12(OCH2C6F5)12 (1b) was synthesized in a manner analogous to that of 1a and was 
isolated as a yellow solid in 63% yield (Figure 3-2 D). UV-vis absorption shows that 1a and 1b 
exhibit similar λmax wavelengths (470 and 454 nm, respectively; Figure 3-2 C), and, notably, 
cyclic voltammetry experiments show a 500 mV increase in the -1/0 redox couple of 1b compared 
to 1a (Figure 3-2 B).  
 
Figure 3-2. (A) Reversible oxidation/reduction of substituted boron-rich clusters (0/-1 is shown). 
(B) Cyclic voltammogram of 1a and 1b. (C) UV/vis spectrum of photooxidants 1a and 1b in their 
fully oxidized states and mono-anionic states. (D,E) Ball-and-stick and space-filling 
representations of the X-ray crystal structure of 1b.  
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Addition of 0.1 mol% 1b to a 2 M CH2Cl2 solution of 2a under ambient lighting resulted 
in the instantaneous formation of a polymer gel with a high dispersity (see Appendix B and Table 
3-1). Surprisingly, reducing the loading of 1b to 0.005 mol% still resulted in immediate gelation 
upon addition to 2a. Under optimized conditions, irradiation of 0.05 mol% 1b in a 0.2 M CH2Cl2 
solution of 2a with 450 nm light for 6 h produced 198 kDa polymer in 97% yield (Table 3-1).  
 
Table 3-1. Polymerization of 2a: number-average molecular weight (Mn) and dispersity (Đ) 
determined by GPC. Reported data are average of two runs.  
To understand the observed photoinitiation, we performed TD-DFT studies on 1a and 1b. 
This work reveals the existence of a favorable charge-transfer (aryl to boron cluster) excitation 
pathway leading to an excited species with a redox potential roughly matching the one-electron 
oxidation potential of styrene (Figure 3-3). This is consistent with the previous computational work 
of Schleid on B12(OH)12
- monoradical species.20 Our proposed mechanism involves the generation 
of a potent photooxidant by visible light promotion of an electron from a low-lying occupied 
orbital on aryl rings to the cluster-based LUMO. The resulting excited species initiates 
polymerization via a single-electron oxidation of styrene (or styrene derivative), producing a 
cluster-based radical anion the stabilities of which are documented12,17c and a monomer-based 
radical cation.  
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Figure 3-3. TD-DFT studies indicating charge-transfer excitation pathway in 1a/1b. Also shown 
are the relative energies of the HOMO levels of monomers 2a−c,e.  
Fluorescence decay measurements were employed to bench-mark the photoexcited 
properties of 1b. The excited-state lifetime of 1b, measured from the 600 nm emission maximum, 
was found to be ∼380 ps (Figure B50). From these data and the known ground-state reduction 
potential (-1/0 couple), an excited-state reduction potential value of ∼2.98 V (vs SCE) was 
estimated for 1b (Appendix B, section 2.5.11). This value is consistent with the ability of 1b to 
initiate the polymerization of 2a. The photoinduced oxidative behavior of these persubstituted 
clusters is unprecedented and stands as a new contribution to the field of molecular photoredox 
chemistry. Furthermore, the kinetic stability of both the neutral and mono-anionic clusters due to 
the 3D delocalization of valence electrons within the cluster core provides an opportunity for 
implementation in systems amenable to photochemistry involving a diversity of functional groups 
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and reactive radical species. Notably, the polymerization of 2a initiated by 1b also proceeds under 
ambient conditions, affording a polymer of similar quality as that generated from a reaction set up 
under inert gas conditions. Given this successful polymerization, we were interested in further 
exploring the reactivity and electron-transfer processes of 1b. We set out to expand our substrate 
scope by employing styrene monomers 2b−2i, which possess a range of electronic and steric 
profiles. Polymerization of styrene (2b) with 0.1 mol% 1b produced polystyrene in yields 
averaging 96% in 4 h without incorporation of 1a in the polymer (Appendix B, Figures B22 and 
B23). Varying the cluster loading did not have an effect on the molecular weight or dispersity of 
poly-2b (Appendix B, Figure B15). Furthermore, propagation proceeds in the absence of light, 
indicating that formation of the radical anion on 1b is irreversible (Appendix B, Figure B46).  
 
Table 3-2. Substrate scope for polymerization using 1b. General reaction conditions: monomer 
(50 μL, 0.2−2.0 M CH2Cl2 solution), 1b (0.1 mol%), 4−24 h. Isolated yields after precipitation.  
Notably, the pyrilium-based catalyst utilized by Nicewicz does not produce polymer, which 
is consistent with the stronger photooxiding power of 1b compared to II. Polymers of other 
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electron-rich styrenes are generated in the presence of 1b within hours in good yield (Table 3-2: 
2c−e,i); more electron-poor substrates can also be polymerized (Table 3-2: 2f−h), albeit with 
somewhat diminished efficiency, consistent with our mechanistic hypothesis. The perfluorinated 
nature of 1b led us to wonder whether the successful polymerization of such a wide range of 
styrene monomers in comparison to either 1a or II (Figure 3-1) may be due, in part, to specific 
interactions between the fluorinated rings of the initiator and the monomer. Such intermolecular 
π−π-type interactions are well-recognized.21 We therefore subjected styrene (2b) to the optimized 
polymerization conditions in the presence of 1b employing benzene as solvent. Polymerization of 
2b produced polystyrene in 96% yield in 4 h, though Mw values observed for polystyrene produced 
in benzene are slightly smaller than those of polymers produced in CH2Cl2. Given the likelihood 
of competitive association of solvent with the fluorinated aryl rings of 1b, one would expect a 
reduction in polymer yield when using aromatic solvents if these π−π-type interactions are 
essential to polymerization. Therefore, this experiment suggests that, if π-type interactions 
between the initiator and the monomer exist, they are not critical for the polymerization overall.  
We were further interested to see if 1b, in light of its high excited-state reduction potential 
(vide supra), might coax reactivity out of more challenging substrates. Cationic polymerization of 
isobutylene, a less activated vinyl substrate than styrene, typically utilizes metal catalysts or harsh 
conditions.22 Irradiation (450 nm) of a 2 mM solution of 1b in CH2Cl2 at isobutylene pressures as 
low as 1 psi for 4 h at room temperature produced polymeric material. Neither irradiation of 
isobutylene in the absence of 1b nor stirring 1b in the presence of isobutylene in the dark, under 
reaction conditions otherwise identical to those described above, afforded polymer. Interestingly, 
1H and 13C NMR spectra of the formed polymer material closely resembles those of the polymer 
obtained previously by Michl and are consistent with the formation of a highly branched 
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poly(isobutylene) (see Figure 3-4 and Appendix B).23 This represents the first example of a visible 
light-activated polymerization of isobutylene under metal-free conditions.  
 
Figure 3-4. 1H NMR spectrum of poly(isobutylene) produced from irradiation of 1b with 450 nm 
light under 4 psi isobutylene. Label A indicates protons of the olefinic chain end; B/C, allylic 
protons of the chain end; D, methine protons.  
3.3 Conclusions 
In conclusion, we have demonstrated for the first time that icosahedral dodecaborate 
clusters of the type B12(OR)12, where R is a benzyl derivative, can undergo photoexcitation with 
visible light and activate styrene derivatives toward polymerization. Increasing the electron-
withdrawing power of the benzyl substituents results in increased activity, and that allowed us to 
develop the first example of a metal-free visible light photooxidant capable of polymerizing 
isobutylene. DFT calculations suggest that photoexcitation in these species occurs through the 
promotion of an electron from a low-lying, aryl-based orbital on the cluster substituent to an 
unoccupied cage-based orbital by visible(∼450nm) light. Overall, our work indicates that B12- 
90 
 
based clusters can behave as powerful yet air-stable photoredox reagents. This work also expands 
on an exciting untapped potential of molecular main-group systems as unique photoactive 
components.11,24 Current efforts in our group are focused on underpinning the mechanism of the 
discovered photoexcitation and the further tuning of the disclosed system.25  
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3.5 Appendix B 
3.5.1 Reagent Information 
All commercially available chemicals were used as received unless otherwise stated. All 
polymerizations were prepared in the glovebox under nitrogen atmosphere unless otherwise stated. 
All solvents were purified via a solvent purification system and kept in the glovebox. All 
monomers were degassed and stored with 4Å molecular sieves. 4-Vinylanisole (97%), 4-
methylstyrene (96%), styrene (≥99%), 4-fluorostyrene (99%), 4-tert-butylstyrene (93%), 4-
chlorostyrene (97%), 3-chlorostyrene (98%), and 2,6-difluorostyrene (99%) were purchased from 
Sigma-Aldrich. Closo-dodecahydrododecaborate ([NEt3H]2[B12H12]) was purchased from Boron 
Specialties  (USA). Ethanol (200 proof) was purchased from Decon Labs and used as received. 
Iron(III) chloride hexahydrate (≥97%), cesium hydroxide monohydrate (≥99.5%), hydrogen 
peroxide (30% in H2O), tetrabutylammonium hydroxide (40% in H2O), acetonitrile (≥99.9%), 
dichloromethane (≥99.5%), ethyl acetate (≥99.5%), hexanes (≥98.5%), methanol (≥99.8%), N,N-
diisopropylethylamine (≥99%), and tetrabutylammonium hexafluorophosphate (≥99.0%, 
electrochemical grade), 2-methylpropene (99%) were purchased from Sigma-Aldrich. 
Tetrabutylammonium hexafluorophosphate was further purified by recrystallization from ethanol 
and drying under vacuum at 90 °C and benzyl bromide (99%) was purchased from Alfa Aesar. 
Tetramethylammonium tetrafluoroborate (>98%) was purchased from TCI. 
3.5.2 General Analytical Information 
NMR spectra were recorded using spectrometers at 400 or 500 MHz (1H), 125 MHz (13C), 80 MHz 
(11B), and 282 MHz (19F) reported in δ (parts per million) relative to tetramethylsilane (1H, 13C), 
BF3·Et2O (
11B) or C6H5F (
19F), respectively, and referenced to residual 1H/13C signals of the 
deuterated solvent (1H (δ) CDCl3 7.26; 13C (δ) CDCl3 77.16; 11B (δ) BF3·Et2O 0.00 ppm; 19F (δ) 
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C6H5F -113.15 ppm). Deuterated solvents (Cambridge Isotope Laboratories) for NMR 
spectroscopic analyses were stored over 4Å molecular sieves.  1H NMR spectra were acquired 
with a relaxation of 2 s for small molecules and 30 s for polymers. Gel permeation chromatography 
(GPC) for all polymers was conducted on a Jasco system equipped with a refractive index detector, 
a UV detector, one Waters Styragel guard column, and four Waters HR Styragel 5 μm columns 
(100-5K, 500-30K, 50-100K, 5-600 K) using tetrahydrofuran (THF) at 30 °C and a flow rate of 
1.0 mL/min. Calibration was performed using near-monodisperse polystyrene standards from Jordi 
Laboratories and chromatograms were analyzed using ChromNAV chromatography software. 
GPC for poly-4-methoxystyrene was conducted on a Shimadzu high performance liquid 
chromatography (HPLC) system with a refractive index RID-10A, one Polymer Laboratories 
PLgel guard column, and two Polymer Laboratories PLgel 5 μm mixed D columns. Eluent was 
DMF with LiBr (0.1 M) at 40 °C (flow rate: 0.60 mL/min). Chromatograms from DMF GPC were 
analyzed using LabSolutions software. GPC was also conducted on a Shimadzu HPLC 
Prominence-i system equipped with a UV detector,  Wyatt DAWN Heleos-II Light Scattering 
detector, Wyatt Optilab T-rEX RI detector, one MZ-Gel SDplus guard column, and two MZ-Gel 
SDplus 100 Å 5μm 300x8.0 mm columns. Eluent was CHCl3 at 40 °C (flow rate: 0.70 mL/min). 
Chromatograms from CHCl3 GPC were analyzed using Astra 6.0 software. Calibration was 
performed using near-monodisperse polystyrene standards from Polymer Laboratories. All GPC 
samples were dissolved in HPLC grade solvent at a concentration of 1-2 mg/mL and filtered 
through a 0.2 µm TFE filter. All reported molecular weight and dispersity data determined by GPC 
are the average of two runs unless otherwise noted. A Bruker EMX EPR spectrometer was used to 
acquire EPR spectra, with all spectra collected in CH2Cl2 at ambient temperature. Mass 
spectrometry data was acquired using a Thermo ScientificTM Q-ExactiveTM Plus instrument with 
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a quadrupole mass filter and Orbitrap mass analyzer. ICP-MS was performed on an Agilent 7500c 
quadrupole with hydrogen/helium octopole collision cell. Thermogravimetric analysis was 
performed on a Perkin Elmer Diamond TG/DTA instrument. UV-Vis spectra were recorded on a 
Hewlett-Packard 8453 diode array spectrometer. Extinction coefficients were determined through 
a series of 5 dilutions with a maximum absorption between 0.1 and 0.7. 
3.5.3 Microwave Reactor Information 
Microwave reactions were performed using a CEM Discover SP microwave synthesis reactor. 
Except where noted otherwise, all reactions were performed in glass 10 mL microwave reactor 
vials purchased from CEM with silicone/PTFE caps. Flea micro PTFE-coated stir bars were used 
in the vials with magnetic stirring set to high and 15 seconds of premixing prior to the temperature 
ramping. All microwave reactions were carried out at 140 °C with the pressure release limit set to 
250 psi (no reactions exceeded this limit to trigger venting) and the maximum wattage set to 250W 
(the power applied was dynamically controlled by the microwave instrument and did not exceed 
this limit for any reactions). Column chromatography was performed using 2.0 - 2.25 cm inner 
diameter glass fritted chromatography columns with 20-30 cm of slurry-packed silica gel to ensure 
full separation of reagents and products. Unfiltered pressurized air was used to assist column 
chromatography. 
3.5.4 LED Light Source 
Irradiation of photochemical polymerizations were performed utilizing a 120V Blue LED Custom 
Rope Light Kit ½” 2 wire 3 foot cable purchased from Novelty Lights, Inc. (Eaglewood, CO). 
3.5.5 Cyclic Voltammetry Information 
Cyclic voltammetry was performed on using a BAS Epsilon potentiostat with a glassy carbon disc 
working electrode, platinum wire counter electrode, and Ag/Ag+ wire pseudoreference. All 
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experiments were conducted in 0.1 M [NBu4]PF6/CH2Cl2 with ~5 mM analyte concentrations. The 
CH2Cl2 was dried in house with a custom drying system running through two alumina columns 
prior to use. The solution was degassed by bubbling argon, and the cyclic voltammetry was 
performed under argon gas. A scan rate of 0.1 mV/s was used with Fc/Fc+ as an external standard.  
3.5.6 X-ray data collection and processing parameters 
A single crystal of 1b was mounted on a nylon loop using perfluoropolyether oil and cooled rapidly 
to 100 K with a stream of cold dinitrogen. Diffraction data were measured using a Bruker APEX-
II CCD diffractometer using Mo-Kα radiation. The cell refinement and data reduction were carried 
out using Bruker SAINT and the structure was solved with SHELXS-97. All subsequent 
crystallographic calculations were performed using SHELXL-2013 
3.5.7 Synthetic Procedures for cluster photoinitiators and polymers 
3.5.7.1 Synthesis of Cs2B12H12, Cs2B12(OH)12, and (NBu4)2B12(OH)12  
CsOH∙H2O (14.0g, 83.4 mmol) was dissolved in 130 mL methanol in a 300 mL round bottom 
flask. 13.4 g of triethylammonium dodecahydrododecaborate was added, the reaction was left to 
stir for 12-18 hours at ambient temperature (~20 ⁰C). The solution mixture was then filtered 
through a 60 ml fritted glass funnel and washed with 20 mL methanol three times. The resulting 
white solid was dried under high vacuum at 50 ⁰C for 12 hours and characterized by NMR to 
confirm complete conversion to Cs2[closo-B12H12]. Cs2[closo-B12H12] was per-hydroxylated to 
form Cs2[closo-B12(OH)12] via previously described methods.
1 The resulting Cs2[closo-B12(OH)12] 
was converted to (TBA)2[closo-B12(OH)12] (1) via previously described methods.
1 
3.5.7.2 Synthesis of Dodeca(benzyloxy)-hypercloso-dodecaborane (B12(OCH2Ph)12, 1a) 
 (TBA)2B12(OH)12 (50.0 mg, 0.061 mmol) was transferred out of a nitrogen filled glovebox, 
opened to the air, and dissolved in 1 mL acetonitrile in a 10 mL glass microwave vial. N,N-
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diisopropylethylamine (0.2 mL, 1.15 mmol) and benzyl bromide (1.74 mL, 14.7 mmol) were added 
along with a magnetic stir bar, the vial was sealed with a Teflon/silicone cap, and the reaction 
mixture was heated under microwave conditions at 140 ⁰C with high stirring for 15 minutes. The 
volatiles were removed via rotary evaporation, and the excess reagent was eluted through a silica 
column with 65/35 hexanes/ethyl acetate, and the pink/purple product mixture was eluted with 
dichloromethane. The dichloromethane was removed via rotary evaporation, the remaining 
charged -1/-2 product mixture was dissolved in ~5 ml 90/5/5 ethanol/acetonitrile/H2O, FeCl3∙6H2O 
(0.3 g, 1.11 mmol) was added and the mixture was left to stir for 12-24 hours. Following oxidation, 
the solvent mixture was removed via rotary evaporation, and an orange band containing the neutral 
product was separated from the FeCl3∙6H2O through a silica column with dichloromethane. The 
dichloromethane was removed via rotary evaporation and the final neutral product 1a was dried 
under high vacuum to obtain an isolated yield of 63%. Compound 1a is an orange solid. 1H NMR 
(500 MHz, CDCl3): δ 7.08 - 7.19 (m, 60H, C6H5), 5.25 (s, 24H, O-CH2). 13C{1H} NMR (125 MHz, 
CDCl3): δ 140.8, 128.4, 127.3, 73.4. 11B{1H} NMR (128 MHz, CDCl3): δ 41.8. HRMS (Orbitrap): 
m/z calculated for C84H84B12O12 (M-), 1414.72 Da; found, 1414.72 Da. 
3.5.7.3 Synthesis of Dodeca(pentafluorobenzyloxy)-hypercloso-dodecaborane 
(B12(OCH2C6F5)12, 1b) 
(TBA)2B12(OH)12 (300 mg, 0.366 mmol) was transferred out of a nitrogen filled glovebox, opened 
to the air, and dissolved in 4 mL acetonitrile in a 30 mL glass microwave vial. N,N-
diisopropylethylamine (1.21 mL, 6.96 mmol) and 2,3,4,5,6-pentafluorobenzyl bromide (6.86 mL 
45.4 mmol) were added along with a magnetic stir bar, the vial was sealed with a Teflon/silicone 
cap, and the reaction mixture was heated under microwave conditions at 140˚C with high stirring 
for 15 minutes. The volatiles were removed via rotary evaporation, and the excess reagent was 
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eluted through a silica column with 65/35 hexanes/ethyl acetate, and the pink/purple product 
mixture was eluted with acetone. The acetone was removed via rotary evaporation and the residue 
was dissolved in ~5 mL 90/5/5 ethanol/acetonitrile/H2O. FeCl3∙6H2O (1.88 g, 6.96 mmol) was 
added and the mixture was left to stir for 24 hours. The mixture was concentrated in vacuo.  The 
residue (while still in the roundbottom flask) was rinsed three times with water. The residue was 
then taken up in toluene and extracted three times with water.  The organic fractions were 
combined and dried under vacuum.  The resulting solid was charged with hexane and isolated by 
filtration to afford an orange/yellow solid (574 mg, 63%). 1H NMR (500 MHz, CDCl3): δ 5.23 (s, 
24H). 13C NMR (125 MHz, CDCl3): δ 60.1. 11B NMR (160 MHz, CDCl3): δ 40.9. HRMS 
(Orbitrap): m/z calculated for C84H84B12O12 (M
-), 2494.1499 Da; found, 2494.1631 Da. 
3.5.7.4 General Procedure for Polymer Synthesis 
Styrene (0.05 mL, 0.435 mmol) was passed through activated basic alumina and added to a dram 
vial equipped with a magnetic stir bar. B12(OCH2C6F5)12 (1b) (1.1 mg, 0.1 mol%) was then added. 
This mixture was dissolved in 219 µL dichloromethane, affording a 2M solution of monomer. The 
dram vial was sealed with a polypropylene cap containing a Teflon coated septum and brought out 
of the glove box. The mixture was then irradiated with blue LED light (450 nm) (see picture of 
representative setup below) while stirring for 4 hours at room temperature. For all reactions, the 
reaction setup is covered with aluminum foil to keep out ambient light. Once the polymerization 
was complete, the reaction was diluted with ~500 µL dichloromethane and precipitated with cold 
methanol. The resulting suspension was transferred to a tared falcon tube and centrifuged for 5 
minutes at 4,400 RPM. The supernatant was discarded, methanol was then added, stirred to 
solubilize any excess initiator, and centrifuged again. The supernatant was discarded and the 
polymer was dried under vacuum. Polymer conversion experiments: Polymerizations were set 
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up using optimized conditions (vide supra) along with the addition of an equimolar amount of 
hexamethyldisilane (as an internal reference) with respect to monomer. Aliquots (50 μL) of 
reaction mixture were taken at given time points and added into a mixture of trimethylamine (5 
μL) and CDCl3 (700 μL). Conversions were calculated by 1H NMR spectroscopy by integration of 
unreacted monomer to hexamethyldisilane. 
 
3.5.7.5 General Procedure for Polymerization of Isobutylene (1-4 psi of Isobutylene) 
In the glovebox, 1b (3.4mg, 1.36 μmol) was added to a Schlenk vessel, equipped with a teflon 
stopper, containing a magnetic stir bar. Dichloromethane (680 μL) was then added to provide a 
2mM solution of 1b.  The vessel was sealed and brought out of the glovebox. The Schlenk vessel 
containing the mixture was connected to a vacuum transfer bridge; the other outlets were connected 
to a Schlenk manifold (for vacuum) and the isobutylene regulator (Airgas Part # Y11N570L510), 
which is connected directly to the isobutylene canister.  The entire bridge was then put under 
vacuum.  The mixture of 1b was submerged in a dry ice bath until the solvent froze, opened to 
vacuum for ~5 minutes, and then closed to vacuum and allowed to thaw. This cycle was repeated 
two more times.  The bridge was then closed off from vacuum.  Once the mixture containing 1b 
thawed, the headspace of the closed system was then backfilled with isobutylene, with the 
regulator dial set to the desired pressure; for higher amounts of resulting product, 4 psi was used. 
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The mixture of 1b in CH2Cl2 in the isobutylene atmosphere was then irradiated with blue LED 
light for 4 hours at room temperature with stirring. After 4 hours, the isobutylene source was closed 
off, and the reaction vessel was carefully vented to let excess isobutylene escape.  The mixture 
was then charged with ~4mL methanol and subsequently all volatiles were removed in vacuo. The 
resulting white residue was qualitatively characterized as highly branched isobutylene by 1H and 
13C NMR spectroscopy, with reference to NMR spectra collected by Michl and co-workers (see 
Volkis, V.; Shoemaker, R. K.; Michl, J. Macromolecules 2012, 45, 9250-9257). 
3.5.7.6 Electrochemical Bulk Electrolysis (Fe-free) Oxidation of 1b 
Microwave synthesis of 1b was carried out according to the general procedure, excluding the 
oxidation with FeCl3∙6H2O. [NnBu4]2B12(OH)12 (99.0 mg, 0.121 mmol) was added to a 10 mL glass 
microwave vial and transferred out of a nitrogen filled glovebox, opened to air, and dissolved in 2 
mL acetonitrile. N,N-diisopropylethylamine (0.4 mL, 2.30 mmol) and  2,3,4,5,6-pentafluorobenzyl 
bromide (1.70 mL, 11.3 mmol) were added along with a flea micro stir bar, the vial was sealed 
with a PTFE/silicone cap, and the mixture was heated at 140 °C with stirring under microwave 
conditions for 15 min. The volatiles were removed via rotary evaporation and the excess reagent 
was eluted through a slurry-packed silica gel column with 65/35 hexanes/ethyl acetate, and the 
pink/purple product mixture was eluted with CH2Cl2. The CH2Cl2 was removed via rotary 
evaporation, and the remaining 2-/1- product mixture was dissolved in 25 mL dichloromethane 
containing 50 mM tetramethylammonium tetrafluoroborate in a 50 mL beaker. Pt mesh was used 
as the working electrode, Pt wire inside of a 1 cm diameter glass fritted chamber as the counter 
electrode, and Ag wire as a pseudoreference electrode. A flea micro stir bar was added, and a 
potential of -1.3 V was applied for 1 h with stirring. The initially pink solution turned clear outside 
of the fritted inner chamber, and the solution in the chamber turned orange-red, progressing toward 
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a final yellow-orange color. The fritted chamber containing the yellow-orange solution was 
removed, the dichloromethane was removed via rotary evaporation, and the remaining yellow-
orange solid was dried under high vacuum to yield pure 1b (5.0 mg, 1.6%). NMR analysis of the 
product confirmed the complete oxidation of the fraction collected. Note: This is a non-optimized 
experiment. The purpose of this procedure was to obtain a small amount of oxidized 1b without 
contacting Fe for control experiment use. 
3.5.7.7 Synthesis of 2,4,6-tri(p-tolyl)pyrylium tetrafluoroborate. 
 
 
 
 
p-Methylacetophenone (5 mL, 5.095 g, 42.4 mmol) and p-tolualdehyde (11.32 mL, 11.38 g, 84.8 
mmol) were allowed to stir. To this mixture boron trifluoride diethyl etherate (12.56 mL, 14.44 g, 
101.8 mmol) was added dropwise. Reaction temperature was then raised to 100 °C and kept stirring 
for 2 hours. After two hours, reaction was cooled to room temperature and diethyl ether was 
removed under reduced pressure producing a black oil. To this oil, acetone was added and product 
was precipitated upon addition of diethyl ether. Product was then collected via filtration and 
recrystallized five times out of acetone.   
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3.5.8 Cluster Characterization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B4. 11B NMR spectrum of closo-B12(OH12) in D2O at 298 K. 
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Figure B5. 1H NMR spectrum of closo-B12(OH12) in D2O at 298 K. 
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Figure B6. 11B NMR spectrum of B12(OCH2Ph)12 (1a) in CDCl3 at 298 K. 
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Figure B7. 13C NMR spectrum of B12(OCH2Ph)12 (1a) in CDCl3 at 298 K. 
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Figure B8. 1H NMR spectrum of B12(OCH2Ph)12 (1a) in CDCl3 at 298 K. 
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Figure B9. 11B NMR spectrum of B12(OCH2C6F5)12 (1b) in CDCl3 at 298 K. 
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Figure B10. 1H NMR spectrum of B12(OCH2C6F5)12  (1b) in CDCl3 at 298 K. 
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Figure B11. 13C NMR spectrum of B12(OCH2C6F5)12 (1b) in CDCl3 at 298 K. 
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Figure B12. 19F NMR spectrum of B12(OCH2C6F5)12 (1b) in CDCl3 at 298 K. 
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Figure B13. HRMS spectrum of B12(OCH2C6F5)12 (1b). 
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Figure B14. HRMS spectrum of B12(OCH2C6F5)12 (1b). 
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Figure B15. 1H NMR spectrum of 2,4,6-tri(p-tolyl)pyrylium tetrafluoroborate in CDCl3 at 298 
K. 
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3.5.9 Polymer Characterization 
 
 
Figure B16. GPC trace from polymerization of 2a treated with 0.5 mol% 1a for two days. 
Calculated yield after precipitation is 71%. Smaller peak has a reported Mn value of 31.1 kDa and 
a dispersity of 1.1. GPC performed in chloroform. 
 
 
 
Figure B17. GPC trace overlay of a 2M solution of 2a in CH2Cl2 treated with 0.5 mol% of 1a. 
GPC performed in THF. 
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Figure B18. GPC trace overlay of polystyrene from experiments treating styrene (2b) with varying 
concentrations of 1b. GPC performed in THF. 
 
 
 
 
Figure B19. GPC trace overlay of styrene (2b) polymerization experiments varying concentrations 
of methanol to 1b under optimized conditions. GPC performed in THF. 
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3.5.9.1 Polymerization of 4-methoxystyrene (2a) 
 
 
Figure B20. GPC trace overlay of poly-(4-methoxystyrene) generated using 1b as initiator. GPC 
performed in DMF. 
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Figure B21. 1H NMR spectrum of poly-(4-methoxystyrene) in CDCl3 at 298 K. 
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3.5.9.2 Polymerization of styrene (2b) 
 
 
Figure B19. GPC trace overlay of polystyrene. GPC performed in CHCl3. 
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Figure B20. 1H NMR spectrum of polystyrene in CDCl3 at 298 K. 
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Figure B21. 1H NMR spectrum of polystyrene in CDCl3 at 298 K indicating the potential presence 
of a proton attached onto the end of the polymer. 
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Figure B22. 11B NMR spectrum of purified polystyrene synthesized utilizing optimized reaction 
conditions which shows that 1b is not attaching to the polymer. Additional ICP-MS analysis on a 
polystyrene sample generated using 1b determined that it contains 0.003% of boron by mass.  
 
 
 
Figure B23. 19F NMR spectrum of purified polystyrene synthesized utilizing optimized reaction 
conditions which shows that 1b is not attaching to the polymer. 
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Figure B24. TGA analysis of 3.3 mg sample of polystyrene. Temperature ramping from 25 °C to 
500 °C at 15 °C/min.  
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3.5.9.3 Polymerization of 4-methylstyrene (2c) 
 
 
 
Figure B25. GPC trace overlay of poly-(4-methylstyrene). 
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Figure B26. 1H NMR spectrum of poly-(4-methylstyrene) in CDCl3 at 298 K. 
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3.5.9.4 Polymerization of 4-tert-butylstyrene (2d) 
 
 
Figure B27. GPC trace of poly-(4-tert-butylstyrene). GPC performed in THF. 
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Figure B28. 1H NMR spectrum of poly-(4-tert-butylstyrene) in CDCl3 at 298 K. 
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3.5.9.5 Polymerization of 4-fluorostyrene (2e) 
 
 
 
Figure B29. GPC trace overlay of poly-(4-fluorostyrene). GPC performed in CHCl3. 
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Figure B30. 1H NMR spectrum of poly-(4-fluorostyrene) in CDCl3 at 298 K. 
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3.5.9.6 Polymerization of 4-chlorostyrene (2f) 
 
 
 
Figure B31. GPC trace overlay of poly-(4-chlorostyrene). GPC performed in CHCl3. 
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Figure B32. 1H NMR spectrum of poly-(4-chlorostyrene) in CDCl3 at 298 K. 
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3.5.9.7 Polymerization of 3-chlorostyrene (2g) 
 
 
 
 
Figure B33. GPC trace overlay of poly-(3-chlorostyrene). GPC performed in CHCl3. 
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Figure B34. 1H NMR spectrum of poly-(3-chlorostyrene) in CDCl3 at 298 K. 
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3.5.9.8 Polymerization of 2,6-difluorostyrene (2h) 
 
 
 
Figure B35. GPC trace overlay of poly-(2,6-difluorostyrene). GPC performed in CHCl3. 
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Figure B36. 1H NMR spectrum of poly-(2,6-difluorostyrene) in CDCl3 at 298 K. 
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3.5.9.9 Polymerization of 2,4,6-trimethylstyrene (2i) 
 
 
 
 
Figure B37. GPC trace overlay of poly-(2,4,6-trimethylstyrene). GPC performed in CHCl3. 
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Figure B38. 1H NMR spectrum of poly-(2,4,6-trimethylstyrene) in CDCl3 at 298 K. Signal next 
to 1b due to residual CH2Cl2. 
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3.5.9.10 Polymerization of isobutylene 
 
 
Figure B39. GPC trace of poly(isobutylene). GPC performed in THF. 
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Figure B40. 1H NMR spectrum of poly(isobutylene) in CDCl3 at 298 K. 
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Figure B41. 13C NMR of poly(isobutylene) in CDCl3 at 298K. 
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Figure B42. GPC trace overlay of optimized styrene reaction utilizing 1b in benzene. GPC 
performed in CHCl3. 
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Monomer Yield    Mn (kDa) Ð 
4-methoxystyrene  97%             198 1.7 
Styrene  96% 9.9 2.3 
4-methylstyrene  96% 21.2 5.8 
4-tert-butylstyrene  85% 9.7 2.4 
4-fluorostyrene  99% 170 2.4 
4-chlorostyrene  94% 227 3.2 
3-chlorostyrene  41% 6.2 2.2 
2,6-difluorostyrene  28% 10.0 1.6 
2,4,6-trimethylstyrene  98% 79.6 2.6 
Isobutylene <10% 458 Da 1.2 
4-fluorostyrene  21% 16.8 1.7 
4-chlorostyrene  24% 9.7 1.7 
4-methylstyrene  32% 31.7 2.1 
Styrene  34% 5.3 1.7 
 
Table B1. Polymer yields, Mn and Ð (averaged over two runs) of polymerizations. Polymerizations 
of monomers in bold were prepared in ambient conditions utilizing optimized conditions (2M 
[monomer] in CH2Cl2 with 0.1 mol% 1b and not passed through activated basic alumina.  
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Figure B43. Conversion of optimized styrene polymerization utilizing 1b. Time points taken every 
two minutes. 
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Figure B44. Conversion, Mn (Squares), and Ɖ (Triangles) of optimized styrene polymerization 
utilizing 1b (Same experiment as shown in Figure B29). The high Mn (21.9 kDa) at 20% 
conversion (2 minutes) followed by the drop in Mn at 80% conversion is unusual but can best be 
explained by the higher amount of termination events as conversion increases—there are a larger 
amount of shorter polymer chains as conversion increases. 
 
Figure B45. GPC trace overlay of optimized styrene polymerization utilizing 1b with aliquots 
taken every two minutes (Same Experiment as Figure B43 and B44). 
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Figure B46. Polymerization of styrene under optimized conditions utilizing 1b with light “on” 
and “off” cycling.   
 
 
 
Figure B47. Solvent screen (single run) for the polymerization of styrene (2b) in the presence of 
1b with accompanying yield, dispersity, and molecular weight data. 
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3.5.10 Theoretical Studies: 
 
3.5.10.1 Methods 
The geometry optimizations of the ground states of the neutral molecules were performed using 
Turbomole,2 and the Density Functional Theory (DFT) B3LYP method,3 with the def2-SVP4,5 
basis set. Initial coordinates were adopted from the single crystal X-ray structures of 1a and 1b.  
In order to access the energies of the unoccupied molecular orbitals (MOs) and to calculate the 
electronic absorption spectra, the time-dependent DFT (TD-DFT)5,6 formalism was using with the 
same choice for the functional and basis set. Gaussian 097 was used for these calculations. 
GaussView8 was used for visualization. 
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3.5.10.2 Computational results 
Initiator structures. Figure 1 shows the optimized structures for 1a and 1b, and the MOs relevant 
to the discussion below. One may notice the oblong shapes of the optimized structures, deviating 
significantly from the Ih symmetry generally dictated by the B12 core. 
 
 
Figure B48. Optimized structures of the 1a (left) and 1b (right, fluorine atoms omitted for clarity) 
and the MOs relevant to the proposed photocatalytic mechanism.  (Fig. 1, Left) a. Calculated 
structure, b. HOMO-15, c. HOMO, d. LUMO. (Fig1b) a. Calculated structure, b. HOMO-27, c. 
HOMO, d. LUMO. 
Theoretical electronic spectra  
The theoretical electronic spectra of 1a and 1b computed with TD-DFT, as described above, are 
shown in Tables B3 and B4, and the most relevant features are given in Tables B3-1 and B3-2 (see 
below). In both molecules, the HOMO to LUMO transition, and a few other transitions involving 
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the orbitals near the HOMO were found to have near-zero oscillator strengths (i.e. being loosely 
forbidden). There are very few bright transitions, which is surprising, considering the high density 
of states. For 1b, the experimentally observed feature at 454 nm was assigned to the promotion of 
an electron from the HOMO-27 to the LUMO (both MOs are shown in Figure B40, right). The 
computed excitation energy was 474.07 nm (455.36 nm at M06), in a good agreement with the 
experiment. The HOMO-27 is the MO delocalized over the system and mainly localized on the 
pentafluorophenyl substituents and B-O bonds. The LUMO, on the other hand, is the MO 
belonging almost exclusively to the B12 core. Thus, the excitation corresponds to a 
pentafluorophenyl-to-boron cage charge transfer. For 1a, the bright excitation involves electron 
transfer from the HOMO-15 to the LUMO (Figure B40, left). These MOs are very similar to those 
involved in the transition in 1b. The process is again a ring-to-boron cage charge transfer. 
Interestingly, the calculated absorption maximum is hypsochromically shifted compared to 1b. It 
is important to note that the donor orbital in 1a, the HOMO-15, is significantly higher in energy 
than that of the HOMO-27 in 1b. This is consistent with the reactivity of 1b with a wider range of 
substrates than 1a. Overall, computational characterization of the molecular and electronic 
structure of the photoinitiators agrees well with the experimental results, giving confidence in the 
performance of DFT calculations for these systems, and in theory-substantiated mechanism. 
Table B3-1. TD-DFT results (at B3LYP/def2-SVP). 
Initiator Experimental 
Absorption 
(nm) 
TD-DFT 
Absorption 
(nm) 
Excitation 
Energy (eV) 
Transition 
MOs 
Energy of 
LUMO (eV) 
Energy of 
Vacancy 
(eV) 
1b 454 474.07 2.6153 HOMO-
27LUMO 
-5.310 -7.925 
1a 470 468.17 2.6482 HOMO-
15LUMO 
-4.125 -6.773 
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Table B3-2. TD-DFT results (at M06/def2-SVP). 
Initiator Experimental 
Absorption 
(nm) 
TD-DFT 
Absorption 
(nm) 
Excitation 
Energy (eV) 
Transition 
MOs 
Energy of 
LUMO (eV) 
Energy of 
Vacancy 
(eV) 
1b 454 455.36 2.7228 HOMO-
27LUMO 
-5.711 -8.434 
1a 470 452.66 2.7390 HOMO-
15LUMO 
-4.485 -7.224 
 
Polymerization mechanism. Experimentally, the initiator is irradiated with blue LED light at 450 
nm in the presence of monomer. In order to rule out the possibility of the styrene molecule 
undergoing the excitation at this wavelength, we calculated its absorption spectrum and found that 
the lowest energy bright excitation would occur at much higher energies, significantly blue-shifted 
from the 450 nm light source. Additionally, if styrene excitation initiated the polymerization, the 
reaction would proceed in the absence of 1a or 1b.  This control experiment was performed and, 
as expected, no polymer was observed. Therefore, we hypothesize that the mechanism of initiation 
involves the electronic photo-excitation of the initiator 1a/1b, resulting in the creation of a low-
lying vacancy in the valence MO manifold. The hole then accepts an electron from the HOMO of 
the styrene monomer, producing the stable radical anion of 1a/1b; the styrene radical-cation then 
propagates to form polymer. This oxidation process is energetically favorable, and contributes to 
the driving force behind electron transfer to the initiator. 
Initiator tuning. Since the proposed mechanism involves hole generation in a low-lying ring-based 
orbital on the initiator, followed by electron transfer from the styrene monomer to that hole, the 
critical component of the catalytic functional is the proper positioning of the hole with respect to 
the HOMO of the monomer. Thus, the MO of the initiator from which the initial excitation occurs 
is the one to be tuned through the nature of the ligands in order to provide a good match for the 
HOMO of the monomer of interest. The nature and energy of the LUMO of the initiator is less 
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easily manipulated, since the LUMO is centered on the B12 core. Therefore, when the donor orbital 
is modulated in energy, the excitation energy will shift, possibly requiring a different light source 
to initiate the reaction.  
Initiators 1a and 1b, as well as representative styrenes, were examined to further investigate this 
design opportunity. Four styrene derivatives were considered: 4-methoxystyrene (2a), styrene 
(2b), 4-methylstyrene (2c) and 4-fluorostyrene (2e). These molecules differ in the energies of the 
HOMO (Figure B41). All of the four styrene derivatives could be polymerized in the presence of 
1b under blue LED irradiation under the same conditions. With 1a, under the same conditions, 2a 
was polymerized, albeit in low yields. We compared the energy levels of the substrates and 
photoinitiators, and found a reasonable explanation:  the HOMO energy of styrene and its 
derivatives decreases as follows: 2a > 2c > 2e >2b, spreading over ca 0.5 eV, whereas the energy 
of vacancy site of 1b and 1a differ by ca. 1.2 eV. Therefore, the driving force for monomer 
oxidation should decrease in the order of 2a, 2c, 2e, 2b, and the electron affinity of the hole is 
higher in 1b than in 1a. Hence, only the monomer with the highest HOMO energy, 2a, could 
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transfer an electron to vacancy site in 1a, while for 1b all four substrates are polymerized 
efficiently. 
 
 
Figure B49. Depiction of the relative energy levels of initiators 1a and 1b with respect to the 
HOMO levels of monomers 2a, 2b, 2c, 2e.  The schematic shows forbidden electronic transitions 
within the cluster core for both 1a and 1b, as well as the allowed (and experimentally measured) 
transitions (454nm and 470nm, 1b and 1a, respectively) from low-lying HOMO levels to a cluster-
based LUMOs that give rise to monomer oxidation. 
Energy calculations for relevant molecular orbitals in 1a, 1b, and monomers 2a, 2b, 2c, and 2e 
using both B3LYP/def2-SVP and M06/def2-SVP. 
M06_1a 
Ground State MO: 
MO#357 eigenvalue = -.2654934 H =  -7.224 eV  
HOMO#372 eigenvalue = -.2255475 H =  -6.137 eV 
B3LYP_1a 
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Ground State MO: 
MO#357 eigenvalue = -0.248912 H =  -6.77324eV 
HOMO#372 eigenvalue = -0.208523 H =  -5.674 eV 
M06_2a, 2b, 2c, 2e 
Ground State MO: 
2a HOMO: -0.223699 H =  -6.087 eV 
2b  HOMO: -0.235116 H =  -6.398 eV 
2c  HOMO: -0.241813 H =  -6.580 eV 
2e  HOMO: -0.243277 H =  -6.620 eV 
B3LYP_2a, 2b, 2c, 2e 
Ground State MO: 
2a HOMO: -0.206900 H =  -5.630 eV 
2b HOMO: -0.219830 H =  -5.982 eV 
2c HOMO: -0.227429 H =  -6.189 eV 
2e HOMO: -0.227245 H =  -6.184 eV 
B3LYP_1b 
Ground State MO: 
MO#583 eigenvalue=-.3006032 H =  -8.180eV  
MO#584 eigenvalue=-.2993478 H =  -8.146eV 
MO#585 eigenvalue=-.2912243 H =  -7.925eV 
MO#586 eigenvalue=-.2901954 H =  -7.897eV 
HOMO#612 eigenvalue=-0.245620 H =  -6.684 eV 
M06_1b 
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Ground State MO: 
MO#583 eigenvalue=-.3197782 H = -8.702 eV 
MO#584 eigenvalue=-.3175671 H = -8.641 eV 
MO#585 eigenvalue=-.3099336 H = -8.434 eV 
MO#586 eigenvalue=-.3086511 H = -8.399 eV 
HOMO#612 eigenvalue=-.2617867 H = -7.124 eV 
Full Calculated Electronic Spectrum: 
Two different computational analyses were performed to calculate additional probable transitions 
within initiators 1a and 1b.  As shown above, the results using either B3LYP or M06 functionals 
with the def2-SVP basis set closely reproduced relevant excitations to monomer initiation. 
Table B3. Probable electronic transitions within 1a and 1b using B3LYP/def2-SVP. 
 1a (B3LYP / def2-SVP)  
 Excitation Energy / eV Absorption / nm 
Transition 
Probability 
Excited State 4 2.2742 545.18 0.0138 
Excited State 5 2.2754 544.9 0.0138 
Excited State 10 2.4149 513.42 0.069 
Excited State 16 2.5821 480.16 0.0428 
Excited State 17 2.5825 480.09 0.0428 
Excited State 18 2.6482 468.17 0.1275 
Excited State 27 2.7279 454.5 0.0381 
Excited State 28 2.7287 454.38 0.0382 
Excited State 36 3.634 341.18 0.2726 
Excited State 37 3.8708 320.3 0.0225 
Excited State 38 3.872 320.21 0.0228 
    
 1b (B3LYP/ def2-SVP)  
 Excitation Energy / eV Absorption / nm 
Transition 
Probability 
Excited State 23 2.2506 550.89 0.0206 
Excited State 26 2.4187 512.6 0.016 
Excited State 28 2.5084 494.28 0.0986 
Excited State 29  2.5713 482.18 0.0722 
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Excited State 30 2.6153 474.07 0.1576 
Excited State 32 3.0214 410.36 0.0122 
Excited State 34 3.361 368.89 0.0653 
Excited State 35 3.3707 367.83 0.0844 
Excited State 37 3.6992 335.17 0.0312 
Excited State 38 3.7377 331.71 0.0485 
 
 
Table B4. Probable transitions in 1a and 1b computed using M06/def2-SVP. 
 1a (M06 / def2-SVP)  
 Excitation Energy / eV Absorption / nm 
Transition 
Probability 
Excited State 4 2.3628 524.74 0.0131 
Excited State 5 2.3649 524.26 0.013 
Excited State 10 2.51 493.95 0.0851 
Excited State 16 2.6625 465.67 0.0529 
Excited State 17 2.6635 465.49 0.053 
Excited State 18 2.739 452.66 0.1235 
Excited State 26 2.8195 439.73 0.0248 
Excited State 27 2.8201 439.65 0.0249 
Excited State 36 3.7614 329.62 0.2485 
Excited State 37 3.9588 313.19 0.0221 
Excited State 38 3.9597 313.12 0.0221 
    
 1b (M06 / def2-SVP)  
 Excitation Energy / eV Absorption / nm 
Transition 
Probability 
Excited State 12 2.0612 601.5 0.0751 
Excited State 18 2.2581 549.07 0.0456 
Excited State 28 2.6378 470.03 0.0431 
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Excited State 29  2.6388 469.85 0.0434 
Excited State 30 2.7228 455.36 0.1733 
Excited State 36 3.5637 347.91 0.0158 
Excited State 37 3.7697 328.9 0.0454 
Excited State 38 3.7718 328.71 0.0454 
 
3.5.11 Fluorescence Spectroscopy: 
Steady-state fluorescence profiles were obtained with 457.9 nm excitation (Coherent Innova 70 
argon-ion laser). Luminescence was collected using an optical fiber optic and directed to a Melles 
Griot 13 FOS 200 spectrometer. A 457.9 nm long-pass cutoff filter was used to reject excitation 
light. 
Fluorescence decay measurements were performed as previously described.9,10 Briefly, a mode-
locked Nd:YAG laser (Vanguard 2000-HM532; Spectra-Physic) generated ~10ps pulses which 
were then regeneratively amplified (Continuum) and frequency tripled to produce 355 nm sample 
excitation. Fluorescence was collected with a single lens and focused tonto the entrance slit of a 
spectrograph (Acton Research Corp SpectraPro 275). A 355 nm dielectric mirror was placed 
before the slit of the spectrograph to reject scattered excitation light. We observed fluorescence in 
two different wavelength regions:  spectrograph center wavelengths of 420 or 600 nm were chosen 
to characterize the decay kinetics of the two fluorophores. Fluorescence decays were collected 
using a streak camera (C5680; Hamamatsu Photonics) in photon counting mode over a 50 ns 
window. 
Based on 1H, 13C, and 19F NMR studies, 1b is the only observable species in solution, so it is likely 
that both observed emissions are associated with neutral 1b.  The first (420 nm) emission likely 
arises from the excitation of the perfluoroaromatic rings situated on the periphery of the cluster; 
the strong emission and longer lifetime (~4ns) are consistent with that of fluorinated aromatic 
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systems.11 The second, weaker emission at 600 nm, which exhibited solvent-dependent intensity 
and lifetime, may be associated with the cluster core. 
The reduction potential of photo-excited 1b was approximated12 using in Eq. 1, 
𝐸𝑟𝑒𝑑
∗ 0 =  𝐸𝑟𝑒𝑑
0 +  𝐸0,0 (1) 
 
where 𝐸𝑟𝑒𝑑
0 represents the ground state 0/1- redox couple of 1b and 𝐸0,0 represents the wavelength 
of the onset of fluorescence (550 nm). Redox values are initially calculated based on the Fc/Fc+ 
reference and converted to SCE based on values reported by Connelly and Geiger,13 where the 
formal potential of Fc/Fc+ referenced to SCE in CH3CN with [NBu4][PF6] as the supporting 
electrolyte is 0.40 V. 
 
 
Figure B50. Fluorescence of 1b in various solvents. Emission maximum is at 600 nm. Acquisition 
time was 1 s for 1,2-difluorobenzene and 2.5 s for all others. 
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Figure B51. Fluorescence decay and fit at 420 nm for 1b in C6H6. Single exponential fit gave a 
lifetime of 5 ns.  
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Figure B52. Fluorescence decay of 1b in C6H6 at 420 nm fit to a double exponential. Lifetimes of 
the two species are 4 and 40 ns. 
 
Figure B53. Fluorescence decay of 1b in 1,2-dichlorobenzene at 600 nm. Single exponential fit 
gave a lifetime of 380 ps. 
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Figure B54. Fluorescence decay of 1b in acetonitrile at 600 nm. Single exponential fit gave a 
lifetime of 110 ps. 
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Chapter 4 
Carborane RAFT Agents as Tunable and Functional Molecular 
Probes for Polymer Materials 
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4.1 Introduction 
There exist myriad molecular tools employed at the interface of polymer chemistry and 
biology to help elucidate the structure and/or functions of molecules. These tools come in the form 
of small molecule probes, affinity labels, and spectroscopic handles frequently applied to polymer 
chain ends.1–10 Conjugation of such tools to polymer end groups is typically performed through 
rational design of polymer initiators or chain transfer agents, which are retained on the ends of 
polymers made from controlled polymerization processes.11–19 Specifically, RAFT polymerization 
is a versatile method used to obtain polymers of uniform molecular weight.20–23 This method has 
gained widespread attention due to its broad monomer scope, solvent compatibility, and ease of 
constructing well-defined macromolecular architectures, such as block co-polymers and brush 
polymers.22,24 Key to this method is the use of the RAFT agent (Figure 4-1).25–28 
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Figure 4-1. (A) Structures of frequently utilized chain transfer agents in RAFT polymerization. 
(B) Introduction of carborane RAFT agents as multi-purpose functional molecular probes and 
affinity label. 
The RAFT agent confers control over polymerization processes through a reversible radical 
chain transfer reaction to and from the thiocarbonyl moiety. By greatly reducing the amount of 
active radicals capable of polymerization, thereby decreasing unwanted termination pathways, 
polymers with narrow molecular weight distributions are formed.26,27 RAFT agents are comprised 
of thiocarbonylthio compounds, common classes of which include dithioesters, xanthates, 
trithiocarbonates, and dithiocarbamates (Figure 4-1 A).26,27,29 The RAFT agent structure can be 
conceptually split into two parts wherein the “Z” group modulates the rates of addition and 
fragmentation during reversible chain transfer on the thiocarbonyl carbon and determines the 
stability of the intermediate radical, and the “R” group functions to re-initiate polymerization of 
another monomer upon homolytic cleavage from the RAFT agent structure (Figure 4-1 A).26,30 
Both the R and Z groups are incorporated on the polymer chain end upon termination. As a result, 
the structure of the RAFT agent is often tailored to serve as a functional handle and/or probe for 
characterization.2,5,31,32 Some examples of functional handles include the use of carboxylic acid, 
succimidyl ester, azide, maleimide, aminooxy, or pyridyl disulfide functionalized RAFT agents, 
which serve as conjugation sites for molecular cargo such as fluorescence tags, affinity labels, and 
biomolecules.2,7,14,15,33–42 Trimethylsilyl (TMS) substituted RAFT agents have also served as 
spectroscopic handles in the determination of polymer molecular weight via 1H NMR 
spectroscopy.5  
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While these functional RAFT agents are able to perform one or two tasks, tunable and 
stable RAFT agents capable of performing multiple tasks simultaneously while retaining 
modularity are rare. We envisaged ortho-carborane functionalized RAFT agents as being ideally 
suited to interface many different applications through their ability to act as spectroscopic probes, 
easily modifiable molecular conjugation sites, and as affinity labels. Icosahedral carboranes 
(C2B10H12) are boron-rich molecules which exhibit 3-dimensional (3D) electron delocalization 
non-uniformly due to the addition of carbon atoms within the cluster.43,44 Carboranes are highly 
tunable, boasting multiple B–H vertices which are amenable to functionalization with a wide array 
of substituents through well-established methodology.45–52 Due to the unique electronic character 
of ortho-carborane, substituents attached to boron at the vertices most distal to the carbon atoms 
experience a strong electronic shielding effect which results in a low chemical shift (methyl C–H 
≈ 0.2 ppm) in the 1H NMR spectrum (Figure 4-1 B).52–54 The hydrophobic nature of carboranes 
allows them to bind into hydrophobic spaces within proteins and cell membranes, adding potential 
for their use as affinity labels.55–58 Additionally, the B–H vibration resonates at ∼2350–2600 cm−1, 
a silent region in Raman spectra of biological milieu, and unique amongst other commonly used 
Raman tags, such as alkynes and nitriles, which vibrate at ∼2000–2300 cm−1 (Figure 4-1 B).59 
Herein, we present a new class of functional RAFT agents containing an ortho-carborane scaffold. 
We demonstrate their ability to serve as tunable Raman active molecular probes (Figure 4-1 B), 
spectroscopic handles for determination of molecular weight via 1H NMR spectroscopy, and as 
affinity labels through β-cyclodextrin binding as judged by isothermal titration calorimetry (ITC) 
studies. 
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4.2 Results and Discussion 
4.2.1 Synthesis of RAFT Agents, Polymerization, and their use as 1H NMR Spectroscopy 
Handles 
 
 
Figure 4-2. (A) Synthetic scheme for the preparation of carborane RAFT agents 1 and 2. (B) Solid-
state crystal structure of 1, hydrogen atoms omitted for clarity. 
We developed a facile and scalable synthetic method towards carborane-functionalized 
RAFT agents (Figure 4-2 A). Treatment of a lithiated o-carborane slurry in tetrahydrofuran (THF) 
with carbon disulfide (CS2) at 0 °C resulted in the formation of a dark red mixture indicating the 
formation of a sulfide anion which was trapped upon addition of 1-chloro-1-phenylethane to form 
1 (Figure 4-2 A). Following column chromatography and crystallization from a saturated solution 
of CH2Cl2 layered with pentane, 1 was isolated as an orange crystalline solid in 60% yield. Single 
crystals of 1 were grown and subjected to X-ray crystallographic analysis confirming the structural 
identity of this compound (Figure 4-2 B). We employed 1 in our preliminary polymerization 
attempts using styrene as the model substrate due to the monomer similarity with the R-group of 
1 (Figure 4-3 A).26  
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Figure 4-3. (A) Thermal polymerization of styrene utilizing either 1 (produces polymer 1-PS) or 
2 (produces polymer 2-PS) as the RAFT agent. (B) Kinetic analysis for 1-PS polymerization 
exhibits first-order kinetics. (C) Evolution of Mn as a function of monomer conversion for 1-PS 
polymerization. (D) Table comparing molecular weight determined by 1H NMR spectroscopy and 
GPC of polymerizations using 1 as the RAFT agent to produce 1-PS or 2 to produce 2-PS. 
Polymerization performed in bulk styrene solution. (E) GPC curves of 2-PS depicting experiments 
performed with different equivalents of monomer to CTA (red and black traces) as well as a control 
in which no CTA is added (blue trace). Polymerization was carried out in bulk styrene solution 
and stopped after 4 hours. 
Polymerization of styrene using 2,2′-azobisisobutyronitrile (AIBN) as the thermal initiator 
and 1 resulted in nearly monodisperse (Đ = 1.07–1.15) polystyrene (1-PS), as determined by gel 
permeation chromatography (GPC), the length of which was controlled by varying the loading of 
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1 (Figure 4-3 A, see Figure C11 for GPC traces). Polymerization using 1 exhibits first order 
kinetics and a linear evolution of number average molecular weight (Mn) versus conversion, 
highlighting the controlled nature of the polymerization and demonstrating the utility of carborane-
based CTAs in RAFT processes (Figure 4-3 B and C). Control experiments in the absence of 1 
resulted in highly disperse (Đ = 3.00) polymers indicating loss of control over the polymerization 
process as expected (see Figure C11). The cage C–H proton of 1 exhibits a diagnostic chemical 
shift (∼4.8 ppm, Figure 3 A) which does not overlap with any polystyrene 1H NMR resonances. 
To investigate the potential usefulness of carboranes to act as spectroscopic probes to accurately 
determine Mn, we used this highly diagnostic resonance to determine the Mn via end-group analysis 
using 1H NMR spectroscopy. Integration of the carborane C–H proton with the aryl protons of 
polystyrene resulted in Mn readings which deviated drastically with the Mn values determined by 
GPC with a multi-angle light scattering (MALS) detector (Figure 4-3 D, see Appendix C for dn/dc 
values). It is possible to lose the carborane due to its location at the Z group, which would also 
increase the apparent molecular weight by NMR. However we were unable to find appropriate 
synthetic conditions to place the carborane at the R group (data not shown). But more likely this 
deviation is due to the inherent broadness of the carborane cage C–H proton resonance which leads 
to a higher inaccuracy in Mn determination as the polymer length increases, as is typical for most 
end groups used for end-group analysis (Figure 4-3 D, 1-PS; Figure C12). Additionally, the 
resonance at 4.8 ppm is not located in a generally silent region in most polymer samples, which 
would eliminate its use as a spectroscopic handle for other types of polymers.  
To bypass these complications, we synthesized a carborane derivative bearing methyl 
groups on the B(9) and B(12) vertices (opposite to those of the carbon atoms) to take advantage of 
the electronic shielding effect of substituents attached on the B(9) and B(12) vertices, which results 
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in upfield chemical shifts of exohedral methyl proton resonances in 1H NMR spectra and sharper 
signals.52,53,60 Synthesis of 2 was carried out in a similar manner to that of 1 (Figure 2 A). 
Compound 2 was isolated as a dark orange oil in 69% yield after purification via column 
chromatography and removal of the benzyl chloride precursor by heating under reduced pressure 
(100 mTorr, 95 °C; Figure 4-2 A; see Appendix C for detailed synthetic procedures). Indeed, the 
proton signals of the B(9) and B(12) methyl substituents resonate in a characteristic region of the 
1H NMR spectrum (∼0.2 ppm, see Appendix C). This provides a unique spectroscopic handle as 
the protons are sufficiently separated from resonances, which may overlap and make for inaccurate 
Mn determination via end-group analysis.  
Polymerization of a bulk solution of styrene in the presence of 2 and AIBN produced well-
defined (Đ = 1.08, Figure 4-3 D and E) polystyrene (2-PS) bearing 2 on the chain end as 
determined by 1H NMR after polymer purification via precipitation from a cold (0 °C) methanol 
solution (see Appendix C for characterization of all polymers). To test the accuracy of this method, 
we made polystyrene using different equivalents of 2 (2.45 and 4.35 kDa, Figure 4-3 D and E), 
determined their Mn values via end-group analysis using 
1H NMR spectroscopy, and compared the 
results with those of molecular weight readings measured via GPC. In all instances, the Mn values 
measured with GPC matched closely with the molecular weight determined by 1H NMR 
spectroscopy (Figure 4-3 D, E, see Figure C14, C16, C19, and C22 for example of calculations).  
We next sought to determine the applicability of 2 with a range of monomers. Matching 
the “R” and “Z” groups of the RAFT agent to the monomer is vital for controlled RAFT 
polymerization. As this is the first example of a carborane RAFT agent, we sought to match the 
R-group with the appropriate monomer classes. We tested N-isopropyl acrylamide, methyl 
acrylate, and 4-chlorostyrene monomers since the reactivity of the benzyl R-group on 2 matches 
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with those monomers.26 Polymerization of 4-chlorostyrene and N-isopropyl acrylamide under 
thermal polymerization conditions in the presence of 2 and AIBN produced polymers with narrow 
molecular weight distributions, but with high molecular weight shoulders in the GPC spectra, 
indicating some polymer coupling (2-pNIPAAm and 2-(4-Cl)-PS, Figure 4-4A and B).  
 
Figure 4-4. (A) Polymerization of methyl acrylate, 4-chlorostyrene, and N-isopropylacrylamide. 
(B) GPC traces for 2-pNIPAAm, 2-(4-Cl)-PS, and 2-PMA at different monomer to CTA ratios. 
(C) Table depicting results from polymerization experiments performed in bulk reaction conditions 
and in solvent. aPolymerizations were performed in 2 M solvent conditions. bTheoretical Mn values 
were calculated via 1H NMR using tetralin as an internal standard. 
Polymerization of methyl acrylate produced monodisperse polymers containing 2 on the 
polymer chain ends (2-PMA, Figure 4-4 A–C and Figure C25). The Mn determined by 1H NMR 
spectroscopy matches closely with the Mn determined by GPC for a range of polymer sizes (Figure 
4-4 B and C). Impressively, the methyl C–H protons on carborane are readily visible on the 1H 
NMR spectrum and are competent spectroscopic handles to accurately determine Mn even at 
polymer molecular weights up to 30 kDa (Figure 4-4 C, entry 9, and Figure C21). It should be 
noted that we observe a significant disagreement between the theoretical and observed polymer 
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Mn values for 2-(4-Cl)-PS and 2-PMA when polymerized in bulk reaction conditions (Figure 4-4 
C, entries 4–9), yet the dispersities remain narrow. This is also apparent in bulk polymer kinetic 
experiments, which indicate a loss of control over the course of the polymerization (Figure C32). 
The disagreement between theoretical and observed Mn values with maintenance of low molecular 
weight dispersity has been observed in previous reports detailing the RAFT polymerization of 
acrylamides.61,62 However, we find that polymerization in solvent (2 M) leads to better agreement 
between both theoretical and observed Mn values for 2-PMA (Figure 4-4, entries 10–14). Control 
is also maintained over the course of polymerization in solvent in the kinetic plots (Figure C34 
and C35). This demonstrates that for these monomers the polymerization should be conducted in 
solution rather than the bulk phase.  
 
Figure 4-5. (A) Modification of carborane dithioester end-group of pNIPAAm. The end-group 
can either be removed via aminolysis and end-capping or the formation of nido-carborane can be 
achieved via deboronation of carborane using a 0.05 M solution of TBAF in THF. (B) The end-
group modification can be followed by UV-Vis spectroscopy. The disappearance of the absorption 
band at 319 nm indicates the loss of the dithioester. Formation of an absorption band at 375 nm 
along with a shift in the absorption of the dithioester indicates deboronation of carborane.   
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The dithioester carborane end-group allows for a high degree of end-group functionality 
and tunability and can be easily removed or modified after polymerization.32,63,64 We prepared 
pNIPAAm derivatives in which the carborane end-group was removed or deboronated (vide infra) 
to serve as controls for binding studies and to also investigate the properties invoked by having a 
nido-carborane terminated polymer. The carborane end-group of 2-pNIPAAm was removed via 
aminolysis, thereby leaving an exposed thiol at the polymer end.63 Despite our use of 
tributylphosphine to eliminate disulfide formation over the course of the deprotection reaction, we 
observed polymer coupling by GPC analysis (Figure C36).65 In order to avoid disulfide formation, 
we introduced 2-hydroxyethylacrylate which undergoes Michael addition with the exposed thiol 
thereby attaching onto the end of the polymer and preventing polymer coupling (Figure 4-5 A).66 
The deprotection reaction was monitored via UV-Vis spectroscopy by the disappearance of the 
dithioester absorption band at ∼319 nm (Figure 4-5 B). Complete removal of the carborane end-
group could also be visualized by 1H NMR spectroscopy after polymer purification by the 
disappearance of the carborane methyl proton signals at 0.2 ppm.  
Deboronation is the partial degradation of the carborane cage where one of the cage boron 
atoms is stripped away through the use of a strong base. This leads to the formation of an anionic 
nido-carborane species [7,8-C2B9H12]
−.67 Having the monoanionic nido-carborane at the polymer 
end lends potential to interesting self-assembly properties as the polymer is rendered amphiphilic. 
Additionally, nido-carborane is used frequently to bind metal ions thereby forming 
metallacarboranes.68,69 One can envisage the binding of metal ions in this system to synthesize 
block co-polymers and other higher order macromolecular architectures.70 Preparation of nido-
carborane terminated pNIPAAm (nido-2-pNIPAAm) was carried out by stirring 2-pNIPAAm in 
a solution of 0.05 M tetrabutylammonium fluoride (TBAF) in THF (Figure 4-5 A).71 We were 
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unable to follow deboronation by 11B NMR or 13C NMR due to the large size of the polymer 
relative to the carborane endgroup. However, over the course of the reaction we noticed a 
diagnostic resonance corresponding to the formed hydride in the 1H NMR spectrum at -2.1 ppm 
(Figure C38). We also followed deboronation by the appearance of a new UV band at ∼375 nm as 
well as a shift of the dithioester absorption band (Figure 4-5 B). 
4.2.2 Binding studies with polymers terminated with functional carborane handles 
Affinity tags such as biotin are frequently exploited within the chemical biology 
community in purification and detection strategies such as in tandem orthogonal proteolysis-
activity based protein profiling (TOP-ABPP) and enzyme-linked immunosorbent assay 
(ELISA).72,73 To probe the ability of carborane appended onto a polymer chain to act as an affinity 
tag, we investigated the binding of 2-pNIPAAm, nido-2- pNIPAAm, and 3 to β-cyclodextrin, a 
cyclic molecule composed of seven α-D-glucopyranoside units. The hydrophobic inner cavity of 
β-cyclodextrin is well-suited for the incorporation of hydrophobic guests thereby forming host–
guest inclusion complexes through non-covalent bonding interactions. Carboranes are known to 
form 1:1 and 2:1 inclusion complexes with β-cyclodextrin exhibiting association constants (Ka) as 
strong as ≈106 M−1.74–78 Previous studies have shown this interaction as a means to solubilize 
carborane scaffolds in aqueous solutions and for the immobilization of biomolecules on 
surfaces.79,80  
We measured binding of 2-pNIPAAm to β-cyclodextrin via isothermal titration 
calorimetry (ITC) in MilliQ water. A solution of a known concentration of β-cyclodextrin was 
titrated into a solution of 2-pNIPAAm. Based on the titration curve, we calculated a Ka of 9.37×10
4 
M−1 which agrees with previous literature reports of free carborane binding in the hydrophobic 
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pocket of β-cyclodextrin (Figure 4-6 A). An N = 0.5 value was also calculated, which is indicative 
of a 2:1 binding of carborane to β-cyclodextrin. While the binding of two carborane groups into β-
cyclodextrin has not been reported, it is possible that the substituents on the carborane end-group 
of 2-pNIPAAm block full incorporation of one carborane unit into β-cyclodextrin thereby 
allowing room for a second unit to partially bind. We were unable to perform the reverse titration 
due a lack of solubility of 2-pNIPAAm in water at high concentrations. 
 
Figure 4-6. (A) ITC curve of a 0.1 mM solution of 2-pNIPAAm titrated into a 1.06 mM β-
cyclodextrin solution shows 2:1 binding (N=0.5). (B) ITC curve of nido-2-pNIPAAm shows only 
minimal binding (N=0.06) which can be attributed to small amounts of 2-pNIPAAm still present 
in solution. The inability of nido-2-pNIPAAm to bind to β-cyclodextrin can possibly be attributed 
to the bulkiness of the TBA+ counterion present on the polymer chain end. (C) ITC curve of 3 and 
β-cyclodextrin shows no observable binding. 
We observed a negligible amount of binding (N = 0.06) when we carried out similar ITC 
studies with nido-2-pNIPAAm (Figure 4-6 B). While the binding of nido-carboranes to β-
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cyclodextrin has not been studied, nido-carborane drug derivatives were shown to bind in the 
hydrophobic subpockets of the proteins carbonic anhydrase (CA) and cyclooxygenase-2 (COX-
2).81,82 It is likely that in this instance, the bulkiness of the TBA+ counterion does not allow for 
binding of nido-2-pNIPAAm in the hydrophobic β-cyclodextrin pocket. Likewise, compound 3 
does not exhibit any detectable binding, highlighting that only polymer samples terminated with 
carborane end-groups can undergo self-assembly processes thereby emphasizing their potential 
application in affinity labeling (Figure 4-6 C). 
4.2.3 Carborane CTA for use in Raman spectroscopy and self-assembly processes 
Raman spectroscopy, especially stimulated Raman spectroscopy (SRS), is emerging as a 
powerful technique for use in bioimaging.83 Although fluorescence techniques still remain 
ubiquitous, there are many inherent limitations which include photobleaching of small molecule 
dyes, which shortens their lifetimes, and the need to use external chemical or photophysical stimuli 
which could damage biological samples.83 Raman spectroscopy bypasses these limitations by 
relying on the inherent molecular vibrations in samples. Label-free Raman spectroscopy has been 
utilized in the analysis of biological samples, primarily investigating bond vibrational signals in 
the fingerprint (500–1700 cm−1) region as well as higher regions (2800–3200 cm−1).83 However, 
there is a need to develop Raman active labels as a way to overcome limitations with label-free 
analysis which include difficulty in differentiating signals within biological media, weak signal-
to-noise ratios, and the inability to track molecules within samples. Because the B–H vibrational 
signal (∼2350–2600 cm−1) of carborane compounds appear in silent regions within the Raman 
spectra of biological samples (∼1740–2800 cm−1), they are ideally suited to serve as bioorthogonal 
molecular probes for Raman applications.59,83  
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We first analyzed the polymers via infrared spectroscopy and found that despite the 
carborane only accounting for 144 Da of polymers ranging 2000 to 6000 Da, we still observed the 
B–H vibrational signal (Figure C39 and C40). To demonstrate the potential utility of carborane 
terminated polymers to act as probes for Raman imaging, a thin film of 1-pNIPAAm on a glass 
substrate was scanned using spontaneous Raman scattering. The B–H vibration occurs at a unique 
frequency (2549 cm−1) which is in a Raman-silent region of biological samples (Figure 4-7 A). 
We also drop-cast a thin-film of 1-pNIPAAm on a quartz substrate and performed a Raman scan 
at the edge of the film. A significant Raman amplitude at 2549 cm−1 is observed only in areas 
where the thin film is present, the amplitude quickly drops off when scanning over areas where 
the 1-pNIPAAm film is absent (Figure 4-7 B). The intensity of the B–H Raman vibration is also 
worthy to note in this application, with an estimated cross section per bond that is 3 times that of 
a typical C–H stretching mode cross section (Appendix C). This experiment therefore 
demonstrates the potential utility of the B–H vibrational stretches inherent to carboranes for Raman 
imaging in polymer materials made via controlled polymerization. 
 
Figure 4-7. (A) Representative Raman spectrum of 1-pNIPAAm thin film indicating B-H Raman 
signal at 2549 cm-1. (B) Film-edge Raman scan of a 1-pNIPAAm thin film showing Raman 
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activity only in areas where the polymer is present. Inset: optical image of the thin film analyzed, 
the blue line denotes the region scanned. 
4.3 Conclusions 
In summary, we present the utilization of tunable carborane functionalized RAFT agents. 
We investigated their ability to control polymerization processes of multiple monomer classes, and 
to serve as universal 1H NMR spectroscopic handles, affinity labels, and Raman active molecular 
probes. We were able to accurately determine polymer molecular weight via end-group analysis 
using 1H NMR spectroscopy. ITC studies of carborane terminated pNIPAAm samples showed a 
2:1 (carborane : β-cyclodextrin) binding with a Ka value of 9.37×104 M−1. Similar studies using 
nido-carborane terminated pNIPAAm and pNIPAAm samples without carborane end-groups 
showed no binding to β-cyclodextrin. Additionally, the B–H bonds on carborane are able to act as 
a Raman active spectroscopic probes with a vibrational signal (2350–2600 cm−1), a Raman silent 
region of biological samples. This new class of RAFT agents adds to the expanding chemical 
toolbox available to biologists, chemists, and materials scientists while providing a new avenue of 
study at the intersection of main-group chemistry and polymer materials.84–89 
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4.5 Appendix C 
4.5.1 Reagent Information 
All commercially available chemicals were used as received unless otherwise stated. All 
polymerizations were prepared in the glovebox under nitrogen atmosphere unless otherwise stated. 
Benzene, diethyl ether, and tetrahydrofuran were purified via a solvent purification system and 
kept in the glovebox over 4 Å molecular sieves. Toluene (Fisher) and ethyl acetate (Fisher) were 
degassed and stored over 4 Å molecular sieves. Dichloromethane (Fisher), hexanes (Fisher), 
pentane (Sigma-Aldrich), and 1,4-dioxane (Sigma-Aldrich) were used as received. All monomers 
were degassed and stored with 4Å molecular sieves. Styrene (≥99%), 4-chlorostyrene (97%), 
methyl acrylate (99%), N-isopropylacrylamide (97%), tributylphosphine (97%), 1-hexylamine 
(99%), 2-hydroxyethyl acrylate (96%), dithranol (>90%), silver trifluoroacetate (98%), n-
butyllithium (2.5 M solution in hexanes), and carbon disulfide (99%) were purchased from Sigma-
Aldrich. O-carborane was purchased from Boron Specialties (USA). Tetrabutylammonium 
fluoride hydrate (TBAF) (97%) was purchased from Oakwood Chemicals. 1-chloro-1-
phenylethane (97%) was purchased from Acros Organics. 2,2′-Azobis(2-methylpropionitrile) was 
purchased from Sigma-Aldrich and recrystallized from methanol. 1,2,3,4-tetrahydronapthalene 
(tetralin) was purchased from TCI. 
 
4.5.2 General Analytical Information 
NMR spectra were recorded on DRX 400, DRX 500, and AVIII 500 spectrometers at 500 MHz 
(1H), 125 MHz (13C), and 80 MHz (11B) reported in δ (parts per million) relative to 
tetramethylsilane (1H, 13C) or BF3·Et2O (
11B), and referenced to residual 1H/13C signals of the 
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deuterated solvent (1H (δ) CDCl3 7.26; 13C (δ) CDCl3 77.16; 1H (δ) (CD3)2CO 2.05; 1H (δ) CD3CN 
1.94; 11B (δ) BF3·Et2O 0.00 ppm). Deuterated solvents (Cambridge Isotope Laboratories) for NMR 
spectroscopic analyses were stored over 4Å molecular sieves. Gel permeation chromatography 
(GPC) was conducted on a Shimadzu HPLC Prominence-I system equipped with a UV detector, 
Wyatt DAWN Heleos-II Light Scattering detector, Wyatt Optilab T-rEX RI detector, one MZ-Gel 
SDplus guard column, and two MZ-Gel SDplus 100 Å 5μm 300x8.0 mm columns. Eluent was 
THF at 40 °C (flow rate: 0.70 mL/min). Chromatograms from THF GPC were analyzed using 
Astra 6.0 software using dn/dc values of 0.1828 for polystyrenes and 0.048 for poly(methyl 
acrylate) at 664 nm. Polymer analysis of poly(NIPAAm) was performed on a Shimadzu high 
performance liquid chromatography (HPLC) system with a refractive index RID-10A, one 
Polymer Laboratories PLgel guard column, and two Polymer Laboratories PLgel 5 μm mixed D 
columns in DMF eluent with LiBr (0.1 M) at 40 °C (flow rate: 0.80 mL/min). Calibration was 
performed using near-monodisperse pMMA standards from Polymer Laboratories. 
Chromatograms from DMF GPC were analyzed using LabSolutions software. All GPC samples 
were dissolved in HPLC grade solvent at a concentration of 4-5 mg/mL and filtered through a 0.2 
µm TFE filter. UV-Vis spectroscopy was performed on an Agilent / HP 8453 spectrophotometer 
with an Agilent 89090A Peltier temperature controller. Thin-layer chromatography (TLC) samples 
for carborane-containing compounds were stained with 1 wt. % PdCl2 in 6M HCl and were 
developed with heat. Mass spectrometry was performed on a Q Exactive™ Plus Hybrid 
Quadrupole-Orbitrap™ Mass Spectrometer with Dionex UltiMate 3000 RSLCnano Systems. 
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4.5.3 Isothermal Titration Calorimetry 
Isothermal Titration Calorimetry (ITC) data were recorded on a MicroCalTM iTC200 System (GE 
Healthcare Life Sciences) housed in the University of California, Los Angeles (UCLA) 
Department of Energy (DOE) Biochemistry Instrumentation Core Technology Center. All 
titrations were recorded at 25 ºC in neat water. Syringe concentration was typically 10-20 times 
larger than the cell concentration. The syringe volume is approximately 39 µL and the cell volume 
is approximately 250 µL. The first data point (a 0.4µL injection) was removed before data 
processing using MicroCal Analysis Software and Origin Software. Heats of dilution were 
determined by titrating the titrant of interest into neat water at the same injection volume used for 
each experiment. Heats of dilution were subtracted from the data prior to curve fitting. Exact 
concentrations, number of injections, and volume of injection are reported for each experiment.  
4.5.4 Raman Experimental Details 
Samples for Raman imaging were prepared by dissolving 4.44 mg of 1-pNIPAAm in 0.888 mL 
of water and drop casting the solution onto a quartz coverslip. A sharp edge was created by 
scraping some of the 1-pNIPAAm off of the coverslip with a razor blade. 
Imaging was completed using a 633 nm HeNe continuous wave laser (Thorlabs). A 20x objective 
with a numerical aperture of 0.40 was used to focus the laser onto the sample. The sample was 
mounted on a 3D nano-positioning stage (Mad City Labs Nano-3D200 Stage). The laser power at 
the sample was 1.09 mW. Raman scattering was collected in a backscatter orientation, focused 
into a spectrograph, and dispersed by a 600 gr/mm grating blazed at 750 nm. The signal was then 
detected with a PIXIS 400BR CCD array detector (Princeton Instruments) with 100 rows binned. 
Three exposures of 12 s were averaged together at each postion. 
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The relative Raman cross section for the B-H vibration can be approximated by comparing the 
number of B-H bonds to the number of C-H bonds in an average-sized 1-pNIPAAm polymer and 
the relative intensities of their Raman peaks. The efficiency of the detector at the wavelength of 
the vibration must also be considered. For a given Raman peak, 
𝐼 ∝ 𝑄𝑛𝑅        (1) 
𝑅 ∝
𝐼
𝑄𝑛
       (2) 
where I is the area under the peak, Q is the quantum efficiency of the detector at the center 
wavelength of the peak, n is the number of bonds in the polymer undergoing the particular 
vibration, and R is the Raman cross section for that vibration. By dividing equation (2) for B-H by 
equation (2) for C-H, an equation for the ratio of the Raman cross sections is obtained. 
𝑅𝐵𝐻
𝑅𝐶𝐻
=
𝑄𝐶𝐻𝑛𝐶𝐻𝐼𝐵𝐻
𝑄𝐵𝐻𝑛𝐵𝐻𝐼𝐶𝐻
   (3) 
QCH and QBH are 0.95 and 0.94 respectively The average 1-pNIPAAm polymer was composed of 
20 NIPAm subunits and one 1. This results in 210 C-H bonds and 10 B-H bonds per molecule. 
Signal intensities for ICH and IBH were calculated to be 73900 and 10500 respectively by fitting the 
spectrum using a multipeak Gaussian fit with a linear baseline. By entering these values into 
equation (3), we can determine RBH≈3RCH. As C-H stretches are frequently used for Raman 
imaging, this relationship demonstrates carborane’s exciting potential as a Raman probe. 
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4.5.5 Small Molecule Synthesis and Characterization 
4.5.5.1 Purification of o-carborane purchased from Boron Specialties 
O-carborane (15g, 10.4 mmol) was charged to a round bottom flask with MeOH (150 mL).  12 M 
HCl (50 mL) was added slowly to the reaction vessel, and the resulting mixture was heated to 50 
˚C and stirred for 16 hours. The solution was then cooled, charged with H2O (200 mL) and the 
resulting white solid was isolated by vacuum filtration, washed with water, and air dried.  The 
solid was then dissolved in CH2Cl2, dried over MgSO4, and filtered through Celite.  The solution 
was dried in vacuo to afford a white powder.  The powder was then sublimed at 60 ˚C under 
dynamic vacuum.  After sublimation away from the yellow residue, the white crystals were taken 
up in C2H4Cl2, charged with activated carbon/charcoal, and stirred for 2-3 hours at 75˚C.  The 
suspension was then filtered and the filtrate was evaporated under vacuum.  The resulting white 
solid was again sublimed at 60˚C to produce white crystals. 
4.5.5.2 Synthesis of 1 
 
O-carborane (324 mg, 2.24 mmol, 1.0 eq.) was dissolved in dry THF (3 mL) in a dry and degassed 
round-bottom flask equipped with magnetic stir bar. The reaction temperature was lowered to 0 
°C at which point nBuLi (2.5 M in hexanes, 988.0 µL, 2.47 mmol, 1.1 equiv) was added dropwise 
slowly, the immediate formation of white precipitate was observed. The reaction temperature was 
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raised to 50 °C and stirred for 3 h. After 3 h, the reaction was cooled to 0 °C at which point carbon 
disulfide (148.0 µL, 2.47 mmol, 1.1 equiv) was added slowly dropwise, an immediate red color 
change was observed. The reaction was stirred at room temperature for 1 h. After 1 h, the reaction 
temperature was lowered to 0 °C and 1-chloro-1-phenylethane (328.0 µL, 2.47 mmol, 1.1 equiv) 
was then added dropwise slowly. An immediate dark purple color change was observed. The 
reaction was stirred at room temperature for 16 h at which point the solvent was removed under 
reduced pressure to afford the crude material as a dark orange oil. The product was purified via 
column chromatography using (90:10 hexanes: CH2Cl2). Product was further purified via 
crystallization from dichloromethane layered with pentane at -30 °C to remove excess 1-chloro-1-
phenylethane. Pure product is a bench-stable crystalline orange solid. Yield: 60%. 
Single crystals suitable for x-ray crystallographic analysis were obtained from a concentrated 
solution of dichloromethane layered with pentane at -20 °C. 
Rf = 0.67 (90:10 hexanes : CH2Cl2; PdCl2 stain) 
1H NMR (500MHz, Chloroform-d, 298K): δ 7.37-7.25 (m, 5H, HAr), 4.91 (q, J = 7.1 Hz, 1H, -
CH), 4.81 (s, 1H, cage-CH), 3.30-1.60 (bm, 10H, cage-BH), 1.72 (d, J = 7.1 Hz, 3H, -CH3). 
13C{1H} NMR (125MHz, Chloroform-d, 298K): δ 217.40, 139.56, 129.00, 128.41, 127.92, 82.31, 
60.74, 53.28, 20.45. 
11B{1H} NMR (128 MHz, Chloroform-d, 298K) δ -3.24, -8.76, -10.93, -11.37, -13.43. 
IR: ṽ (cm-1):  3053, 2972, 2926, 2572, 1493, 1445, 1371, 1195, 1126, 1087, 1038, 1013, 931, 766, 
719, 694. 
HRMS (Q-Exactive Plus) [M-H]1-: 323.19 (calc’d for C11H20B10S2 323.19) m/z 
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Figure C1. 1H NMR spectrum of 1 in chloroform-d at 298 K. 
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Figure C2. 13C NMR spectrum of 1 in chloroform-d at 298 K. 
 
 
 
195 
 
 
Figure C3. 11B NMR spectrum of 1 in chloroform-d at 298 K. 
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Figure C4. Infrared spectrum of 1. 
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Figure C5. HRMS of 1. 
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4.5.5.3 Synthesis of 9,12-diiodo-o-carborane 
 
Ortho-C2B10H12 (1.44 g, 10.0 mmol), was added to an oven-dried Schlenk flask capped with a 
rubber septum and evacuated/backfilled with N2 three times. I2 (2.54 g, 10.0 mmol) was added 
under a positive N2 flow before the addition of dry CH2Cl2 (50 mL) via cannula. AlCl3 (0.266 g, 
20 mol%) was added to the stirring solution under a positive N2 flow before the rubber septum 
was replaced with a greased glass stopper. The reaction mixture was subsequently refluxed (~37 
°C) until the color faded to pale yellow (~4 h). A second equivalent of I2 (2.54 g, 10.0 mmol) and 
AlCl3 (0.133 g, 10 mol%) were added and the reaction was stirred at 37 °C overnight. The dark 
brown reaction mixture was diluted with deionized H2O (25 mL), and unreacted I2 was quenched 
by the dropwise addition of a saturated aqueous Na2S2O3 solution until the solution was no longer 
colored. The opaque organic layer was collected and the aqueous layer was extracted with CH2Cl2 
(2 x 15 mL). The organic portions were combined and dried with MgSO4 resulting in a clear, 
colorless solution. The solution was then filtered through a pad of Celite on a fritted funnel and 
the CH2Cl2 was removed under reduced pressure to yield an off-white solid that was further 
purified by sublimation at 130 °C to produce the title compound as a white solid. Spectral data 
matches that previously reported in the literature (see: Kirlikovali, K. O.; Axtell, J. C.; Gonzalez, 
A.; Phung, A. C.; Khan, S. I.; Spokoyny, A. M. Chem. Sci. 2016, 7, 5132-5138).  
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4.5.5.4 Synthesis of 9,12-dimethyl-o-carborane 
9,12-dimethyl-o-carborane was prepared from 9,12-diiodo-o-carborane according to the procedure 
reported in the following manuscript: Li, J.; Logan, C. F.; Jones, M. Inorg. Chem. 1991, 30 (25), 
4866-4868. 
4.5.5.5 Synthesis of 2 
 
9,12-dimethyl-o-carborane (770.6 mg, 4.48 mmol, 1.0 equiv) was dissolved in dry THF (6 mL) in 
a dry and degassed round-bottom flask equipped with magnetic stir bar. The reaction temperature 
was lowered to 0 °C at which point nBuLi (2.5 M in hexanes, 1.98 mL, 4.94 mmol, 1.1 equiv) was 
added dropwise slowly, the immediate formation of white precipitate was observed. The reaction 
temperature was raised to 50 °C and left stirring for 3 hours. After 3 hours, the reaction was cooled 
to 0 °C at which point carbon disulfide (296.0 µL, 4.94 mmol, 1.1 equiv) was added dropwise 
slowly, an immediate red color change was observed. The reaction was stirred at room temperature 
for 1 hour. After 1 hour, the reaction temperature was lowered to 0 °C and 1-chloro-1-phenylethane 
(656.0 µL, 4.94 mmol, 1.1 equiv) was then added dropwise slowly. The reaction was stirred at 
room temperature for 16 hours at which point the solvent was removed under reduced pressure. 
The product was purified via column chromatography (95:5 hexanes:acetone) to remove residual 
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carborane. Excess 1-chloro-1-phenylethane was removed under dynamic vacuum and heating (100 
mTorr at 95 °C). Pure product is a bench-stable dark orange oil. Yield: 69%. 
Rf = 0.8 (95:5 hexanes:acetone; PdCl2 stain) 
1H NMR (500MHz, Chloroform-d, 298K): δ 7.36 – 7.30 (m, 5H, HAr), 4.90 (q, J = 7.0 Hz, 1H, -
CH), 4.61 (s, 1H, cage-CH), 3.12 – 1.59 (bm, 10H, cage-BH), 1.72 (d, J = 7.2 Hz, 3H, -CH3), 0.23 
(s, 3H, -BCH3), 0.20 (s, 3H, -BCH3).  
13C{1H} NMR (125MHz, Chloroform-d, 298K): δ 218.32, 139.70, 128.96, 128.33, 127.92, 76.36, 
54.44, 53.13, 20.42. 
11B{1H} NMR (161 MHz, Chloroform-d, 298K) δ 6.95, 6.37, -7.00, -11.56, -12.18, -13.78.  
IR: ṽ (cm-1):  3059, 2906, 2591, 1493, 1452, 1314, 1199, 1094, 1071, 1022, 990, 912, 761, 738, 
695. 
HRMS (Q-Exactive Plus) [M-H]1-: 351.22 (calc’d for C13H24B10S2 351.22) m/z 
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Figure C6. 1H NMR spectrum of 1 in chloroform-d at 298 K. 
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Figure C7. 13C NMR spectrum of 1 in chloroform-d at 298 K. 
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Figure C8. 11B NMR spectrum of 1 in chloroform-d at 298 K. 
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Figure C9. Infrared spectrum of 1. 
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Figure C10. HRMS of 2. 
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4.5.6 Polymer Synthesis, Characterization, and End-group Modification  
4.5.6.1 General Polymerization Procedure for Liquid Monomers (Methyl Acrylate, Styrene, 
4-chlorostyrene) 
Polymerizations were prepared in the glovebox under nitrogen atmosphere. Methyl acrylate (0.20 
mL, 2.20 mmol, 60 equiv.) was passed through dry activated basic alumina and added to a dram 
vial equipped with a magnetic stir bar. CTA 2 (12.7 mg, 0.036 mmol, 1 equiv.) and AIBN (1.8 mg, 
0.011 mol, 0.3 equiv.) were dissolved in a minimal amount of EtOAc (~70 µL) and transferred to 
the dram vial containing the monomer. Tetralin (20 µL) was then added to the solution. The 
solution was stirred for 1 minute before collecting a 50 µL aliquot (t=0 min). The dram vial was 
then sealed with a polypropylene cap containing a Teflon coated septum and brought out of the 
glove box. The polymerization was initiated by immersing the dram vial in an 80 ˚C oil bath. 
Aliquots (50 µL) of the reaction mixture were collected at pre-determined time intervals and added 
into 700 µL of CDCl3 to determine monomer conversion via 
1H NMR spectroscopy. The reaction 
was quenched by opening the dram vial to the atmosphere and the polymer was purified via 
precipitation from cold methanol.  
4.5.6.2 General Polymerization Procedure for NIPAAm 
All reactions were prepared in a glovebox under nitrogen atmosphere. N-isopropylacrylamide 
(500.0 mg, 4.42 mmol, 60 equiv), 2 (25.9 mg, 7.31x10-5 mol, 1 equiv), and AIBN (6.05 mg, 
3.68x10-5 mol, 0.3 equiv) were added to a dram vial equipped with a magnetic stir bar. The reagents 
were dissolved in 2.2 mL toluene making a 2 M solution. The dram vial was sealed with a 
polypropylene cap containing a Teflon coated septum and brought out of the glove box. The 
polymerization was started by immersing the dram vial in an 80 ˚C oil bath. The reaction was 
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quenched by the opening dram vial to atmosphere and the polymer was purified via precipitation 
from cold methanol or diethyl ether.  
4.5.6.3 Polymer conversion experiments 
The reactions were prepared using optimized conditions (vide supra) along with the addition of an 
internal standard (≈20 µL tetralin). Aliquots (50 μL) of the reaction mixture were collected at 
predetermined time intervals and added into CDCl3 (700 μL) for analysis via 1H NMR 
spectroscopy. Monomer conversion was calculated by 1H NMR spectroscopy by integration of 
unreacted vinyl monomer signal to the tetralin proton resonance at ~2.75-2.8 ppm.  
 
 
Figure C11. GPC overlay of 1-PS. 
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4.5.6.4 Polymer Characterization 
 
Figure C12. 1H NMR spectrum of 1-PS in acetonitrile-d3 at 298 K and sample calculation of 
polymer molecular weight. 
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Figure C13. 1H NMR spectrum of 1-PS in acetonitrile-d3 at 298 K and sample calculation of 
polymer molecular weight. 
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Figure C14. 1H NMR spectrum of 2-PS in chloroform-d at 298 K and sample calculation of 
polymer molecular weight. 
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Figure C15. 1H NMR spectrum of 2-PS in chloroform-d at 298 K. 
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Figure C16. 1H NMR spectrum of 2-pNIPAAm in chloroform-d at 298 K and sample calculation 
of polymer molecular weight. 
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Figure C17. 1H NMR spectrum of 2-pNIPAAm in chloroform-d at 298 K. 
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Figure C18. 1H NMR spectrum of 2-pNIPAAm in chloroform-d at 298 K. 
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Figure C19. 1H NMR spectrum of 2-(4-Cl)-PS in acetone-d6 at 298 K and sample calculation of 
polymer molecular weight.   
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Figure C20. 1H NMR spectrum of 2-(4-Cl)-PS in in acetone-d6 at 298 K. 
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Figure C21. 1H NMR spectrum of 2-(4-Cl)-PS in in acetone-d6 at 298 K. 
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Figure C22. 1H NMR spectrum of 2-PMA in chloroform-d at 298 K and sample calculation of 
polymer molecular weight. 
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Figure C23. 1H NMR spectrum of 2-PMA in chloroform-d at 298 K. 
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Figure C24. 1H NMR spectrum of 2-PMA in chloroform-d at 298 K. 
 
 
 
 
 
 
221 
 
 
Figure C25. 1H NMR spectrum of 2-PMA in acetonitrile-d3 at 298 K. 
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Figure C26. GPC traces of styrene and methyl acrylate in various solvents. GPC acquired using 
THF as the eluent. 
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Figure C27. 1H NMR spectrum of 2-PS in acetone-d6 at 298 K, related to entry 10, Figure C19. 
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Figure C28. 1H NMR spectrum of 2-PS in chloroform-d at 298 K, related to entry 11, Figure C19. 
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Figure C29. 1H NMR spectrum of 2-PS in acetone-d6 at 298 K, related to entry 12, Figure C19. 
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Figure C30. 1H NMR spectrum of 2-PMA in acetonitrile-d3 at 298 K, related to Entry 13, Figure 
C19. 
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Figure C31. 1H NMR spectrum of 2-PMA in acetonitrile-d3 at 298 K, related to Entry 14, Figure 
C19. 
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Figure C32. Polymer kinetic plot of polymerization of a bulk methyl acrylate solution. Black line 
indicates fitting without 90 minute time aliquot included (R2 = 0.97). Red line indicates fitting with 
90 minute time aliquot included (R2 = 0.93). Experiment performed by making separate reaction 
aliquots in dram vials with Teflon coated caps from a stock solution of the monomer, initiator, and 
CTA. Aliquots were quenched at pre-determined time intervals by exposing the reaction mixture 
to air. It is possible that the final 90 minute aliquot losing linearity is due to minor pipetting error 
or due to the viscosity of the bulk solution. 
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Figure C33. Evolution of Mn as a function of monomer conversion from the experiment in Figure 
C32. 
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Figure C34. Polymer kinetic plot of polymerization of a 2M solution of methyl acrylate in PhMe 
(R2 = 0.99). 
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Figure C35.  Evolution of Mn as a function of monomer conversion from the experiment in Figure 
C34. 
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4.5.6.5 Polymer end-group modification 
 
2-pNIPAAm (370.0 mg mg, 2.66x10-5 mol, 1 equiv) was added to a dry and degassed 4-mL dram 
vial sealed with a Teflon coated septum cap and equipped with a magnetic stir bar. 
Tributylphosphine (66.4 uL, 0.27 mmol, 10 equiv) dissolved in 1,4-dioxane (5 mL) and added to 
the vial containing 2-pNIPAAm. The solution was sparged with argon for 10 minutes. After 
sparging, 1-hexylamine (176.0 uL, 1.33 mmol, 50 equiv) was added and the solution was stirred 
at room temperature for 16 hours. Precipitation of the polymer from cold methanol afforded both 
deprotected and coupled polymer products.  
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Figure C36. GPC spectrum of carborane deprotection reaction, which shows a high degree of 
polymer coupling over the course of the reaction. GPC acquired using DMF with 0.1 M LiBr as 
the eluent. 
 
2-pNIPAAm (20.0 mg, 8.37x10-6 mol, 1 equiv) was added to a dry and degassed 4-mL dram vial 
sealed with a Teflon coated septum cap and equipped with a magnetic stir bar. Tributylphosphine 
(41.3 uL, 0.17 mmol, 20 equiv) and 2-hydroxyethyl acrylate (96.0 uL, 0.84 mmol, 100 equiv) were 
dissolved in 1,4-dioxane (1 mL) and added to the vial containing 2-pNIPAm. The solution was 
sparged with argon for 10 minutes. After sparging, 1-hexylamine (22.1 uL, 0.17 mmol, 20 equiv) 
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was added and the solution was stirred at room temperature for 16 hours. Precipitation of the 
polymer from cold methanol afforded pure product as a light yellow solid.  
 
Figure C37. GPC spectrum of 3. GPC acquired using DMF with 0.1 M LiBr as the eluent. 
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2-pNIPAAm (26.1 mg, 2.0x10-6 mol, 1 equiv) and TBAF (2.6 mg, 1.0x10-5 mol, 5 equiv) were 
added to a 4 mL scintillation vial equipped with a magnetic stir bar and dissolved in THF (200 
μL). The reaction was left stirring at room temperature for 3 hours at which point the solution was 
diluted in water (2 mL) and purified via dialysis (MWCO = 3500 Da) against water for 2 days. 
The water was removed via lyophilization to produce the pure product as a yellow solid.  
1H NMR (500MHz, acetonitrile-d3, 298K): δ 6.57 (bs, -NH), 3.94 (s, -CH(CH3)2), 2.43 (bs, -CH), 
2.05 (bs, -CH2), 1.67 (bs, -CH2), 1.51 – 1.10 (bs, -CH(CH3)2), 0.23 (bs, -BCH3), 0.16 (bs, -BCH3), 
-2.1 (bs, HHydride). 
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Figure C38. 1H NMR spectrum of nido-2-pNIPAAm in acetonitrile-d3 at 298 K. 
 
 
237 
 
 
Figure C39. IR spectrum of 1-pNIPAAm. 
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Figure C40. IR spectrum of 2-PMA. 
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4.5.7 Crystallographic Characterization 
Identification code  PC18 
Empirical formula  C11 H20 B10 S2 
Formula weight  324.49 
Temperature  150.0 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/c  
Unit cell dimensions a = 12.427(2) Å  
 b = 12.068(3) Å = 92.622(9)°. 
 c = 11.6342(17) Å  = 90°. 
Volume 1742.9(6) Å3 
Z 4 
Density (calculated) 1.237 Mg/m3 
Absorption coefficient 0.291 mm-1 
F(000) 672 
Crystal size 0.98 x 0.28 x 0.26 mm3 
Theta range for data collection 2.354 to 26.391°. 
Index ranges -11<=h<=15, -15<=k<=9, -14<=l<=13 
Reflections collected 8343 
Independent reflections 3449 [R(int) = 0.0581] 
Completeness to theta = 25.242° 97.4 %  
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Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7454 and 0.5007 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3449 / 2 / 209 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.0868, wR2 = 0.2110 
R indices (all data) R1 = 0.1578, wR2 = 0.2405 
Extinction coefficient n/a 
Largest diff. peak and hole 0.454 and -0.546 e.Å-3 
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Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for 1.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
S(1) 6670(1) 3636(2) 6609(1) 46(1) 
S(2) 6367(1) 3491(2) 9154(1) 54(1) 
C(2) 4718(3) 3759(5) 7501(3) 26(1) 
C(6) 8734(3) 3121(5) 6248(3) 29(2) 
C(1) 3881(3) 3648(5) 8541(3) 26(1) 
C(4) 8068(4) 3620(6) 7190(4) 34(2) 
C(5) 8417(4) 4763(7) 7591(4) 48(2) 
C(3) 5911(4) 3636(6) 7825(4) 34(2) 
B(10) 4154(4) 3263(6) 6241(4) 30(2) 
B(7) 3951(4) 2579(7) 7579(4) 33(2) 
B(3) 2709(5) 3030(7) 8097(5) 33(2) 
B(9) 3027(4) 4126(7) 5935(4) 31(2) 
B(2) 2794(5) 4480(7) 8342(4) 34(2) 
B(8) 2834(5) 2792(7) 6596(5) 35(2) 
B(1) 4107(5) 4943(7) 7986(4) 37(2) 
B(6) 4245(5) 4688(7) 6490(4) 38(2) 
B(4) 2130(5) 3985(7) 7070(5) 40(2) 
B(5) 3000(6) 5160(8) 7013(5) 48(2) 
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C(9) 9953(4) 2202(8) 4554(5) 54(2) 
C(11) 9022(6) 2040(7) 6296(5) 59(2) 
C(10) 9618(7) 1568(7) 5441(5) 68(2) 
C(8) 9686(5) 3280(7) 4504(5) 59(2) 
C(7) 9075(4) 3779(5) 5343(4) 49(2) 
_____________________________________________________________________________  
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Chapter 5 
Organometallic Gold(III) Reagents for Cysteine Arylation 
 
Reproduced with permission from: Messina, M. S.; Stauber, J. M.; Waddington, M. A.; Rheingold, 
A. L.; Maynard, H. D.; Spokoyny, A. M. “Organometallic Gold(III) Reagents for Cysteine 
Arylation” J. Am. Chem. Soc. 2018, 140, 7065-7069. Copyright 2018 American Chemical Society. 
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5.1 Introduction 
Cysteine bioconjugation is a powerful tool that allows for the introduction of a diverse 
array of substrates to biomolecules via the formation of covalent linkages.1−5 Transition-metal-
mediated reactions have emerged recently as attractive methods for the modification of complex 
biomolecules due to the high functional group tolerance, chemoselectivity, and rapid reaction 
kinetics associated with these metal-based transformations.6−13 Additionally, the rational choice of 
transition-metal ion and ligand platform can provide the ability to design organometallic-based 
bioconjugation reagents with highly tailored reactivity, solubility, and stability properties. This 
concept is embodied by the versatile and efficient palladium-mediated cysteine arylation methods 
reported by Buchwald, Pentelute, et al. in the past three years that enable access to a broad range 
of bioconjugates under mild reaction conditions (Scheme 1).9−13  
 
Scheme 5-1. Previous work utilizing PdII reagents (references 9–13) and this work detailing AuIII-
mediated cysteine S-arylation of biomolecules.  
Herein, we expand the scope, generality, and utility of transition-metal-mediated cysteine 
arylation via a C−S bond forming, reductive elimination process occurring from a class of robust 
organometallic Au(III) complexes. The reluctance of Au(I) to undergo oxidative addition14−19 
potentially provides gold-based species with high functional-group tolerance, minimizing the 
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propensity for background reactivity with the variety of functional groups present in complex 
biomolecules. Furthermore, the thiophilic nature of gold renders Au(III)- based complexes prime 
candidates for reduction by cysteine thiols, engendering such systems as potential reagents for 
bioconjugation.20,21 Surprisingly, there are currently no auxiliary-free methods using gold-based 
complexes for cysteine arylation.22 Here we introduce such a methodology using easily accessed, 
air-stable Au(III)-aryl complexes. The resulting methodology provides rapid access to a diverse 
array of protein and peptide bioconjugates with high conversion under mild reaction conditions. 
The broad scope and utility of the described method are highlighted by the variety of well-defined, 
air-stable, crystalline Au(III)-based arylation reagents that were prepared in one synthetic step 
from commercial reagents. The present strategy is positioned at the interface of organometallic 
and bioconjugation chemistry and aims to provide new and efficient tools for biomolecule 
modification.  
5.2 Results and Discussion 
Bourissou et al. recently described an elegant approach to enhance the reactivity of Au(I) 
species toward oxidative addition by using pre-organized ligand architectures that support the 
square planar geometry of the ensuing Au(III) products.14,23,24 These systems appeared ideal to us 
to accommodate the elementary steps of oxidative addition, trans-metalation, and reductive 
elimination17,19,25−27 required for C−S bond formation in cysteine arylation processes (Scheme 1). 
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Figure 5-1. Gold(III) reagents 1 and 2a (X = Cl/I), and glutathione arylation scheme with reaction 
optimization parameters.  
Optimization of cysteine arylation reaction conditions with 1 were carried out using L-
glutathione (GSH) as the model peptide substrate (Figure 5-1). Full conversion to the S-tolyl GSH-
conjugate was observed in GSH-conjugate <5 min upon treatment of GSH with 1 (5 equiv) at 25 
°C in the presence of Tris buffer (pH 8) as determined by LC-MS analysis of the crude reaction 
mixture. Reaction solutions containing up to 80% H2O in H2O/MeCN mixtures were tolerated 
(Figure 5-1), whereas higher ratios of H2O led to reduced reaction conversion. This limited 
efficiency led us to seek another Au(III)-based system that would exhibit improved compatibility 
in biologically relevant reaction media.  
We prepared the Au(III)-tolyl oxidative addition complex, [(Me-
DalPhos)Au(tolyl)Cl][SbF6] ([2a][SbF6], Me-DalPhos = (Ad2P(o-C6H4)NMe2) 
28,29),24 isolated as 
a crystalline, airstable solid. We next evaluated the suitability of 2a to serve as a cysteine arylation 
reagent under a variety of reaction conditions. Quantitative conversion of GSH to the 
corresponding S-tolyl conjugate was observed in minutes (<5 min) at 25 °C in a 80:20 H2O:MeCN 
(v/v) mixture, as assayed by LC-MS analysis of the crude reaction mixture. The optimized reaction 
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conditions provided significant improvements upon those employing complex 1, such as lower 
reagent loading (3 vs 5 equiv), and a reduced percentage of organic solvent required (20% vs 50%, 
see Figure 5-1). Notably, the 2a-mediated cysteine arylation reactions proceeded to completion 
within a large pH range (0.5−14) and in the presence of several common buffers (Tris, HEPES, 
Na2CO3). The bioconjugation reactions were also compatible with the disulfide reducing agent, 
TCEP (tris(2-carboxyethyl)phosphine, 1 equiv), protein denaturing agent, guanidine·HCl (4 M) 
and several other unconventional solvents (SI Figure D79).  
 
Figure 5-2. A: Scope of [(Me-DalPhos)AuArCl][SbF6] bioconjugation reagents. B: LC traces of 
cysteine arylation reaction mixtures with two peptides using reagents 2m (left) and 2n (right). 
Gold-based species are highlighted in grey. See Appendix D for further experimental details.  
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We further prepared a library of [(Me-DalPhos)AuArCl][SbF6] oxidative addition 
complexes (Figure 5-2A) bearing various biorelevant groups including heterocycles (2m, 2p), an 
affinity label (2q), fluorescent tag (2r), complex drug molecule (2n), and a poly(ethylene glycol) 
(PEG) polymer (2o). Oxidative addition reactions to generate complexes 2a−2r proceeded rapidly 
and cleanly upon treatment of CH2Cl2 solutions of (Me-DalPhos)AuCl with the corresponding aryl 
iodide electrophile in the presence of the halide scavenger, AgSbF6.
24 After removal of the 
liberated AgI byproduct by filtration, the [(Me-DalPhos)AuArCl][SbF6] salts readily crystallized 
directly from the resulting solution upon standing at 25 °C. This purification procedure afforded 
X-ray diffraction quality single crystals of several complexes that enabled their structural 
determination (see Appendix D section 4.5.25 for crystallographic data). Notably, iodide to 
chloride exchange occurs at the gold center during the course of the oxidative addition reaction, as 
confirmed by X-ray diffraction analysis of several complexes that display Cl/I disorder with a 
75−100% range of chloride occupancy (Appendix D section 4.5.25). This observation is in line 
with X-ray diffraction studies of closely related complexes prepared under similar conditions,24 
and is consistent with formation of the more stable gold(III) chloride derivative.30  
Interestingly, despite the exclusion of oxygen and water from the reported preparation of 
2a and related complexes previously,24 we found that the synthesis and purification of all [(Me-
DalPhos)AuArCl][SbF6] salts presented in this work proceeded cleanly even when performed 
under open atmosphere conditions using commercial, unpurified solvents. The salts exhibited 
excellent long-term air and water stability, and no observable degradation was detected after 
prolonged periods (>3 months) when the reagents were stored on the benchtop at 25 °C as assayed 
by 1H and 31P NMR spectroscopy. Complex 2o displayed solubility in neat H2O due to the 
hydrophilicity imparted by the PEG group. This species also demonstrated excellent water 
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stability, showing only limited degradation (ca. 20%) after a sample was allowed to stand for 4 
days at 25 °C in H2O as judged by 31P NMR spectroscopy (see Figure D69).  
A comprehensive demonstration of the aryl scope was performed with GSH under the 
optimized bioconjugation conditions (25 °C, 3 equiv Au complex, 80:20 H2O:MeCN, 0.1 M Tris 
buffer, pH 8.0). Quantitative conversion to the GSH S-aryl conjugates was observed in <5 min for 
all 17 substrates displayed in Figure 5-2A (b−r). Notably, the reaction does not inherently 
necessitate organic cosolvent when the organometallic reagent is soluble in water (2o, see 
Appendix D Figure D93). As a representative example, the S-(C6H4-p-Cl) conjugate was easily 
separated from small-molecule byproducts and Au-based species by reversed-phase HPLC, and 
ICP-AES analysis of the purified peptide indicated more than 99.9% of gold was removed using 
this purification procedure (see Appendix D section 4.5.20).  
The chemoselectivity of oxidative addition was probed through treatment of (Me-
DalPhos)AuCl with p-chloro- and p-bromoiodobenzene electrophiles in the presence of AgSbF6 
(see Appendix D). For both substrates, oxidative addition occurs exclusively across the Ar−I bond, 
resulting in the formation of complexes 2i and 2j (Figure 5-2A), respectively. Furthermore, 
treatment of GSH with 2i and 2j generated the p-Cl-C6H4 and p-Br-C6H4 tagged peptides as the 
sole products, without any evidence for iodoaryl-based conjugates as judged by LC-MS analyses. 
The high chemoselectivity of the (MeDalPhos)Au system is in stark contrast to that observed for 
reported Pd-based platforms that readily react with all Ar−X (X = Cl, Br, I) species with limited 
selectivity.9 Thus, the functional group tolerance coupled with the high selectivity of the reported 
Au-based system may provide complementary advantages to the previously developed Pd-based 
reagents for transferring aryl groups of various complexities to biomolecules.  
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To further establish the versatility and utility of this methodology, we applied our 
bioconjugation strategy to more complex peptide substrates. Cysteine arylation of two different 
peptide sequences was observed in nearly quantitative conversion for a variety of aryl substrates 
(see Appendix D; representative examples shown in Figure 5-2B). No reaction was observed using 
a control peptide where the cysteine residue was mutated to serine, highlighting the 
chemoselectivity of the Au(III)-mediated bioconjugation method. Additionally, trypsin digest and 
MS/MS analyses of a (p-Cl-C6H4)−peptide conjugate support modification at the cysteine residue 
exclusively (see Appendix D section 4.5.24 for experimental details).  
We next extended the scope of Au(III)-mediated cysteine bioconjugation to the 
modification of proteins. Cysteine arylation of DARPin (designed ankyrin repeat protein) was 
observed using complex 2a within 30 min at 25 °C, as verified by LC-MS analysis of the reaction 
mixture (Figure 5-3A). The presence of a small amount of DMF cosolvent (5%) was required for 
efficient bioconjugation due to the inherent solubility constraints of 2a. However, treatment of 
fibroblast growth factor 2 (FGF2)31 with water-soluble 2o (15 equiv) in aqueous buffer only 
resulted in complete conversion to the PEGylated conjugate as confirmed by the deconvoluted 
mass spectrum from LC-MS analysis of the reaction mixture (see Appendix D Figure D102). The 
rapid and efficient protein bioconjugation reactions demonstrate the potential generality and 
suitability of the described Au(III)-mediated methodology for the modification of complex 
proteins under mild, biologically relevant conditions and at low micromolar concentration of 
protein (36 μM).  
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Figure 5-3. A: DARPin modification using 2a, and deconvoluted mass spectra of the protein 
before and after conjugation. B: Solid-state structure of peptide stapling reagent, [((Me-
DalPhos)AuCl)2(µ2-1,4-C6H4)]
2+ (2s), with thermal ellipsoids rendered at the 50% probability 
level and with hydrogen atoms and two SbF6
– anions removed for clarity. C: LC-MS trace of the 
purified phenylene-stapled peptide. [M+H]+: 670.1965 (calc’d, 670.1968) m/z. 
With a protocol for Au-mediated cysteine arylation, we envisaged the same route could 
furnish a stapled peptide through the construction of an intramolecular cysteine−cysteine linkage. 
There has been significant interest in the development of stapled peptides as therapeutic agents; 
however, there is still a growing need for easily accessible peptide macrocyclization methods that 
allow for modular tuning of cross-linking units.32−36 The straightforward and efficient Au(III)-
mediated bioconjugation procedures together with the use of commercially available (Me-
DalPhos)AuCl and diiodoaryl reagents provide a versatile and systematic approach to peptide 
stapling that is complementary to existing state-of-the-art methods.4,10,34−37 The o-phenylene-
bridged digold(III) stapling reagent, 2s, was prepared in a single synthetic step through treatment 
of (Me-DalPhos)AuCl (2 equiv) with 1,4- diiodobenzene (1 equiv) in the presence of AgSbF6 (2 
equiv), and isolated as a crystalline solid in 64% yield. A single-crystal X-ray diffraction study 
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confirmed the solid-state structure of [2s][SbF6]2 (Figure 5-3B). Peptide stapling was observed 
under optimized conditions (30 min, 50:50 H2O:MeCN, 25 °C, 0.1 M Tris, pH 8) using a 2-fold 
excess of the 2s macrocyclization reagent for a peptide containing cysteine residues at the i, i+4 
positions (Figure 5-3C). The o-phenylene i, i+4 stapled peptide was isolated away from gold-based 
impurities after purification by reversed-phase HPLC.  
 
Scheme 5-2. Competition experiment between (RuPhos)Pd(tolyl)I and [2b][SbF6] with GSH. 
The apparent exceptionally rapid kinetics of Au(III)- mediated bioconjugation were 
benchmarked by performing a comparative study against a closely related Pd(II)-based analogue. 
The (RuPhos)Pd(tolyl)Cl complex reported previously9 was ideally suited for comparison with the 
[(MeDalPhos)Au(p-ethylbenzene)Cl]+ complex 2b on account of its performance as a cysteine 
arylation reagent and the similar electronic and steric properties of the aryl substituents on both 
complexes. Treatment of GSH with equimolar amounts of 2b and (RuPhos)Pd(tolyl)Cl (Scheme 
2) under conditions compatible with both systems resulted in 92 ±1% conversion to the 
ethylbenzene conjugate, indicating that the Au-mediated conjugation outperformed the Pd-based 
arylation in over 9:1 kinetic ratio. These data suggest that the kinetics for Au-mediated 
bioconjugation are on the order of, or faster than those estimated for the Pd-based systems (103 
−104 M−1 s−1).9  
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5.3 Conclusions 
In summary, we present a general protocol for cysteine S-arylation of unprotected peptides 
and proteins using robust, Au(III) oxidative addition complexes bearing a diverse array of aryl 
substituents. The reported method operates in a large pH range under mild reaction conditions and 
displays rapid reaction kinetics, high chemoselectivity, and excellent functional group tolerance. 
With this work, we expand the scope of biomolecule modification3,5,38−40 by providing tools that 
interface bond-forming processes characteristic of organometallic complexes18,25,41−46 with 
bioconjugation. The straightforward synthetic procedures and commercially available or otherwise 
easily accessible reagents presented should expand the bioconjugation space well beyond the 
substrates and peptides reported in this study. This work also expands on a relatively under-
represented class of organometallic reagents containing metal−carbon bonds capable of 
withstanding relatively harsh environmental conditions.47 
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5.5 Appendix D 
5.5.1 Methods and Materials 
All commercially available chemicals were used as received unless otherwise stated. The 
Au(THT)Cl and (RuPhos)Pd(tolyl)I complexes were prepared according to literature 
procedures.1,2 Dry solvents were obtained from Grubbs columns with activated alumina and copper 
catalysts and stored in a Vacuum Atmospheres glovebox over 4Å molecular sieves. O-carborane 
was purchased from Boron Specialties (USA). Phosphorus trichloride (98%), N,N’-
diisopropylethylenediamine (97%), chlorobis(3,5-dimethylphenyl)phosphine (90%), and silver 
bis(trifluoromethanesulfonyl)imide (AgNTf2) were purchased from Alfa Aesar. N,N′-Di-tert-
butylethylenediamine (98%), chloro[di(1-adamantyl)-2-dimethylaminophenylphosphine]gold(I), 
2-iodonaphthalene (99%),  4-iodotoluene (99%), and L-glutathione reduced (BioXtra grade) were 
purchased from Sigma-Aldrich. Silver hexafluoroantimonate (AgSbF6) (98%), silver 
tetrafluoroborate (AgBF4) (98%), 4-iodobenzotrifluoride (98%), 1-fluoro-4-iodo-benzene (99%), 
1-bromo-4-iodobenzene (99%), 4-iodophenol (98%), 2-iodopyridine (98%), 4-iodoaniline (98%) 
and 4-(trifluoromethoxy)iodobenzene (97%) were purchased from Oakwood Chemical. 
Trametinib (GSK1120212, 99%), and 1-ethyl-4-iodobenzene (98%) were purchased from Fisher 
Scientific. Monodisperse PEG12 was purchased form JenKem Technology USA. 1-Hydroxy-7-
azabenzotriazole solution (HOAt, 0.6 M in DMF), 1-[Bis(dimethylamino)methylene]-1H-1,2,3-
triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU), N,N,N′,N′-Tetramethyl-O-(1H-
benzotriazol-1-yl)uronium hexafluorophosphate (HBTU), D-Biotin, Fmoc-Rink amide linker, 
Fmoc-L-Arg(Pbf)-OH, Fmoc-L-Ala-OH, Fmoc-L-Cys(Trt)-OH, Fmoc-L-Gly-OH, Fmoc-L-
Asp(OtBu)-OH, Fmoc-L-Ser(tBu)-OH, Fmoc-L-Lys(Boc)-OH were purchased from Chem-Impex 
International. 
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5.5.2 General Analytical Information: 
NMR spectra were recorded on DRX 400, DRX 500, and AVIII 500 Bruker spectrometers at 400 
or 500 MHz (1H), 125 MHz (13C), 282 MHz (19F), 80 MHz (11B), and 121 MHz (31P). Spectra are 
reported in δ (parts per million) relative to residual protio-solvent signals for 1H and 13C, C6H5F -
(δ -113.15 ppm) for 19F, BF3·Et2O (δ 0.00 ppm) for 11B, and H3PO4 (δ 0.00 ppm) for 31P.   
Deuterated solvents (Cambridge Isotope Laboratories) used for NMR spectroscopic analyses were 
stored over 4Å molecular sieves. Electrospray ionization mass spectra of small molecules and Au-
based complexes (ESI-MS(+)) were collected on a Waters LCT premier mass spectrometer. 
Samples were prepared in MeCN at concentrations <1 µM, and the data were processed using the 
program mMass Version 5.4.1.0.  
5.5.3 Peptide Purification and LC-MS Analysis: 
Peptide purification was carried out on an Agilent Technologies 1260 Infinity II HPLC system 
equipped with an Agilent ZORBAX 300SB-C18 column (5 µm, 9.4 × 250 mm) using 0.1% TFA 
in water and 0.1% TFA in acetonitrile as the eluent. Data were processed using Agilent Mass 
Hunter software. Deconvoluted mass spectra of proteins were gathered using maximum entropy 
setting. Peptide modification yield was calculated s integrations of the peptide and modified 
peptide peaks in the TIC spectra using the following formula: (I[MP]/I[MP+SP])×100 where I[MP] is 
the integration of the modified peptide peak and I[MP+SP] is the sum of integrations of the modified 
peptide peak and the starting peptide peak. 
5.5.3.1 Peptide Purification Method Information: Column temperature: 23 °C. Flow rate: 3 
mL/min. Gradient: 95-60% water (0.1% TFA) over 22 min.  
LC-MS analysis was carried out using an Agilent 6530 ESI-Q-TOF. Peptide and DARPin analyses 
were carried out using an Agilent ZORBAX 300SB C18 column (5 µm, 2.1 × 500 mm). Analysis 
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of FGF2 was carried out using an Agilent ZORBAX 300SB C3 column (3.5 µm, 3.0 × 150 mm) 
using 0.1% TFA in water and 0.1% TFA in acetonitrile as the eluent. 
5.5.3.2 LC-MS Method Information:  
Method used for peptides: Column temperature: 23 °C. Flow rate: 0.8 mL/min. Gradient: 99% 
water (0.1% formic acid (FA)) for 2 minutes; 99%-91% water (0.1% FA) 2-11 minutes; 5% water 
(0.1% FA) from 12-15 min.  
Method used for proteins: Column temperature: 23 °C. Flow rate: 0.8 mL/min. Gradient: 99% 
water (0.1% formic acid (FA)) for 2 minutes; 99%-9% water (0.1% FA) 2-11 minutes; 5% water 
(0.1% FA) from 11-12 min. 
MS/MS analysis was performed using a 30 eV collision energy and fragment analysis was carried 
out using ProSight Lite software. 
 
 
5.5.4 ICP-AES Measurements 
Gold ICP-AES analyses were conducted using a Shimadzu ICPE-9000 inductively coupled plasma 
atomic emission spectrometer (ICP-AES). Solutions of standard concentrations were used for 
calibration purposes and were prepared from a gold standard solution purchased from Sigma 
Aldrich, designated suitable for ICP analysis. Standard solutions were prepared with 
concentrations of 50, 100, 300, and 600 ppb in 2% OmniTrace HCl diluted with Milli-Q H2O, and 
analyses were run at λ = 242.795 nm.  
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5.5.5 Synthetic Procedures 
5.5.5.1 Synthesis of 1,3-diisopropyl-2-chloro-1,3,2-diazaphospholidine 
 
Phosphorus trichloride (483 μL, 5.55 mmol, 1.00 equiv) was added to C6H6 (7 mL), and the 
solution was cooled to 0 °C. Once at 0 °C, a solution of N,N’-diisopropylethylenediamine (1.0 mL, 
5.6 mmol, 1.0 equiv) and triethylamine (787 μL, 5.55 mmol, 1.00 equiv) in C6H6 (8 mL) cooled 
to 0 °C, was added dropwise slowly to the solution containing phosphorus trichloride. White 
precipitate formed immediately upon addition. The suspension was then stirred at room 
temperature for 2 h. After 2 h, the precipitate was filtered off and the filtrate was concentrated 
under reduced pressure to afford the pure product as a yellow oil in quantitative yield. 
The product is unstable in open atmosphere, and a degradation product was observed by 31P NMR 
spectroscopy (δ ~7 ppm in CH2Cl2) within minutes of exposure to air. All manipulations with this 
product were conducted in a glovebox under an atmosphere of purified N2 and with dried and 
degassed reagents and solvents. 
1H NMR (400 MHz, CD2Cl2, 298 K): δ 3.48-3.42 (m, 2H, CH), 3.32 (s, 2H, CH2), 3.31 (s, 2H, 
CH2), 1.30 (d, 12H, CH3, J = 6.6 Hz) ppm. 
13C{1H} NMR (125 MHz, CD2Cl2, 298 K): δ 48.90 (CH), 47.25 (CH2), 22.20 (CH3) ppm. 
31P{1H} NMR (121 MHz, CD2Cl2, 298 K): δ 168.0 ppm. 
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5.5.5.2 Synthesis of 1,2-bis(diaminophosphino)-1,2-dicarba-closo-dodecaborane 
Syntheses and full characterization for 1,2-Bis(diaminophosphino)-1,2-dicarba-closo-
dodecaborane compounds shown below can be found in the literature.3 Adapted syntheses are 
included here for convenience. 
 
A round bottom flask was charged with a solution of o-carborane (318 mg, 2.20 mmol, 1.00 equiv) 
in Et2O (5 mL) under an atmosphere of N2, and the temperature of the solution was lowered to 0 
°C. Once at 0 °C, nBuLi (2.5 M in hexane, 1.85 mL, 4.63 mmol, 2.10 equiv) was added dropwise, 
resulting in the formation of white precipitate. After complete addition, the mixture was refluxed 
at 40 °C for 3 h. After 3 h, the reaction temperature was lowered to -41 °C, at which point a solution 
of 1,3-diisopropyl-2-chloro-1,3,2-diazaphospholidine (1.15 g, 2.20 mmol, 2.50 equiv) in Et2O (12 
mL) was added via cannula transfer. The formation of an off-white precipitate was observed upon 
complete addition, at which point the reaction was allowed to warm to room temperature, and then 
stirred for 12 h. After 12 h, complete consumption of the starting materials was confirmed by TLC, 
and the solvent was evaporated under reduced pressure to yield an off-white solid. This solid was 
subjected to flash chromatography in a hexane and acetone (95:5) mixture to yield the pure product 
as a white solid (Rf = 0.77). The product was further purified via crystallization in dichloromethane 
layered with n-pentane at -30 °C. 
The product was isolated as a white and crystalline solid and is stable for months when stored in 
the solid state under an N2 atmosphere at -30 °C. 
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31P{1H} NMR (121 MHz, CDCl3, 298 K): δ 112.6 ppm. 
5.5.5.3 Synthesis of (DPCb)AuCl ((1,2-bis(1,3-diisopropyl-1,3,2-diazaphospholidin-2-yl)-1,2-
dicarba-closo-dodecaborane)AuCl) 
 
In the glovebox, a solution of 1,2-bis(1,3-diisopropyl-1,3,2-diazaphospholidin-2-yl)-1,2-dicarba-
closo-dodecaborane (DPCb, 65 mg, 0.13 mmol, 1.0 equiv) in CH2Cl2 (4 mL) was cooled to -30 
°C. This solution was then added dropwise to a cooled solution (-30 °C) of AuCl(tht) (43 mg, 0.13 
mmol, 1.0 equiv) in CH2Cl2 (4 mL) over the course of 5 min. After stirring at room temperature 
for 30 min, the solution was concentrated in vacuo to afford the crude (DPCb)AuCl complex as a 
white solid. The crude material was purified via crystallization from a concentrated solution of 
CH2Cl2 layered with n-pentane at -30 °C. The pure product was isolated as a white crystalline solid 
that is yellow in solution, and the product is stable for months when stored in the solid state under 
an N2 atmosphere at -30 °C. 
31P{1H} NMR (121 MHz, CDCl3, 298 K): δ 116.6 ppm. 
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5.5.5.4 Synthesis of (DPCb)AuNTf2 
 
In the glovebox, a CH2Cl2 (7 mL) solution of (DPCb)AuCl (91 mg, 0.12 mmol, 1.0 equiv) was 
cooled to -30 °C. This solution was then added dropwise to a cooled suspension (-30 °C) of 
AgNTf2 (49 mg, 0.12 mmol, 1.0 equiv) in CH2Cl2 (8 mL) over 5 min under protection from light. 
The reaction mixture was allowed to warm to room temperature, and after 1 h of stirring, the 
suspension was filtered through a pad of Celite and the filtrate was concentrated in vacuo to afford 
the (DPCb)AuNTf2 product as a yellow solid. The product was used without further purification 
and is stable for months when stored in the solid state under an N2 atmosphere at -30 °C. 
31P{1H} NMR (121 MHz, CDCl3, 298 K): δ 138.3 ppm. 
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5.5.5.5 Synthesis of 1 
 
In the glovebox, a solution of (DPCb)AuNTf2 (10 mg, 0.010 mmol, 1.0 equiv) in CH2Cl2 (350 L) 
was cooled to -30 °C. To this cold solution was added a cooled (-30 °C) solution of 4-iodotoluene 
(12 mg, 0.053 mmol, 5.0 equiv) in CH2Cl2 (350 L). The reaction was allowed to warm to room 
temperature for 5 min, during which time a color change to dark yellow was observed. The yellow 
solution was concentrated in vacuo to afford the product as a yellow solid. The isolated material 
was used for bioconjugation studies without further purification. 
31P{1H} NMR (121 MHz, CH2Cl2, 298 K): δ 132.09 (d, J = 22.7 Hz), 124.01 (d, J = 22.8 Hz) ppm. 
5.5.5.6 Synthesis of Biotin Aryl-I 
 
Aryl iodide substituted biotin (Biotin Aryl-I) was synthesized following Steglich esterification 
conditions.4  
A 2-neck round bottom flask was charged with a solution biotin (217 mg, 0.890 mmol, 1.00 equiv) 
in dry DMF (5 mL) under an atmosphere of Ar. To this solution was added DMAP (11 mg, 0.080 
267 
 
mmol, 10 mol%) and 4-iodoaniline (778 mg, 3.55 mmol, 4.00 equiv) under stirring. The 
temperature of the reaction mixture was lowered to 0 ˚C, at which point a solution of DCC (202 
mg, 0.980 mmol, 1.10 equiv) in DMF (5 mL) was added dropwise under stirring. The reaction 
mixture was allowed to warm to room temperature and then stirred for an additional 16 h. After 
16 h, the solution was concentrated under reduced pressure, and CH2Cl2 (25 mL) was added, 
resulting in the precipitation of colorless solids that were isolated by filtration, washed with CH2Cl2 
(2 × 25 mL) and then methanol (2 × 25 mL) to afford the product as a white solid. 
1H NMR (400 MHz, DMSO-d6): δ 9.96 (s, 1H, -NH), 7.61 (d, 2H, J = 8.8 Hz, HAr), 7.43 (d, 2H, 
J = 8.8, HAr), 6.42 (s, 1H, -NH), 6.35 (s, 1H, -NH), 4.30 (m, 1H), 4.22–4.08 (m, 1H), 3.17–3.08 
(m, 1H, -CH2SCHCH2-), 2.82 (dd, 1H, J = 12.4 Hz, 5.1 Hz, -CH2SCHCH2-), 2.57 (d, 1H, J = 12.4 
Hz, -CH2SCHCH2-), 2.30 (t, 2H, J = 7.4 Hz, -CH2CONH-), 1.70–1.53 (m, 2H, -CH2), 1.55–1.48 
(m, 2H, -CH2), 1.36 (m, 2H, -CH2) ppm. 
13C NMR (125 MHz, DMSO-d6): δ 174.48, 171.36, 162.71, 139.13, 137.29, 121.23, 61.04, 59.20, 
55.39, 36.26, 33.36, 28.22, 28.09, 25.02 ppm. 
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Figure D22. 1H NMR spectrum of Biotin Aryl-I in DMSO-d6 at 298 K. 
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Figure D23. 13C NMR spectrum of Biotin Aryl-I in DMSO-d6 at 298 K. 
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5.5.5.7 Synthesis of PEG-Tosyl 
 
A 2-neck round bottom flask was charged with a solution of poly(ethylene glycol) (577 mg, 1.05 
mmol, 1.00 equiv) in dry CH2Cl2 (5 mL) under an atmosphere of Ar. To this solution was added 
4-dimethylaminopyridine (26 mg, 0.21 mmol, 0.20 equiv) under stirring, and then the temperature 
of the reaction mixture was lowered to 0 ˚C. A solution of tosyl chloride (141 mg, 0.740 mmol, 
0.700 equiv) in CH2Cl2 (15 mL) was added dropwise to this solution, followed by dropwise 
addition of triethylamine (177 µL, 1.26 mmol, 1.20 equiv). The reaction mixture was allowed to 
warm to room temperature, and then stirred for an additional 16 h, at which point the reaction was 
diluted with water and the product was extracted three times with CH2Cl2. The organic layers were 
collected, dried over MgSO4, and the solvent was removed under reduced pressure to afford the 
product as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.80 (d, 1H, J = 8.3 Hz, HAr), 7.34 (d, 1H, J = 8.3 Hz, HAr), 4.19–
4.10 (m, 2H), 3.70–3.62 (m, 44H), 3.00 (s, 2H), 2.45 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ 144.78, 133.01, 129.82, 127.99, 72.52, 70.57, 69.24, 68.69, 
61.76, 21.66 ppm. 
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Figure D24. 1H NMR spectrum of PEG-Tosyl in CDCl3 at 298 K. 
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Figure D25. 13C NMR spectrum of PEG-Tosyl in CDCl3 at 298 K. 
 
 
 
 
 
 
 
 
273 
 
5.5.5.8 Synthesis of PEG-Aryl-I 
 
A 2-neck round bottom flask was charged with a solution of SI-2 (395 mg, 0.520 mmol, 1.00 
equiv) and 4-iodophenol (164 mg, 0.750 mmol, 1.45 equiv) in dry MeCN (20 mL). To this solution 
was added potassium carbonate (427 mg, 3.09 mmol, 6.00 equiv) under stirring. The reaction 
mixture was stirred at 80 °C for 16 h, at which point the solvent was removed under reduced 
pressure to afford colorless solids, which were dissolved in ethyl acetate and washed with water. 
The organic layer was collected, dried over MgSO4, and the solvent was removed under reduced 
pressure. The crude product was purified via column chromatography (90:10 CHCl3:MeOH) to 
afford pure PEG-Aryl-I as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ 7.54 (d, 2H, J = 9.0 Hz, HAr), 6.69 (d, 2H, J = 9.0 Hz, HAr), 4.10–
4.05 (m, 2H), 3.88–3.79 (m, 2H), 3.74–3.60 (m, 44H), 2.60 (t, 1H, t, J = 6.2 Hz) ppm. 
13C NMR (125 MHz, CDCl3): δ 158.79, 138.27, 117.18, 83.02, 72.81, 70.65, 69.70, 67.65, 61.78 
ppm. 
 
 
274 
 
 
Figure D26. 1H NMR spectrum of PEG-Aryl-I in CDCl3 at 298 K. 
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Figure D27. 13C NMR spectrum of PEG-Aryl-I in CDCl3 at 298 K. 
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5.5.6 General synthetic procedure for the preparation of [(Me-DalPhos)AuArX][SbF6] 
oxidative addition complexes (X = Cl/I) 
 
The AgSbF6 and (Me-DalPhos)AuCl reagents were stored in the glovebox under an atmosphere 
of N2 and then removed for use.  
In the fume hood, AgSbF6 was dissolved in DCM (2 mL) under protection from light, and the 
colorless solution was cooled to -20 °C. A DCM solution (2 mL) containing the aryliodide and 
(Me-DalPhos)AuCl reagents was prepared and also cooled to -20 °C. While both solutions were 
cold, the colorless aryliodide and (Me-DalPhos)AuCl solution was added in one portion to the 
solution of AgSbF6, resulting in an immediate color change to bright yellow concomitant with 
precipitation of pale yellow solids. The reaction mixture was filtered through a pad of Celite to 
remove liberated AgX (X = Cl, I). Slow evaporation of solvent from the yellow filtrate over the 
course of 48 h at 25 °C resulted in saturation of the solution and the formation of yellow crystals. 
The supernatant was removed and the crystals were washed with C6H6 (2 × 3 mL), followed by n-
pentane (2 × 3 mL), and then dried under reduced pressure to afford the [(Me-
DalPhos)AuArCl][SbF6] product as a yellow crystalline solid. 
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Following the general procedure, (Me-DalPhos)AuCl (43 mg, 0.066 mmol, 1.0 equiv), AgSbF6 
(23 mg, 0.066 mmol, 1.0 equiv) and 4-iodotoluene (43 mg, 0.20 mmol, 3.0 equiv) were used. The 
[2a][SbF6] salt was isolated as a yellow crystalline solid in 72% yield (47 mg, 0.045 mmol). This 
complex has been previously reported.5 
 1H NMR (400 MHz, CD3CN): δ 8.03 (m, 1H, HAr), 8.01–7.88 (m, 2H, HAr), 7.68 (m, 1H, HAr), 
7.43 (d, 2H, J = 8.4 Hz, HAr), 7.14 (d, 2H, J = 8.4 Hz, HAr), 3.45 (s, 6H, N(CH3)2), 2.34 (s, 3H, 
Tolyl-CH3), 2.33–2.25 (m, 6H, HAd), 2.03–1.98 (m, 12H, HAd), 1.80–1.66 (m, 12H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 75.0 ppm. 
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Figure D28. 1H NMR spectrum of [2a][SbF6]  in CD3CN at 298 K. 
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Figure D29. 31P{1H} NMR spectrum of [2a][SbF6]  in CD3CN at 298 K. 
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Following the general procedure, (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 equiv), AgSbF6 
(16 mg, 0.046 mmol, 1.0 equiv) and 4-ethyliodobenzene (20 µL, 0.14 mmol, 3.0 equiv) were used. 
The [2b][SbF6] salt was isolated as a yellow crystalline solid in 59% yield (27 mg, 0.027 mmol). 
A single crystal of suitable quality for an X-ray diffraction study was obtained using this procedure. 
The X-ray crystallographic analysis indicates 100% Cl occupancy (see section V for 
crystallographic details). 
1H NMR (400 MHz, CD3CN): δ 8.03 (m, 1H, HAr 8.00–7.89 (m, 2H, HAr), 7.69 (m, 1H, HAr), 
7.46 (d, 2H, J = 8.4, HAr), 7.17 (d, 2H,  J = 8.2, HAr), 3.45 (s, 6H, N(CH3)2), 2.65 (q, 2H, J = 7.6 
Hz, -CH2CH3), 2.28 (m, 6H, HAd), 2.11–2.08 (s, 6H, HAd) 2.04–1.99 (s, 6H, HAd), 1.73 (m, 12H, 
HAd), 1.23 (t, 3H, J = 7.6, -CH2CH3) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 74.9 ppm. 
ESI-MS(+):  768.33 (calc’d 768.33) m/z.  
Note this sample was run in the presence of formic acid, and as a result, the [(Me-DalPhos)Au(p-
ethylbenzene)OCHO]+ ion is observed (C37H50NO2PAu).  
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Figure D9. 1H NMR spectrum of [2b][SbF6] in CD3CN at 298 K. 
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Figure D10. 31P{1H} NMR spectrum of [2b][SbF6] in CD3CN at 298 K. 
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Figure D11. ESI-MS(+) of 2b. Note this sample was run in the presence of formic acid, resulting 
in Cl-/OCHO- exchange.  
 
 
 
 
 
 
 
 
 
 
284 
 
 
 
In the fume hood, a solution of AgBF4 (9 mg, 0.05 mmol, 1 equiv) in DCM (2 mL) was prepared 
under protection from light, and then cooled to -20 °C. A DCM solution (2 mL) containing 4-
ethyliodobenzene (20 µL, 0.14 mmol, 3.0 equiv) and (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 
equiv) reagents was prepared and also cooled to -20 °C. While both solutions were cold, the 
colorless 4-ethyliodobenzene and (Me-DalPhos)AuCl solution was added in one portion to the 
solution of AgBF4, and the reaction mixture was sonicated for 2 min, during which time the 
solution became yellow concomitant with the precipitation of pale yellow precipitate. The resulting 
suspension was filtered through a pad of Celite, and the filtrate was dried in vacuo to give a pale-
yellow powder. The solids were washed with C6H6 (2 × 3 mL), followed by n-pentane (2 × 3 mL), 
and then dried under reduced pressure to afford [2b][BF4] as a pale yellow powder in 86% yield 
(36 mg, 0.043 mmol).  
1H NMR (400 MHz, CD3CN): δ 8.05–8.01 (m, 1H, HAr), 7.99–7.92 (m, 2H, HAr), 7.73–7.67 (m, 
1H), 7.46 (d, 2H, d, J = 8.4 Hz), 7.17 (d, 2H, J = 8.2 Hz), 3.45 (s, 6H, N(CH3)2), 2.65 (q, 2H, J = 
7.7 Hz, -CH2CH3), 2.29 (s, 6H, HAd), 2.10 (s, 6H, HAd), 2.01 (s, 6H, HAd), 1.75 (s, 12H, HAd), 1.23 
(t, 3H, J = 7.6 Hz, -CH2CH3) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 75.7 ppm. 
 
285 
 
 
 
Figure D12. 1H NMR spectrum of [2b][BF4] in CD3CN at 298 K. 
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Figure D13. 31P{1H} NMR spectrum of [2b][BF4] in CD3CN at 298 K. 
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Following the general procedure, (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 equiv), AgSbF6 
(16 mg, 0.046 mmol, 1.0 equiv) and 2-iodonaphthalene (35 µL, 0.14 mmol, 3.0 equiv) were used. 
The [2c][SbF6] salt was isolated as a yellow crystalline solid in 64% yield (30 mg, 0.029 mmol). 
A single crystal of suitable quality for an X-ray diffraction study was obtained using this procedure 
(see section V for crystallographic details). 
 1H NMR (400 MHz, CD3CN): δ 8.10 (m, 1H, HAr), 8.06 (m, 1H, HAr), 8.01–7.89 (m, 3H, HAr), 
7.84 (m, 2H, HAr), 7.75–7.66 (m, 2H, HAr), 7.57 (m, 2H, HAr), 3.51 (s, 6H, N(CH3)2), 2.35 (m, 3H, 
HAd), 2.29–2.25 (m, 3H, HAd), 2.15 (m, 3H, HAd), 2.02 (m, 10H, HAd), 1.84–1.61 (m, 14H, HAd) 
ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 76.1 ppm. 
ESI-MS(+):  780.21 (calc’d 780.28) m/z (C38H47ClNPAu).  
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Figure D14. 1H NMR spectrum of 2c in CD3CN at 298 K. 
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Figure D15. 31P{1H} NMR spectrum of 2c in CD3CN at 298 K. 
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Figure D16. ESI-MS(+) of 2c. 
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Following the general procedure, (Me-DalPhos)AuCl (22 mg, 0.034 mmol, 1.0 equiv), AgSbF6 
(12 mg, 0.034 mmol, 1.0 equiv) and 4-iodobenzotrifluoride (25 µL, 0.17 mmol, 5.0 equiv) were 
used. The [2d][SbF6] salt was isolated as a yellow crystalline solid in 60% yield (21 mg, 0.020 
mmol). A single crystal of suitable quality for an X-ray diffraction study was obtained using this 
procedure (see section V for crystallographic details). 
1H NMR (400 MHz, CD3CN): δ 8.08–8.01 (m, 1H, HAr), 8.00–7.90 (m, 2H, HAr), 7.82 (d, J = 8.3 
Hz, 2H, HAr), 7.74–7.66 (m, 1H, HAr), 7.64 (d, J = 8.3 Hz, 2H, HAr), 3.50 (s, 6H, N(CH3)2), 2.36–
2.25 (m, 6H, HAd), 2.02 (m, 11H, HAd), 1.74 (m, 13H, HAd) ppm.  
19F NMR (376 MHz, CD3CN): δ -63.0 ppm.  
31P{1H} NMR (162 MHz, CD3CN): δ 77.6 ppm.  
ESI-MS(+): 798.17 (calc’d 798.25) m/z (C35H44ClF3NPAu).  
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Figure D17. 1H NMR spectrum of [2d][SbF6] in CD3CN at 298 K. 
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Figure D18. 19F NMR spectrum of [2d][SbF6] in CD3CN at 298 K. 
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Figure D19. 31P{1H} NMR spectrum of [2d][SbF6] in CD3CN at 298 K. The signal at 58.3 ppm 
corresponds to the starting (Me-DalPhos)AuCl compound. 
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Figure D20. ESI-MS(+) of 2d. 
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In the fume hood, a solution of AgSbF6 (12 mg, 0.034 mmol, 1.0 equiv) in DCM (2 mL) was 
prepared under protection from light, and then cooled to -20 °C. A DCM solution (2 mL) 
containing 4-iodophenetole (34 mg, 0.14 mmol, 3.0 equiv) and (Me-DalPhos)AuCl (30 mg, 0.046 
mmol, 1.0 equiv) reagents was prepared and also cooled to -20 °C. While both solutions were cold, 
the colorless 4-iodophenetole and (Me-DalPhos)AuCl solution was added in one portion to the 
solution of AgSbF6, at which point an immediate color change to yellow occurred concomitant 
with the precipitation of pale yellow precipitate. The resulting suspension was filtered through a 
pad of Celite, and the filtrate was dried in vacuo to give a pale-yellow powder. The solids were 
washed with C6H6 (2 x 3 mL), followed by n-pentane (2 x 3 mL), and then dried under reduced 
pressure to afford [2e][SbF6] as a pale yellow powder in 85% yield (29 mg, 0.029 mmol).  
 1H NMR (400 MHz, CD3CN): δ 8.02 (m, 1H, HAr), 7.95 (m, 2H, HAr), 7.72–7.64 (m, 1H, HAr), 
7.43 (d, 2H, J = 9.0 Hz), 6.92 (d, 2H, J = 8.9 Hz), 4.04 (q, 2H, J = 7.0 Hz, -CH2CH3), 3.46 (s, 6H, 
N(CH3)2), 2.29 (m, 6H, HAd), 2.12–1.98 (m, 12H, HAd), 1.73 (m, 12H, HAd), 1.37 (t, 3H, J = 7.0 
Hz) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 75.1 ppm. 
ESI-MS(+): 774.23 (calc’d 774.29) m/z (C36H49ClNOPAu). 
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Figure D21. 1H NMR spectrum of [2e][SbF6] in CD3CN at 298 K. 
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Figure D22. 31P{1H} NMR spectrum of [2e][SbF6] in CD3CN at 298 K. 
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Figure D23. ESI-MS(+) of 2e. 
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Following the general procedure, (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 equiv), AgSbF6 
(16 mg, 0.046 mmol, 1.0 equiv) and 4-iodophenol (31 mg, 0.14 mmol, 3.0 equiv) were used. The 
[2f][SbF6] salt was isolated as an orange crystalline solid in 65% yield (29 mg, 0.030 mmol). A 
single crystal of suitable quality for an X-ray diffraction study was obtained using this workup 
(See section V for crystallographic details). Elem. Anal. (Calc’d) for [2f][SbF6]·H2O, 
C34H47AuClF6NO2PSb: C, 40.64 (40.78); H, 4.51 (4.73); N, 1.39 (1.40). Crystallographic analysis 
displays one co-crystallized water molecule for each [2f][SbF6] salt complex (see section V). 
1H NMR (400 MHz, CD3CN): δ 8.02 (m, 1H, HAr), 8.01–7.88 (m, 2H, HAr), 7.67 (m, 1H, HAr), 
7.35 (d, 2H, J = 8.9 Hz, HAr), 6.83 (d, 1H, J = 8.7 Hz, HAr), 3.45 (s, 6H, N(CH3)2), 2.28 (m, 6H, 
HAd), 2.11–2.01 (m, 12H, HAd), 1.75 (m, 12H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 75.6 ppm. 
ESI-MS(+): 746.15 (746.26) m/z (C34H44Cl2NPAu). 
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Figure D24. 1H NMR spectrum of [2f][SbF6] in CD3CN at 298 K. 
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Figure D25. 31P{1H} NMR spectrum of [2f][SbF6] in CD3CN at 298K. 
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Figure D26. ESI-MS(+) of 2f. 
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Following the general procedure, (Me-DalPhos)AuCl (22 mg, 0.034 mmol, 1.0 equiv), AgSbF6 
(12 mg, 0.034 mmol, 1.0 equiv) and 4-(trifluoromethoxy)iodobenzene (27 µL, 0.17 mmol, 5.0 
equiv) were used. The [2g][SbF6] salt was isolated as a yellow crystalline solid in 51% yield (18 
mg, 0.017 mmol). A single crystal of suitable quality for an X-ray diffraction study was obtained 
using this procedure (See section V for crystallographic details). 
1H NMR (400 MHz, CD3CN): δ 8.04 (dd, J = 8.3, 3.9 Hz, 1H, HAr), 7.95 (m, 2H, HAr), 7.79–7.56 
(m, 3H, HAr), 7.30 (d, J = 8.4 Hz, 2H, HAr), 3.49 (s, 6H, N(CH3)2), 2.36–2.24 (m, 6H, HAd), 2.02 
(m, 11H, HAd), 1.73 (m, 13H, HAd) ppm.  
19F NMR (376 MHz, CD3CN): δ -58.7 ppm.  
31P{1H} NMR (162 MHz, CD3CN): δ 76.8 ppm. 
ESI-MS(+): 814.17 (calc’d 814.25) m/z (C35H44ClOF3NPAu). 
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Figure D27. 1H NMR spectrum of [2g][SbF6] in CD3CN at 298 K. 
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Figure D28. 19F NMR spectrum of [2g][SbF6] in CD3CN at 298 K. 
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Figure D29. 31P{1H} NMR spectrum of [2g][SbF6] in CD3CN at 298 K. 
 
 
308 
 
 
Figure D30. ESI-MS(+) of 2g. 
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Following the general procedure, (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 equiv), AgSbF6 
(16 mg, 0.046 mmol, 1.0 equiv) and 1-iodo-4-nitrobenzene (34 mg, 0.14 mmol, 3.0 equiv) were 
used. The [2h][SbF6] salt was isolated as an orange crystalline solid in 75% yield (35 mg, 0.035 
mmol). This complex has been previously reported.3 
1H NMR (400 MHz, CD3CN): δ 8.16 (d, J = 9.0 Hz, 2H, HAr), 8.05 (m, 1H, HAr), 7.96 (m, 1H, 
HAr), 7.90 (d, J = 9.1 Hz, 2H, HAr), 7.70 (m, 1H, HAr), 3.52 (s, 6H, N(CH3)2), 2.41–2.22 (m, 6H, 
HAd), 2.07–1.99 (m, 12H, HAd), 1.74 (m, 12H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 79.9 ppm. 
ESI-MS(+): 775.19 (calc’d 775.25) m/z (C34H44ClN2O2PAu). 
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Figure D31. 1H NMR spectrum of [2h][SbF6] in CD3CN at 298 K. 
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Figure D32. 31P{1H} NMR spectrum of [2h][SbF6] in CD3CN at 298 K.  
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Figure D33. ESI-MS(+)of 2h. 
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Following the general procedure, (Me-DalPhos)AuCl (66 mg, 0.10 mmol, 1.0 equiv), AgSbF6 (34 
mg, 0.10 mmol, 1.0 equiv) and 1-chloro-4-iodobenzene (120 mg, 0.50 mmol, 5.0 equiv) were used. 
The [2i][SbF6] salt was isolated as a yellow crystalline solid in 87% yield (87 mg, 0.087 mmol). 
A single crystal of suitable quality for an X-ray diffraction study was obtained using this procedure 
(see section V for crystallographic details).  
1H NMR (400 MHz, CD3CN): δ 8.04 (dd, J = 8.2, 4.0 Hz, 1H, HAr), 8.00–7.91 (m, 2H, HAr), 
7.73–7.65 (m, 1H, HAr), 7.58 (d, J = 8.7 Hz, 1H, HAr), 7.37 (d, J = 8.6 Hz, 1H, HAr), 3.48 (s, 6H, 
N(CH3)2), 2.29 (m, 6H, HAd), 2.02 (s, 11H, HAd), 1.74 (m, 13H, HAd) ppm.  
31P{1H} NMR (162 MHz, CD3CN): δ 77.6 ppm.  
ESI-MS(+): 764.15 (calc’d 764.23) m/z (C34H44Cl2NPAu). 
Elem. Anal. (Calc’d) for C34H44AuCl2F6NPSb: C, 40.50 (40.76); H, 4.24 (4.43); N, 1.37 (1.40). 
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Figure D34. 1H NMR spectrum of [2i][SbF6] in CD3CN at 298 K. 
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Figure D35. 31P{1H} NMR spectrum of [2i][SbF6] in CD3CN at 298 K. The signal at 59.0 ppm 
corresponds to the starting (Me-DalPhos)AuCl compound. 
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Figure D36. ESI-MS(+) of 2i. 
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In the fume hood, a solution of AgBF4 (9 mg, 0.05 mmol, 1 equiv) in DCM (2 mL) was prepared 
under protection from light, and then cooled to -20 °C. A DCM solution (2 mL) containing 4-
chloroiodobenzene (55 mg, 0.23 mmol, 5.0 equiv) and (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 
1.0 equiv) reagents was prepared and also cooled to -20 °C. While both solutions were cold, the 
colorless 4-chloroliodobenzene and (Me-DalPhos)AuCl solution was added in one portion to the 
solution of AgBF4, and the reaction mixture was sonicated for 2 min, during which time the 
solution became yellow concomitant with the precipitation of pale yellow precipitate. The resulting 
suspension was filtered through a pad of Celite. Slow evaporation of solvent from the yellow 
filtrate over the course of 48 h at 25 °C resulted in saturation of the solution and the formation of 
yellow crystals. The supernatant was removed and the crystals were washed with C6H6 (2 x 3 mL), 
followed by n-pentane (2 × 3 mL), and then dried under reduced pressure to afford [2i][BF4] as a 
yellow crystalline solid in 61% yield (26 mg, 0.031 mmol). 
1H NMR (400 MHz, CD3CN): δ 8.03 (m, 1H, HAr), 7.95 (m, 2H, HAr), 7.73–7.68 (m, 1H, HAr), 
7.58 (d, 2H, J = 8.7 Hz, HAr), 7.37 (d, 2H, J = 8.7 Hz, HAr), 3.48 (s, 6H, N(CH3)2), 2.29 (s, 6H, 
HAd), 2.10 (s, 6H, HAd), 2.03 (s, 6H, HAd), 1.75 (s, 12H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 77.4 ppm.  
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Figure D37. 1H NMR spectrum of [2i][BF4] in CD3CN at 298 K. 
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Figure D38. 31P{1H} NMR spectrum of [2i][BF4] in CD3CN at 298 K. The signal at 59.0 ppm 
corresponds to the starting (Me-DalPhos)AuCl compound. 
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Following the general procedure, (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 equiv), AgSbF6 
(16 mg, 0.046 mmol, 1.0 equiv) and 1-bromo-4-iodobenzene (65 mg, 0.23 mmol, 5.0 equiv) were 
used. The [2j][SbF6] salt was isolated as a yellow crystalline solid in 82% yield (39 mg, 0.038 
mmol). A single crystal of suitable quality for an X-ray diffraction study was obtained using this 
workup (See section V for crystallographic details). Elem. Anal. (Calc’d) for 
C34H44AuBrClF6NPSb: C, 38.56 (39.03); H, 4.03 (4.24); N, 1.29 (1.34). The low value observed 
for carbon is likely due to crystallization of 2j as a mixture of [(Me-DalPhos)Au(p-Br-C6H4)Cl]
+ 
and [(Me-DalPhos)Au(p-Br-C6H4)I]
+ species as confirmed by X-ray structural analysis of a single-
crystal obtained from the described procedure. The X-ray structural analysis indicates 77% Cl and 
23% I occupancy.  
1H NMR (400 MHz, CD3CN): δ 8.02 (m, 1H, HAr), 7.99–7.88 (m, 2H, HAr), 7.72–7.62 (m, 1H, 
HAr), 7.49 (m, 4H, HAr), 3.46 (s, 6H, N(CH3)2), 2.27 (m, 6H, HAd), 2.04 (m, 12H, HAd), 1.72 (m, 
12H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 77.6 ppm.  
ESI-MS(+): 808.18 (calc’d 808.17) m/z (C34H44ClBrNPAu). 
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Figure D39. 1H NMR spectrum of [2j][SbF6] in CD3CN at 298 K. 
 
 
322 
 
 
Figure D40. 31P{1H} NMR spectrum of [2j][SbF6] in CD3CN at 298 K. The signal at 59.2 ppm 
corresponds to the starting (Me-DalPhos)AuCl compound. 
 
 
 
 
 
 
323 
 
 
Figure D41. ESI-MS(+) of 2j. 
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Following the general procedure, (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 equiv), AgSbF6 
(16 mg, 0.046 mmol, 1.0 equiv) and 1,4-diiodobenzene (76 mg, 0.23 mmol, 5.0 equiv) were used. 
The [2k][SbF6] salt was isolated as a yellow crystalline solid in 73% yield (37 mg, 0.034 mmol).  
1H NMR (400 MHz, CD3CN): δ 8.03 (dd, J = 8.4, 4.0 Hz, 1H, HAr), 7.99–7.90 (m, 2H, HAr), 
7.72–7.67 (m, 1H, HAr), 7.66 (d, J = 8.4 Hz, 2H, HAr), 7.38 (d, J = 8.5 Hz, 2H, HAr), 3.47 (s, 6H, 
N(CH3)2), 2.36–2.22 (m, 6H, HAd), 2.04 (d, J = 16.7 Hz, 13H, HAd), 1.73 (d, J = 10.4 Hz, 11H, 
HAd) ppm.  
31P{1H} NMR (162 MHz, CD3CN): δ 77.6 ppm.  
ESI-MS(+): 856.08 (calc’d 856.16) m/z (C34H44ClINPAu). 
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Figure D42. 1H NMR spectrum of [2k][SbF6] in CD3CN at 298 K. 
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Figure D43. 31P{1H} NMR spectrum of [2k][SbF6] in CD3CN at 298 K. 
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Figure D44. ESI-MS(+) of 2k. 
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Following the general procedure, (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 equiv), AgSbF6 
(16 mg, 0.046 mmol, 1.0 equiv) and 4-fluoroiodobenzene (16 µL, 0.14 mmol, 3.0 equiv) were 
used. The [2l][SbF6] salt was isolated as a yellow crystalline solid in 74% yield (34 mg, 0.034 
mmol). The spectroscopic features of the isolated material matched those reported in the literature 
for this salt. 5 
31P{1H} NMR (162 MHz, CH2Cl2): δ 76.2 ppm.  
ESI-MS(+): 748.25 (calc’d 748.20) m/z (C34H44ClN2PFAu). 
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Figure D45. 31P{1H} NMR spectrum of [2l][SbF6] in CH2Cl2 at 298 K. 
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Figure D46. ESI-MS(+) of 2l. 
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In the fume hood, AgSbF6 (9 mg, 0.03 mmol, 1 equiv) was dissolved in DCM (2 mL) under 
protection from light, and the colorless solution was cooled to -20 °C. A DCM solution (2 mL) 
containing 2-iodopyridine (20 µL, 0.17 mmol, 6.0 equiv) and (Me-DalPhos)AuCl (18 mg, 0.028 
mmol, 1.0 equiv) reagents was prepared and also cooled to -20 °C. While both solutions were cold, 
the pale yellow 2-iodopyridine and (Me-DalPhos)AuCl solution was added in one portion to the 
solution of AgSbF6. The solution was allowed to stand at 25 °C for 24 h, during which time pale 
yellow solids precipitated out of solution. The reaction mixture was filtered through a pad of Celite, 
and the resulting pale-yellow filtrate was dried under reduced pressure. The pale-yellow residue 
was washed with C6H6 (2 x 3 mL), followed by n-pentane (2 x 3 mL), and then dried under reduced 
pressure to afford [2m][SbF6] as a pale yellow powder in 77% yield (22 mg, 0.023 mmol).  
1H NMR (400 MHz, CD3CN): δ 8.50–8.46 (m, 1H, HAr), 8.02 (m, 1H, HAr), 8.00–7.88 (m, 3H, 
HAr), 7.74–7.55 (m, 3H, HAr), 7.22 (m, 1H, HAr), 3.42 (s, 6H, N(CH3)2), 2.36 (m, 6H, HAd), 2.00 
(m, 12H, HAd), 1.84–1.64 (m, 12H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 70.4 ppm. 
ESI-MS(+): 731.25 (calc’d 731.26) m/z (C33H44ClN2PAu). 
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Figure D47. 1H NMR spectrum of [2m][SbF6] in CD3CN at 298 K. 
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Figure D48. 31P{1H} NMR spectrum of [2m][SbF6] in CD3CN at 298 K. 
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Figure D49. ESI-MS(+) of 2m. 
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Following the general procedure, (Me-DalPhos)AuCl (4.23 mg, 0.006 mmol, 1.0 equiv), AgSbF6 
(2.22 mg, 0.006 mmol, 1.0 equiv) and Trametinib (19.9 mg, 0.032 mmol, 5.0 equiv) were used. 
Dichloromethane was removed under reduced pressure after filtration through a pad of Celite to 
afford a yellow solid. This material was used without further purification. 
31P{1H} NMR (162 MHz, CD3CN): δ 79.7 ppm.  
ESI-MS(+): 1141.41 (calc’d 1141.40) m/z (C54H63ClFN6O4PAu). 
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Figure D50. 31P{1H} NMR spectrum of [2n][SbF6] in CD3CN at 298 K. 
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Figure D51. ESI-MS(+) of 2n. 
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In the fume hood, AgSbF6 (11 mg, 0.031 mmol, 1.0 equiv) was dissolved in DCM (2 mL) under 
protection from light, and the colorless solution was cooled to -20 °C. A DCM solution (2 mL) 
containing SI-3 (52 mg, 0.078 mmol, 2.5 equiv) and (Me-DalPhos)AuCl (20 mg, 0.031 mmol, 1.0 
equiv) reagents was prepared and also cooled to -20 °C. While both solutions were cold, the 
colorless SI-3 and (Me-DalPhos)AuCl solution was added in one portion to the solution of 
AgSbF6. The colorless solution was allowed to stand at 25 °C for 15 min, during which time pale 
yellow solids precipitated out of solution and a color change to pale yellow was observed. The 
reaction mixture was filtered through a pad of Celite, and the resulting pale-yellow filtrate was 
dried under reduced pressure. This material was used without further purification.  
31P{1H} NMR (162 MHz, CD3CN): δ 74.3 ppm. 
ESI-MS(+): 1262.42 (calc’d 1262.60) m/z (C58H93ClNO13PAu+Na)+.  
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Figure D52. 31P{1H} NMR spectrum of [2o][SbF6] in CD3CN at 298 K. 
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Figure D53. ESI-MS(+) of 2o. 
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Following the general procedure, (Me-DalPhos)AuCl (30 mg, 0.046 mmol, 1.0 equiv), AgSbF6 
(16 mg, 0.046 mmol, 1.0 equiv) and 5-iodoindole (56 mg, 0.23 mmol, 5.0 equiv) were used. The 
[2p][SbF6] salt was isolated as a red crystalline solid in 76% yield (35 mg, 0.035 mmol).  
1H NMR (400 MHz, CD3CN): δ 9.61 (s, 1H, -NH), 8.07 (m, 1H, HAr), 8.03–7.92 (m, 2H, HAr), 
7.69 (m, 1H, HAr), 7.48 (d, 1H, J = 7.6 Hz, HAr), 7.39 (d, 1H, J = 7.7 Hz, HAr), 7.02 (t, 1H, J = 7.7 
Hz, -CHCHNH-), 6.52 (dd, 1H, J = 3.2 Hz, 2.0 Hz, -CHCHNH-), 3.58 (s, 3H, N(CH3)2), 3.52 (s, 
3H, N(CH3)2), 2.36 (s, 4H, HAd), 2.24 (s, 4H, HAd), 2.00 (s, 3H, HAd), 1.84 (s, 4H, HAd), 1.70 (s, 
10H, HAd), 1.54 (s, 5H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 80.7 ppm. 
ESI-MS(+): 769.20 (calc’d 769.28) m/z (C36H46ClN2PAu). 
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Figure D54. 1H NMR spectrum of [2p][SbF6] in CD3CN at 298 K. 
 
343 
 
 
Figure D55. 31P{1H} NMR spectrum of [2p][SbF6] in CD3CN at 298 K. 
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Figure D56. ESI-MS(+) of 2p. 
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In the fume hood, AgSbF6 (3 mg, 0.009 mmol, 1 equiv) was dissolved in DCM (2 mL) under 
protection from light, and the colorless solution was cooled to -20 °C. A DCM suspension (2 mL) 
containing SI-1 (6 mg, 0.01 mmol, 1 equiv) and (Me-DalPhos)AuCl (6 mg, 0.009 mmol, 1 equiv) 
reagents was prepared and also cooled to -20 °C. While both solutions were cold, the colorless SI-
1 and (Me-DalPhos)AuCl suspension was added in one portion to the solution of AgSbF6. The 
colorless suspension was sonicated for 1 min, and then the reaction mixture was filtered through a 
pad of Celite. The resulting pale-yellow filtrate was dried under reduced pressure. This material 
was used without further purification.  
31P{1H} NMR (162 MHz, CD3CN): δ 74.7 ppm.  
ESI-MS(+): 971.27 (calc’d 971.35) m/z (C44H60ClN4O2PSAu). 
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Figure D57. 31P{1H} NMR spectrum of [2q][SbF6] in CD3CN at 298 K. The signal at 57.4 ppm 
corresponds to the starting (Me-DalPhos)AuCl compound. 
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Figure D58. ESI-MS(+) of 2q. 
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Following the general procedure, (Me-DalPhos)AuCl (16 mg, 0.024 mmol, 1.0 equiv), AgSbF6 (8 
mg, 0.02 mmol, 1 equiv) and 3-iodobenzanthrone (13 mg, 0.36 mmol, 1.5 equiv) were used. The 
[2g][SbF6] salt was isolated as an orange crystalline solid in 31% yield (8 mg, 0.007). A single 
crystal of suitable quality for an X-ray diffraction study was obtained using this procedure (See 
section V for crystallographic details). 
1H NMR (400 MHz, CD3CN): δ 8.79 (d, 1H, J = 7.2, HAr), 8.62 (t, 2H, J = 7.6 Hz, HAr), 8.55 (d, 
1H, J = 8.0 Hz, HAr), 8.45 (dd, 1H, J = 7.9 Hz, 1.4 Hz, HAr), 8.22 (d, 1H, J = 8.2 Hz, HAr), 8.14 
(m, 1H, HAr), 8.08 (m, 2H, HAr), 7.95 – 7.85 (m, 1H, HAr), 7.70 (t, 2H, J = 7.5 Hz, HAr), 3.67 (s, 
3H, N(CH3)2), 3.64 (s, 3H, N(CH3)2), 2.49 (s, 4H, HAd), 2.34 (s, 4H, HAd), 2.20 (s, 3H, HAd), 1.86 
(s, 4H, HAd), 1.77 (s, 4H, HAd), 1.70 (4H, s, HAd), 1.45 (s, 7H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 89.9 ppm. 
ESI-MS(+): 892.31 (calc’d 892.33) m/z. 
Note this sample was run in the presence of formic acid, and as a result, the [(Me-
DalPhos)Au(benzanthrone)OCHO]+ ion is observed (C46H50NPO3Au). 
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Figure D59. 31P NMR spectrum of [2r][SbF6] in CD3CN at 298 K. 
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Figure D60. 31P{1H} NMR spectrum of [2r][SbF6] in CD3CN at 298 K. 
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Figure D61. ESI-MS(+) of 2r. Note this sample was run in the presence of formic acid. 
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In the fume hood, AgSbF6 (16 mg, 0.046 mmol, 2.2 equiv) was dissolved in DCM (2 mL) under 
protection from light, and the colorless solution was cooled to -20 °C. A DCM solution (2 mL) 
containing 1,4-diiodobenzene (7 mg, 0.02 mmol, 1 equiv) and (Me-DalPhos)AuCl (30 mg, 0.046 
mmol, 2.2 equiv) reagents was prepared and also cooled to -20 °C. While both solutions were cold, 
the colorless 1,4-diiodobenzene and (Me-DalPhos)AuCl solution was added in one portion to the 
solution of AgSbF6, resulting in an immediate color change to bright yellow concomitant with 
precipitation of pale yellow solids. The reaction mixture was filtered through a pad of Celite, and 
the resulting yellow filtrate was allowed to stand undisturbed at 25 °C for 48 h, during which time 
the [2s][SbF6]2 product crystallized from solution. The pale-yellow supernatant was decanted, and 
the yellow crystals were washed with C6H6 (3 × 2 mL). The crystals were then washed with n-
pentane (3 mL) and dried under reduced pressure to afford [2s][SbF6]2 as a yellow crystalline solid 
in 67% yield (24 mg, 0.013 mmol). A crystal of suitable quality for an X-ray diffraction study was 
obtained using this procedure. The X-ray crystallographic analysis indicated 2s crystallized with 
100% Cl occupancy (see section V). 
1H NMR (400 MHz, CD3CN): δ 8.08–8.04 (m, 2H, HAr), 8.02–7.91 (m, 4H, HAr), 7.70 (m, 2H, 
HAr), 7.53 (s, 4H, HAr), 3.50 (s, 12H, N(CH3)2), 2.28 (d, J = 8.8 Hz, 12H, HAd), 2.09 (s, 12H, HAd), 
2.04–1.99 (m, 11H, HAd), 1.74 (m, 25H, HAd) ppm. 
31P{1H} NMR (162 MHz, CD3CN): δ 78.6 ppm. 
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ESI-MS: 691.17 (calc’d 691.24) m/z for C62H84Cl2N2P2Au2. 
 
Figure D62. 1H NMR spectrum of [2s][SbF6]2 in CD3CN at 298 K. 
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Figure D63. 31P{1H} NMR spectrum of [2s][SbF6]2 in CD3CN at 298K. 
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Figure D64. ESI-MS(+)of 2s. 
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5.5.7 Stability studies of complexes [2a][SbF6] and [2c][SbF6]. 
 
 
Figure D65. 1H NMR spectrum of a newly prepared sample of [2a][SbF6] (top) and spectrum of 
the same sample after storage as a solid for two months at 25 °C (bottom). Spectra collected in 
CD3CN, 298 K. 
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Figure D66. 31P{1H} NMR spectrum of a newly prepared sample of [2a][SbF6] (top) and spectrum 
of the same sample after storage as a solid for two months at 25 °C (bottom). Spectra collected in 
CD3CN, 298 K. 
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Figure D67. 1H NMR spectrum of a newly prepared sample of [2c][SbF6] (top) and spectrum of 
the same sample after storage as a solid for two months at 25 °C (bottom). Spectra collected in 
CD3CN at 298 K. 
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Figure D68. 31P{1H} NMR spectrum of a newly prepared sample of [2c][SbF6] (top) and spectrum 
of the same sample after storage as a solid for two months at 25 °C (bottom). Spectra collected in 
CD3CN at 298 K. 
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Figure D69. 31P{1H} NMR spectra of a newly prepared sample of [2o][SbF6] in water (bottom) 
and after storage for up to 72 hours in water at 25 ˚C. 
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5.5.8 Peptide Synthesis and Protein Expression 
The following general protocol was followed for all solid phase peptide syntheses: 
Preparation of Resin: 
Rink amide resin (1 g, 0.44 mmol/g) was weighed out and added to a 25 mL peptide synthesis 
vessel. Dimethylformamide (DMF; 10 mL) was added and the resin was shaken for a minimum of 
1 h to swell. The resin was subsequently washed with DMF (3 × 10 mL), dichloromethane (3 × 10 
mL), and DMF (3 × 10 mL).  
First Deprotection:  
A 20% solution of 4-methylpiperdine in DMF (10-15 mL/g of resin) was added and the vessel was 
shaken for 20 min. After shaking, the resin was washed once with DMF (10 mL). The 20% solution 
of 4-methylpiperdine in DMF (10-15 mL/g of resin) was added and the vessel was shaken for an 
additional 5 minutes. The resin was then washed three times with DMF (10 mL, 1 min washes) to 
ensure complete removal of 4-methylpiperdine. 
Coupling of Amino Acids: 
Amino acid (3 equiv to resin) and HBTU (2.9 equiv to resin) were weighed out and dissolved in 
DMF (10 mL). Once dissolved, DIPEA (6 equiv to resin) was added and the mixture stirred for 1 
min. This mixture was then added to the resin and the resin was subjected to shaking for 45 min. 
After shaking, the resin was washed with DMF (3 × 10 mL, 1 min intervals) to ensure the complete 
removal of residual amino acid. 
Coupling of Cysteine: 
Coupling of Cysteine was performed using a procedure from: Han, Y. Albericio, F.; Barany, G. J. 
Org. Chem., 1997, 62, 4307-4312. 
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Cysteine (3 equiv to resin), HATU (4 equiv to resin), and HOAt (0.6 M in DMF, 4 equiv to resin) 
were combined in DMF (6 mL) and CH2Cl2 (6 mL). Once dissolved, 2,4,6-trimethylpyridine (4 
equiv to resin) was added and the mixture stirred quickly (1-2 seconds) and added to the resin. The 
mixture was shaken for 1 h. After shaking, the resin was washed with DMF (5 × 10 mL, 1 min 
intervals) to ensure the removal of residual amino acid. After the coupling of cysteine, the normal 
protocol was followed. 
Deprotection of Amino Acids After Coupling: 
A 20% solution of 4-methylpiperdine in DMF (10-15 mL/g of resin) was added and the vessel was 
shaken for 10 min. After shaking, the resin was washed once with DMF (10 mL). The 20% solution 
of 4-methylpiperdine in DMF (10-15 mL/g of resin) was added and the vessel was shaken for an 
additional 5 min. The resin was then washed three times with DMF (10 mL, 1 minute washes) to 
ensure the compete removal of 4-methylpiperdine. 
Cleavage from Resin: 
After the final deprotection, the resin was washed with DCM (3 × 10 mL). The dried resin was 
transferred to a 20 mL scintillation vial equipped with a magnetic stir bar and a septum. Argon gas 
was flowed over the resin for 5 minutes. A cleavage cocktail consisting of a 95:2.5:2.5 mixture of 
TFA:H2O:TIPS (TIPS = triisopropylsilane) was prepared and added to the resin. The slurry was 
stirred for 3-4 hours under argon. Cleavage time depends on the amino acid composition of the 
peptide. Aliquots of the slurry were analyzed via LC-MS after filtration through a small pipette 
filter and dilution with water to determine full removal of peptide protecting groups. After 3-4 h, 
the cleavage cocktail was filtered and the filtrate was concentrated under a stream of argon until 1 
mL remained. To this solution was added cold (-20 °C) diethyl ether, resulting in the precipitation 
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of the crude peptide. The suspension was centrifuged, the supernatant was decanted. This washing 
process was repeated twice more, and then the resulting solids were dried under reduced pressure. 
*It is important to use fresh TIPS solutions. TIPS stored longer than two months is less effective. 
All peptides were stored in sealed containers under argon at -20 °C. 
The isolated crude peptides were purified by reversed-phase HPLC (retention time 5.5-6.6 min 
using procedure described in SI section I). The obtained pure fractions were combined, and 
lyophilized.  
Protein Expression 
DARPin-Cys protein expression and purification was performed following literature procedures.4 
DARPin-Cys Sequence (Calculated Mass: 13747.3 Da): 
GGCGGSDLGKKLLEAARAGQDDEVRILMANGADVNAYDDNGVTPLHLAAFLGHLEI 
VEVLLKYGADVNAADSWGTTPLHLAATWGHLEIVEVLLKHGADVNAQDKFGKTAF 
DISIDNGNEDLAEILQKLN 
FGF2 was expressed and purified from plasmid pET29c (+)hFGF-2, provided by Professor 
Thomas Scheper from the Helmholtz Centre for Infection Research (Braunschweig, Germany) 
according to Chen et al.6 
FGF2 Sequence (Calculated Mass: 17122.6 Da): 
AAGSITTLPALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIK
LQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRK
YTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 
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5.5.9 Peptide Traces and Masses: 
 
 
Figure D70. LC-MS trace for native GSH (BioXtra grade purchased from Sigma Aldrich). 
308.0965 (calc’d 308.0911) m/z for C10H17N3O6S. 
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Figure D71. LC-MS traces for native peptides used in this study. (*) denotes Tris buffer (122 m/z). 
Top panel: 460.2605 (calc’d 460.2627) m/z for C17H33N9O6. Middle panel: 860.4908 (calc’d 
860.4883) m/z for C34H65N15O9S. Bottom panel: 476.2416 (calc’d 476.2398) m/z for C17H33N9O5S. 
 
 
 
 
366 
 
 
Figure D72. LC-MS trace for native dicysteine peptide. 596.1845 (calc’d 596.1803) m/z for 
C20H33N7O10S2. 
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5.5.10 Procedures and Characterization for Cysteine Arylation 
Procedure and Characterization Data for Peptide Arylation Studies Using Complex 
[1][NTf2]. 
After the oxidative addition reaction of 4-iodotoluene with (DPCb)AuNTf2 proceeded to 
quantitative conversion (>99%) as determined by 31P NMR analysis,  the reaction mixture was 
filtered through Celite and dichloromethane was removed from the filtrate under reduced pressure 
to produce a yellow solid. A 15 mM stock solution was prepared by dissolution of the obtained 
yellow solids in MeCN.  
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Figure D73. LC-MS traces for arylation of GSH using 1 at different reagent loadings. (*) denotes 
buffer. 398.1450 (calc’d 398.1380) m/z for C17H23N3O6S. 
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5.5.11 Procedure and Characterization Data for Water Equivalents Screen of Peptide 
Arylation Using [1][NTf2]. 
After the oxidative addition reaction of 4-iodotoluene with (DPCb)AuNTf2 proceeded to 
quantitative conversion (>99%), the solvent was removed under reduced pressure to produce a 
yellow solid. The yellow solid was dissolved in acetonitrile to prepare a 30 mM stock solution. 
Stock solutions of 15 mM and 10 mM were prepared from the initial 30 mM stock solution of the 
gold reagent in acetonitrile. A 2 mM solution of glutathione was prepared in 200 mM pH 8.0 Tris 
buffer. Reaction solutions were prepared in the following manner: 
H2O:MeCN Gold Complex Stock Solution Peptide Stock Solution Water Added 
90:10 10 μL of 30 mM 50 μL 40 μL 
80:20 20 μL of 15 mM 50 μL 30 μL 
70:30 30 μL of 10 mM 50 μL 20 μL 
 
To a 2 mL Eppendorf tube was added 50 μL of the peptide stock solution and the appropriate 
amount of water (MilliQ). To this solution was added the appropriate amount of gold reagent stock 
solution, and the Eppendorf tube was vortexed (<5 seconds). After 1 min, a 20 μL aliquot was 
removed and diluted in a 100 μL solution of 1:1 H2O:MeCN with 0.1% mol TFA. An aliquot from 
this solution was analyzed via LCMS.   
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Figure D74. LC-MS traces for arylation of GSH using [1][NTf2] in different water concentrations. 
398.1433 (calc’d 398.1380) m/z for C17H23N3O6S. 
5.5.12 Procedure and Characterization Data for Reagent Equivalents Screen of Peptide 
Arylation Using [2a][SbF6]. 
Acetonitrile solutions of [2a][SbF6] were prepared in 6, 4, and 2 mM concentrations. A 2 mM 
solution of glutathione was prepared in 200 mM pH 8.0 Tris buffer. In a 2 mL Eppendorf tube was 
added 20 μL of the peptide solution and 20 μL of the reagent solution, and the sample was then 
vortexed (<5 seconds). At one min, a 20 μL aliquot was removed from the reaction mixture and 
diluted in 100 μL of a solution of 1:1 H2O:MeCN with 0.1% TFA. An aliquot from this solution 
was analyzed via LCMS.   
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Reagent:Peptide Gold Complex Stock Peptide Stock 
3:1 20 μL of 6 mM 20 μL 
2:1 20 μL of 4 mM 20 μL 
1:1 20 μL of 2 mM 20 μL 
 
Figure D75. LC-MS traces for arylation of GSH using [2a][SbF6] at different reagent loadings. 
398.1417 (calc’d 398.1380) m/z for C17H23N3O6S. 
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5.5.13 Procedure and Characterization Data for Water Equivalents Screen of Peptide 
Arylation Using [2a][SbF6] 
Acetonitrile solutions of [2a][SbF6] at 30, 15, and 10 mM concentrations were prepared. A 2 mM 
solution of glutathione was prepared in 200 mM pH 8.0 Tris buffer. Reaction solutions were 
prepared in the following manner: 
H2O:MeCN Gold Complex Stock Peptide Stock Water Added 
90:10 10 μL of 30 mM 50 μL 40 μL 
80:20 20 μL of 15 mM 50 μL 30 μL 
70:30 30 μL of 10 mM 50 μL 20 μL 
 
To a 2 mL Eppendorf tube was added 50 μL of peptide stock solution and appropriate amount of 
water (MilliQ). To this solution was added the appropriate amount of gold reagent stock solution, 
and the Eppendorf tube was vortexed (<5 seconds). At one min, a 20 μL aliquot was removed and 
diluted in a 100 μL solution of 1:1 H2O:MeCN with 0.1% mol TFA. An aliquot from this solution 
was analyzed via LCMS.   
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Figure D76. LC-MS traces for arylation of GSH using [2a][SbF6] in different water 
concentrations. 398.1417 (calc’d 398.1380) m/z for C17H23N3O6S. 
5.5.14 Procedure and Characterization Data for Buffer and pH Screen of Peptide Arylation 
Using [2a][SbF6] 
A 15 mM solution of [2a][SbF6] in MeCN was prepared, and a 2 mM solution of glutathione was 
prepared in 1 M buffer.  
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Figure D77. LC-MS traces for arylation of GSH using [2a][SbF6] in different pH ranges. (*) 
denotes buffer. 398.1417 (calc’d 398.1380) m/z for C17H23N3O6S. 
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Figure D78. LC-MS traces for arylation of GSH using [2a][SbF6] in the presence of 4 M 
guanidine·HCl (top) and TCEP·HCl. 398.1399 (calc’d 398.1380) m/z for C17H23N3O6S. 
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5.5.15 Cysteine Arylation in Unconventional Solvents 
To a 2 mL Eppendorf tube was added 10 μL of peptide stock (20 mM) solution in 200 mM Tris 
pH 8.0 and 70 μL of solvent. To this solution was added 20 μL of the gold reagent stock solution 
(15 mM) in acetonitrile, and the Eppendorf tube was vortexed (<5 seconds). At one min, a 20 μL 
aliquot was removed and diluted in a 100 μL solution of 1:1 H2O:MeCN with 0.1% mol TFA. An 
aliquot from this solution was analyzed via LCMS.   
 
Figure D79. Arylation in unconventional solvents using [2a][SbF6] and [2b][SbF6]. Tolyl 
modified GSH: 398.1413 (calc’d 398.1380) m/z for C17H23N3O6S. p-CF3 modified GSH: 452.1142 
(calc’d 452.1098) m/z for C17H20F3N3O6S. 
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5.5.16 Substrate Scope for Glutathione 
To a 2 mL Eppendorf tube was added 50 μL of peptide stock solution in 1 M Tris pH 8.0 and 30 
μL of water (MilliQ). To this solution was added 20 μL of a 15 mM gold reagent stock solution, 
and the Eppendorf tube was vortexed (<5 seconds). At one min, a 20 μL aliquot was removed and 
diluted in a 100 μL solution of 1:1 H2O:MeCN with 0.1% mol TFA. An aliquot from this solution 
was analyzed via LCMS.   
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Figure D80. LC-MS traces for arylation of GSH using [2b][SbF6], [2g][SbF6], and [2d][SbF6] 
with optimized conditions. Top panel: 412.1587 (calc’d 412.1537) m/z for C18H25N3O6S. Middle 
panel: 468.1099 (calc’d 468.1047) m/z for C17H20F3N3O7S. Bottom panel: 452.1152 (calc’d 
452.1098) m/z for C17H20F3N3O6S. 
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Figure D81. LC-MS traces for arylation of GSH using [2f][SbF6], [2h][SbF6], and [2c][SbF6] with 
optimized conditions. (*) denotes Tris buffer (122 m/z). Top panel: 400.1200 (calc’d 400.1173) 
m/z for C16H21N3O7S. Middle panel: 429.1124 (calc’d 429.1075) m/z for C16H20N4O8S. Bottom 
panel: 434.1428 (calc’d 434.1380) m/z for C20H23N3O6S. 
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Figure D82. LC-MS traces for arylation of GSH using [2e][SbF6], [2k][SbF6], and [2l][SbF6] with 
optimized conditions. Top panel: 428.1533 (calc’d 428.1486) m/z for C18H25N3O7S. Middle panel: 
510.0217 (calc’d 510.0190) m/z for C16H20N3O6IS. Bottom panel: 402.1166 (calc’d 402.1130) m/z 
for C16H20N3O6FS. 
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Figure D83. LC-MS traces for arylation of GSH using [2p][SbF6] and [2m][SbF6] with optimized 
conditions. Top panel: 423.1362 (calc’d 423.1333) m/z for C18H22N4O6S. Bottom panel: 385.1205 
(calc’d 385.1176) m/z for C15H20N4O6S. 
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Figure D84. LC-MS traces for arylation of GSH using [2j][SbF6] and [2i][SbF6] with optimized 
conditions. Top panel: 462.0359 (calc’d 462.0329) m/z for C16H20N3O6BrS. Bottom panel: 
418.0869 (calc’d 418.0834) m/z for C16H20N3O6ClS. 
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Figure D85. LC-MS traces for arylation of GSH using [2q][SbF6] and [2r][SbF6] with optimized 
conditions. Top panel: 625.2135 (calc’d 652.2109) m/z for C26H36N6O8S2. Bottom panel: 536.1512 
(calc’d 536.1486) m/z for C27H25N3O7S. 
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Figure D86. Modification of glutathione using [2i][BF4] with optimized conditions. 418.0866 
(calc’d 418.0834) m/z for C16H20N3O6ClS. 
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5.5.17 Au(III) and Pd(II) Competition Experiments with GSH 
To 50 µL of a 2 mM GSH solution in 100 mM Tris buffer (pH 8.0) was added 20 µL of water 
followed by 45 µL of a mixture of [2b][SbF6] (15 µL of a 10 mM MeCN solution) and 
(RuPhos)Pd(tolyl)I (30 µL of a 20 mM MeCN solution) in MeCN. The reaction mixture was 
vortexed for ca. 10 sec, and then allowed to stand at room temperature for 5 min. A 20 µL aliquot 
from the mixture was then diluted with a solution of thiopropionic acid (10 µL of a 0.3 M solution 
in H2O) in a 1:1 H2O:MeCN mixture with 0.1% TFA. An aliquot from this solution was analyzed 
by LCMS. 
 
Figure D87. Representative LCMS trace for Au(III) and Pd(II) competition experiments. 
Ethylbenzene modified GSH: 412.1577 (calc’d 412.1537) m/z for C18H25N3O6S. Tolyl modified 
GSH: 398.1401 (calc’d 398.1380) m/z for C17H23N3O6S. 
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Figure D88. Modification of GSH using (RuPhos)Pd(tolyl)I in conditions replicating those used 
in Scheme 5-2 of the main text (100 mM Tris pH 8.0, 6:4 [H2O]:[MeCN]). 
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5.5.18 Preparation of S-(p-Cl-C6H4) GSH conjugate 
 
To a solution of GSH (16 mg, 0.052 mmol, 1.0 equiv) in H2O (8 mL, 0.2 M Tris, pH 8) was added 
a suspension of [2i][SbF6] (116 mg, 0.116 mmol, 2.23 equiv) in MeCN (2 mL). The resulting 
suspension was sonicated for 30 sec, and then allowed to stand at 25 °C for an additional 4.5 min. 
The reaction mixture was then diluted with a 50/50 mixture of MeCN/H2O containing 0.1%TFA, 
and the resulting suspension was centrifuged for 2 min, at which point the supernatant was 
decanted and passed through a 0.45 μm filter. The filtrate was lyophilized and the obtained solid 
was dissolved in H2O containing 0.1% TFA and purified by semi-preparative reversed-phase 
HPLC.  
Solvent compositions for reversed-phase HPLC purification were: H2O with 0.1% TFA (solvent 
A), MeCN with 0.1% TFA (solvent B). 0-5 min, 100% A; 5-60 min, linear gradient 100-60% A; 
65-75 min, linear gradient 40-100% B. Flow rate: 3 mL/min. HPLC fractions containing the pure 
product were further confirmed by LC-MS, combined, and lyophilized. 
ICP-AES was used to measure the remaining gold content in the purified S-(p-Cl-C6H4) GSH 
conjugate. Of the isolated material, 3.85 mg was dissolved in 10 mL of a 2% HCl (aq) solution 
(385 ppm concentration), and the material was filtered through a 0.45 μm filter. The resulting 
solution was analyzed by ICP-AES, and the concentration of gold in this sample was determined 
to be 55 ppb. This analysis indicates >99.9% efficiency for the removal of gold-containing species 
by the described purification procedure.  
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5.5.19 Substrate Scope for Larger Peptide Sequences 
To a 2 mL Eppendorf tube was added 50 μL of peptide stock solution in 200 mM Tris pH 8.0 and 
30 μL of water (MilliQ). To this solution was added 20 μL of a 15 mM gold reagent stock solution, 
and the Eppendorf tube was vortexed (<5 seconds). At one min, a 20 μL aliquot was removed and 
diluted in a 100 μL solution of 1:1 H2O:MeCN with 0.1% mol TFA. An aliquot from this solution 
was analyzed via LCMS.   
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Figure D89. LC-MS traces for arylation of unprotected peptide using [2m][SbF6], [2f][SbF6], and 
[2d][SbF6] with optimized conditions. Top panel: 553.2710 (calc’d 553.2664) m/z for 
C22H36N10O5S. Middle panel: 568.2700 (calc’d 568.2660) m/z for C23H37N9O6S. Bottom panel: 
620.2639 (calc’d 620.2585) m/z for C24H36F3N9O5S. 
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Figure D90. LC-MS traces for arylation of unprotected peptide using [2i][SbF6] and [2j][SbF6] 
with optimized conditions. (*) denotes Tris buffer (122 m/z). Top panel: 586.2371 (calc’d 
586.2321) m/z for C23H36ClN9O5S. Bottom panel: 630.1864 (calc’d 630.1816) m/z for 
C23H36BrN9O5S. 
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To a 2 mL Eppendorf tube was added 50 μL of peptide stock solution in 1 M Tris pH 8.0. To this 
solution was added 50 μL of a 6 mM gold reagent stock solution, and the Eppendorf tube was 
vortexed (<5 seconds). At one min, a 20 μL aliquot was removed and diluted in a 100 μL solution 
of 1:1 H2O:MeCN with 0.1% mol TFA. An aliquot from this solution was analyzed via LCMS.   
 
 
Figure D91. LC-MS trace of control reaction using serine substituted peptide. 460.2596 (calc’d 
460.2627) m/z for C17H33N9O6. 
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To a 2 mL Eppendorf tube was added 50 μL of peptide stock solution in 200 mM Tris pH 8.0 and 
30 μL of water (MilliQ). To this solution was added 20 μL of a 15 mM gold reagent stock solution 
in acetonitrile, and the Eppendorf tube was vortexed (<5 seconds). At one min, a 20 μL aliquot 
was removed and diluted in a 100 μL solution of 1:1 H2O:MeCN with 0.1% mol TFA. An aliquot 
from this solution was analyzed via LCMS.   
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Figure D92. LC-MS traces for arylation of unprotected peptide using [2i][SbF6], [2j][SbF6], and 
[2p][SbF6] with optimized conditions. Top panel: 970.4885 (calc’d 970.4806) m/z for 
C40H68ClN15O9S. Middle panel: 1014.4373 (calc’d 1014.4301) m/z for C40H68BrN15O9S. Bottom 
panel: 975.5369 (calc’d 975.5305) m/z for C42H70N16O9S. 
Cysteine arylation using compound 2o: To a 2 mL Eppendorf tube was added 50 μL of peptide 
stock solution in 200 mM Tris pH 8.0. To this solution was added 50 μL of a 6 mM gold reagent 
stock solution in water (MilliQ), and the Eppendorf tube was vortexed (<5 seconds). At one min, 
a 20 μL aliquot was removed and diluted in a 100 μL solution of 1:1 H2O:MeCN with 0.1% mol 
TFA. An aliquot from this solution was analyzed via LCMS. Cysteine arylation using compound 
2q To a 2 mL Eppendorf tube was added 50 μL of peptide stock solution in 200 mM Tris pH 8.0 
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and 20 μL of water (MilliQ). To this solution was added 30 μL of a 10 mM gold reagent stock 
solution in acetonitrile, and the Eppendorf tube was vortexed (<5 seconds). At one min, a 20 μL 
aliquot was removed and diluted in a 100 μL solution of 1:1 H2O:MeCN with 0.1% mol TFA. An 
aliquot from this solution was analyzed via LCMS.   
 
Figure D93. LC-MS traces for arylation of unprotected peptide using [2o][SbF6] and [2q][SbF6] 
with optimized conditions. (*) denotes Tris buffer (122 m/z). Top panel: 1480.8350 (calc’d 
1480.8291) m/z for C64H117N15O22S. Bottom panel: 1177.6129 (calc’d 1177.6081) m/z for 
C50H84N18O11S2. 
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Figure D94. LC-MS trace of unprotected peptide modified with [2n][SbF6] (top) as well as a 
control in which no peptide was added (bottom). (*) indicate Tris buffer (122 m/z). 1347.6594 
(calc’d 1347.6539) m/z for C60H87FN20O13S. 
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5.5.20 Peptide Stapling Procedure 
 
To a solution of the peptide (H2N-CDAACD-CONH2) in H2O (2.8 mM, 5 mL, 0.2 M Tris, pH 8) 
was added a solution of [2s][SbF6]2 in MeCN (5.6 mM, 5 mL). The suspension was sonicated for 
1 min, and then allowed to stand at 25 °C for a total of 30 min, at which point the reaction mixture 
was diluted with a 50/50 mixture of MeCN/H2O containing 0.1%TFA, and the resulting suspension 
was centrifuged for 2 min. The supernatant was decanted and passed through a 0.45 μm filter. The 
filtrate was lyophilized and the obtained solid was dissolved in H2O containing 0.1% TFA and 
purified by semi-preparative reversed-phase HPLC.  
Solvent compositions for reversed-phase HPLC purification were: H2O with 0.1% TFA (solvent 
A), MeCN with 0.1% TFA (solvent B). 0-5 min, 100% A; 5-60 min, linear gradient 100-60% A; 
65-75 min, linear gradient 40-100% B. Flow rate: 3 mL/min. HPLC fractions containing the pure 
product were further confirmed by LC-MS, combined, and lyophilized. 
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5.5.21 Double Arylation of Dicysteine Peptide  
To an Eppendorf tube containing 20 µL H2O was added 50 µL (1.0 equiv) of a 2 mM solution of 
the peptide (H2N-CDAACD-CONH2) in H2O (0.2 M Tris, pH 8). To this tube was added 40 µL 
(6.0 equiv) of a 15 mM solution of [2m][SbF6] in MeCN. The reaction mixture was vortexed for 
5 sec, and then allowed to stand for 5 min. A 20 µL aliquot of this solution was diluted with 100 
µL of a 50/50 mixture of MeCN/H2O containing 0.1%TFA, and the resulting solution was 
analyzed by LC-MS.  
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Figure D95. LC-MS trace of di-arylated peptide. 750.2395 (calc’d 750.2334) m/z for 
C30H39N9O10S2. 
 
5.5.22 Trypsin Digest and MS/MS experiments: 
 
Trypsin digest experiment was performed by combining 50 µL of a 2 mM solution of peptide, 30 
µL of water, and 20 µL of a 15 mM solution of [2a][SbF6] or [2i][SbF6], vortexing for <5 seconds 
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and sitting at room temperature for 1 minute. After 1 minute, 20 µL of a 1 mg/mL solution of 
trypsin in water was added, vortexed for <5 seconds, and heated to 37 °C for 10 minutes. A 20 µL 
aliquot was taken from the mixture and added to 100 µL of a 50:50 (H2O:MeCN 0.1% TFA) 
solution and analyzed via LC-MS. 
 
 
Figure D96. LC-MS traces of trypsin digest experiment of modified peptide (top) and native 
peptide (bottom). 
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Figure D97. LC-MS trace of trypsin digested peptide modified with [2i][SbF6]. 
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Figure D98. MS/MS analysis of dicysteine peptide, H2N-CDAACD-CONH2. 
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Figure D99. MS/MS analysis of stapled peptide. 
 
 
 
 
 
 
 
403 
 
 
Figure D100. MS/MS analysis of native peptide sequence used for conjugation. 
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Figure D101. MS/MS analysis of arylated peptide. 
 
 
 
 
 
 
 
 
 
405 
 
5.5.23 Procedure for protein modifications 
DARPin Modification: 50 µL of a 72.9 µM solution of DARPin in 20 mM Tris, 150 mM NaCl 
(pH: 7.5) was added to an Eppendorf tube. To this was added 45 µL of water and 5 µL of a 7.3 
mM solution of 2a in DMF. The solution was pipetted 20 times to ensure proper mixing and 
allowed to stand at room temperature for 30 min. After 30 min, a 20 µL aliquot of the reaction 
mixture was added to 100 µL of a 50:50 water/acetonitrile 0.1% TFA solution. 
FGF2 Modification: 50 µL of a 0.66 µM solution of FGF2 in 200 mM Tris (pH 8.7) was added to 
an Eppendorf tube. To this solution was added 50 µL of a 9.93 µM solution of 2g in water. The 
reaction m mixture was pipetted 20 times to ensure proper mixing and allowed to stand at room 
temperature for 30 min. After 30 min, a 20 µL aliquot of the reaction mixture was added to 100 
µL of a 50:50 water/acetonitrile 0.1% TFA solution. 
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Figure D102. Modification of FGF2 using 2o and corresponding masses. Di-PEGylation is 
consistent with the presence of two accessible cysteine residues. 
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5.5.24 X-Ray Crystallographic Data 
 
 
Solid-state structure of DPCb with thermal ellipsoids rendered at the 50% probability level and 
with hydrogen atoms omitted for clarity.  
Crystallographic Data for 1,2-bis(1,3-diisopropyl-1,3-2-diaminophosphino)-1,2-dicarba-closo-
dodecaborane (DPCb). 
Identification code  MSM-A-2-221 
CCDC Code 1836204 
Empirical formula  C18 H46 B10 N4 P2 
Formula weight  488.63 
Temperature  100.15 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n  
Unit cell dimensions a = 11.492(2) Å = 90° 
 b = 19.277(3) Å = 99.819(5)° 
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 c = 13.003(2) Å  = 90° 
Volume 2838.3(8) Å3 
Z 4 
Density (calculated) 1.143 Mg/m3 
Absorption coefficient 0.169 mm-1 
F(000) 1048 
Crystal size 0.27 x 0.23 x 0.12 mm3 
Theta range for data collection 2.086 to 27.120°. 
Index ranges -14 ≤ h ≤ 14, -24 ≤ k ≤ 22, -16 ≤ l ≤ 16 
Reflections collected 20897 
Independent reflections 6265 [R(int) = 0.0409] 
Completeness to theta = 25.242° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.2612 and 0.2263 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6265 / 0 / 315 
Goodness-of-fit on F2 1.023 
Final R indices [I > 2σ(I)] R1 = 0.0418, wR2 = 0.0958 
R indices (all data) R1 = 0.0619, wR2 = 0.1062 
Extinction coefficient n/a 
Largest diff. peak and hole 0.326 and -0.259 e.Å-3 
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 Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) for 1,2-
bis(1,3-diisopropyl-1,3-2-diaminophosphino)-1,2-dicarba-closo-dodecaborane (DPCb).  U(eq) is 
defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________   
P(1) 2021(1) 3922(1) 3137(1) 13(1) 
P(2) 4592(1) 3186(1) 3011(1) 12(1) 
N(1) 591(1) 4152(1) 2885(1) 19(1) 
N(2) 2102(1) 4047(1) 4434(1) 16(1) 
N(3) 4414(1) 3522(1) 1802(1) 14(1) 
N(4) 5655(1) 2614(1) 2821(1) 16(1) 
C(1) 3292(2) 2555(1) 2925(1) 13(1) 
C(2) 2014(2) 2913(1) 3113(1) 13(1) 
C(3) 4933(2) 3052(1) 1107(1) 16(1) 
C(4) 5964(2) 2668(1) 1771(1) 20(1) 
C(5) 4585(2) 4280(1) 1701(1) 17(1) 
C(6) 3880(2) 4538(1) 677(2) 23(1) 
C(7) 5884(2) 4485(1) 1817(2) 22(1) 
C(8) 6593(2) 2450(1) 3714(1) 20(1) 
C(9) 7507(2) 3026(1) 3935(2) 33(1) 
C(10) 7169(2) 1761(1) 3555(2) 35(1) 
C(11) 34(2) 4070(1) 3812(2) 27(1) 
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C(12) 976(2) 4251(1) 4728(2) 24(1) 
C(13) -165(2) 4261(1) 1868(2) 29(1) 
C(14) -851(2) 4931(1) 1856(2) 45(1) 
C(15) 531(2) 4250(1) 986(2) 36(1) 
C(16) 3200(2) 4336(1) 5035(1) 19(1) 
C(17) 3295(2) 5119(1) 4910(2) 32(1) 
C(18) 3322(2) 4124(1) 6172(2) 30(1) 
B(9) 2865(2) 2481(1) 4131(2) 17(1) 
B(4) 850(2) 2436(1) 2491(2) 16(1) 
B(2) 3048(2) 1818(1) 2176(2) 16(1) 
B(8) 3505(2) 1772(1) 3550(2) 18(1) 
B(1) 2134(2) 2564(1) 1910(2) 15(1) 
B(7) 2333(2) 1232(1) 2924(2) 21(1) 
B(10) 2234(2) 1645(1) 4140(2) 21(1) 
B(5) 1310(2) 2381(1) 3862(2) 18(1) 
B(3) 1486(2) 1729(1) 1898(2) 19(1) 
B(6) 981(2) 1614(1) 3122(2) 21(1) 
______________________________________________________________________________  
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Solid-state structure of [2c][SbF6] with thermal ellipsoids rendered at the 50% probability level 
and with hydrogen atoms, and [SbF6]
- counterion omitted for clarity.  
Crystallographic Data for [2c][SbF6]. 
Identification code  JS-06 
CCDC Code 1835370 
Empirical formula  C38 H47 Au Cl F6 N P Sb   
Formula weight  1016.90 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.0473(12) Å = 100.731(4)° 
 b = 11.3493(14) Å = 103.700(4)° 
 c = 17.4404(18) Å   = 99.465(4)° 
Volume 1852.5(4) Å3 
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Z 2 
Density (calculated) 1.823 Mg/m3 
Absorption coefficient 4.859 mm
-1
 
F(000) 996 
Crystal size 0.3 x 0.22 x 0.08 mm3 
Theta range for data collection 1.871 to 28.288°. 
Index ranges -13 ≤ h ≤ 13, -15 ≤ k ≤ 15, -21 ≤ l ≤ 23 
Reflections collected 24139 
Independent reflections 9144 [R(int) = 0.0292] 
Completeness to theta = 25.242° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5633 and 0.3777 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9144 / 0 / 444 
Goodness-of-fit on F2 1.033 
Final R indices [I > 2σ(I)] R1 = 0.0359, wR2 = 0.0734 
R indices (all data) R1 = 0.0443, wR2 = 0.0762 
Largest diff. peak and hole 2.306 and -2.007 e.Å-3 
SQUEEZE Found 47e/uc; calc’d for CH2Cl2, 42e/uc 
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Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) for 
[2c][SbF6].  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
Au(1) 1025(1) 7043(1) 2269(1) 18(1) 
Sb(1) 1335(1) 12273(1) 4024(1) 15(1) 
Cl(1) -1344(1) 7042(1) 1699(1) 28(1) 
P(1) 3291(1) 6854(1) 2832(1) 13(1) 
F(5) 2351(3) 13520(2) 3687(2) 29(1) 
F(2) 327(3) 11051(2) 4384(2) 30(1) 
N(1) 610(4) 6710(3) 3391(2) 18(1) 
F(3) 1681(3) 13345(3) 5051(2) 31(1) 
C(9) 1293(5) 7600(6) 1270(4) 34(1) 
C(14) 1318(6) 8915(6) 1334(4) 38(1) 
F(6) 999(3) 11198(3) 3014(2) 37(1) 
C(13) 1360(6) 9415(5) 684(4) 40(1) 
C(4) 1683(5) 6323(4) 4721(3) 19(1) 
C(31) 3519(5) 2765(4) 1920(3) 23(1) 
F(1) -310(3) 12824(3) 3654(2) 39(1) 
C(32) 4924(5) 3708(4) 2234(3) 19(1) 
C(1) -588(5) 5635(5) 3218(4) 31(1) 
F(4) 2991(3) 11761(3) 4414(2) 31(1) 
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C(30) 5423(5) 3996(5) 1514(3) 25(1) 
C(8) 3112(4) 6545(4) 3795(3) 14(1) 
C(27) 2433(5) 3303(4) 1400(3) 23(1) 
C(12) 1392(5) 8638(5) -12(4) 33(1) 
C(34) 4180(5) 5729(4) 1517(3) 21(1) 
C(3) 1829(4) 6521(4) 3979(3) 16(1) 
C(2) 197(5) 7859(5) 3750(3) 28(1) 
C(33) 4730(4) 4879(4) 2764(3) 15(1) 
C(20) 6165(4) 8111(4) 3446(3) 15(1) 
C(19) 7225(4) 9364(4) 3678(3) 16(1) 
C(25) 3651(4) 5447(4) 2237(3) 14(1) 
C(26) 2240(4) 4476(4) 1923(3) 20(1) 
C(10) 1290(5) 6883(6) 594(4) 41(2) 
C(23) 5744(5) 10046(5) 2553(3) 30(1) 
C(5) 2808(5) 6159(4) 5287(3) 18(1) 
C(6) 4096(5) 6202(4) 5124(3) 17(1) 
C(24) 4668(5) 8808(4) 2315(3) 24(1) 
C(29) 4334(5) 4533(5) 999(3) 25(1) 
C(16) 4282(4) 9234(4) 3707(3) 21(1) 
C(7) 4242(4) 6385(4) 4389(3) 14(1) 
C(21) 5355(5) 10958(4) 3182(4) 30(1) 
C(28) 2922(5) 3600(5) 682(3) 29(1) 
C(18) 6826(5) 10271(4) 4299(3) 21(1) 
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C(15) 4674(4) 8299(4) 3081(3) 17(1) 
C(22) 7215(5) 9851(4) 2916(3) 25(1) 
C(11) 1356(5) 7417(5) -146(4) 43(2) 
C(17) 5364(5) 10473(4) 3939(3) 24(1) 
C(36) 1439(6) 8480(8) -1435(4) 54(2) 
C(37) 1434(6) 7235(9) -1454(4) 60(2) 
C(38) 1402(6) 6649(7) -811(5) 61(2) 
C(35) 1415(6) 9219(9) -744(4) 60(2) 
______________________________________________________________________________   
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Solid-state structure of [2d][SbF6] with thermal ellipsoids rendered at the 50% probability level 
and with hydrogen atoms, disorder and [SbF6]
- counterion omitted for clarity.  
Crystal Data for [2d][SbF6]. 
Identification code  JS-07 
CCDC Code 1835367 
Empirical formula  C35 H44 Au Cl0.86 F9 I0.14 N P Sb 
Formula weight  1047.65 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.2214(4) Å = 108.9020(10)° 
 b = 11.5151(4) Å = 99.9440(10)° 
 c = 16.2248(6) Å = 100.4260(10)° 
Volume 1721.07(11) Å3 
Z 2 
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Density (calculated) 2.022 Mg/m3 
Absorption coefficient 5.358 mm-1 
F(000) 1018 
Crystal size 0.3 x 0.27 x 0.21 mm3 
Theta range for data collection 1.916 to 28.267°. 
Index ranges -12 ≤ h ≤ 13, -15 ≤ k ≤ 15, -21 ≤ l ≤ 21 
Reflections collected 23765 
Independent reflections 8525 [R(int) = 0.0402] 
Completeness to theta = 25.242° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5633 and 0.4649 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8525 / 0 / 436 
Goodness-of-fit on F2 1.035 
Final R indices [I > 2σ(I)] R1 = 0.0326, wR2 = 0.0604 
R indices (all data) R1 = 0.0459, wR2 = 0.0644 
Extinction coefficient n/a 
Largest diff. peak and hole 2.688 and -1.864 e.Å-3 
418 
 
Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103) for 
[2d][SbF6].  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
Au(1) 6102(1) 6560(1) 7210(1) 11(1) 
Sb(1) 6396(1) 11976(1) 8925(1) 15(1) 
Cl(1) 3712(2) 6382(2) 6713(1) 11(1) 
P(1) 8366(1) 6482(1) 7673(1) 10(1) 
F(6) 7311(3) 13222(3) 8563(2) 28(1) 
F(5) 7111(3) 13094(3) 10129(2) 27(1) 
F(4) 5495(3) 10762(3) 9309(2) 34(1) 
F(8) 4860(3) 12657(3) 8878(2) 26(1) 
F(3) 6033(3) 9529(3) 4118(2) 33(1) 
F(9) 7936(3) 11320(3) 9000(2) 36(1) 
F(7) 5712(3) 10895(3) 7725(2) 41(1) 
F(1) 8059(3) 9275(3) 4309(2) 43(1) 
N(1) 5807(4) 6279(3) 8437(2) 13(1) 
F(2) 6408(5) 7801(3) 3307(2) 60(1) 
C(1) 6259(4) 7107(4) 6154(3) 13(1) 
C(15) 9728(4) 7935(4) 7853(3) 11(1) 
C(12) 9416(5) 6292(4) 10188(3) 15(1) 
C(4) 6490(4) 8096(4) 4822(3) 16(1) 
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C(27) 9059(5) 5024(4) 6115(3) 14(1) 
C(26) 8623(4) 4934(4) 6963(3) 10(1) 
C(6) 6355(4) 6330(4) 5321(3) 13(1) 
C(34) 9730(4) 4501(4) 7489(3) 14(1) 
C(13) 9489(4) 6389(4) 9365(3) 13(1) 
C(11) 8181(5) 6157(4) 10417(3) 18(1) 
C(5) 6471(4) 6825(4) 4659(3) 14(1) 
C(16) 9471(5) 9046(4) 8606(3) 14(1) 
C(22) 11203(4) 7807(4) 8136(3) 15(1) 
C(24) 10528(5) 10281(4) 8777(3) 16(1) 
C(9) 7075(4) 6265(4) 9019(3) 12(1) 
C(18) 10387(5) 10581(4) 7918(3) 17(1) 
C(2) 6210(4) 8358(4) 6299(3) 17(1) 
C(30) 9863(4) 3201(4) 6877(3) 16(1) 
C(3) 6333(4) 8852(4) 5642(3) 16(1) 
C(19) 10658(5) 9500(4) 7174(3) 16(1) 
C(10) 7012(5) 6148(4) 9841(3) 17(1) 
C(28) 9159(5) 3722(4) 5520(3) 20(1) 
C(21) 12245(5) 9068(4) 8319(3) 17(1) 
C(35) 7775(5) 2744(4) 5253(3) 21(1) 
C(14) 8305(4) 6373(4) 8769(3) 11(1) 
C(25) 9607(4) 8257(4) 6988(3) 14(1) 
C(31) 8505(4) 2215(4) 6609(3) 15(1) 
420 
 
C(29) 10284(5) 3328(4) 6044(3) 22(1) 
C(017) 6733(5) 8661(4) 4129(3) 22(1) 
C(7) 4705(5) 5111(4) 8243(3) 23(1) 
C(20) 12113(5) 9372(4) 7461(3) 18(1) 
C(32) 7384(5) 2620(4) 6089(3) 17(1) 
C(33) 7249(4) 3924(4) 6682(3) 14(1) 
C(23) 11979(5) 10133(4) 9064(3) 18(1) 
C(8) 5364(5) 7447(4) 8925(3) 21(1) 
I(1) 3551(3) 6512(3) 6725(2) 11(1) 
______________________________________________________________________________   
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Solid-state structure of [(Me-DalPhos)Au(p-Cl-C6H4)OH2][SbF6]2 with thermal ellipsoids 
rendered at the 50% probability level and with selected hydrogen atoms, disorder, two [SbF6]
- 
counterions and one DCM molecule omitted for clarity.  
Crystallographic Data for [(Me-DalPhos)Au(p-Cl-C6H4)OH2][SbF6]2. 
Identification code  JS-08 
CCDC Code 1835368 
Empirical formula  C70 H95 Au2 Cl6 F18 N2 O2 P2 Sb3 
Formula weight  2372.30 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.3978(4) Å = 90.4650(10)° 
 b = 10.8778(4) Å = 90.5830(10)° 
 c = 17.7061(7) Å = 94.1330(10)° 
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Volume 1997.26(13) Å3 
Z 1 
Density (calculated) 1.972 Mg/m3 
Absorption coefficient 4.989 mm-1 
F(000) 1150 
Crystal size 0.25 x 0.2 x 0.15 mm3 
Theta range for data collection 1.877 to 28.297°. 
Index ranges -13 ≤ h ≤ 13, -14 ≤ k ≤ 14, -20 ≤ l ≤23 
Reflections collected 35922 
Independent reflections 9931 [R(int) = 0.0460] 
Completeness to theta = 25.242° 100.0%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6326 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9931 / 3 / 483 
Goodness-of-fit on F2 1.010 
Final R indices [I > 2σ(I)] R1 = 0.0294, wR2 = 0.0529 
R indices (all data) R1 = 0.0411, wR2 = 0.0560 
Extinction coefficient n/a 
Largest diff. peak and hole 1.184 and -1.134 e.Å-3 
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Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) for 
[(Me-DalPhos)Au(p-Cl-C6H4)OH2][SbF6]2. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
Au(1) 4358(1) 3696(1) 3656(1) 9(1) 
Sb(1) 8445(1) 2689(1) 4772(1) 19(1) 
Sb(2) 0 0 0 25(1) 
P(1) 3440(1) 3112(1) 2514(1) 9(1) 
Cl(1) 7351(1) 9156(1) 3384(1) 26(1) 
Cl(2) 5598(1) 7420(1) 1479(1) 32(1) 
Cl(3) 7534(1) 6345(1) 558(1) 41(1) 
F(6) 9644(2) 2832(2) 5568(1) 32(1) 
F(2) 7790(2) 4204(2) 5056(2) 31(1) 
O(1) 5134(2) 4002(2) 4720(1) 14(1) 
F(4) 7193(2) 2579(2) 3987(1) 34(1) 
F(1) 9016(2) 1159(2) 4506(2) 37(1) 
F(3) 7214(2) 1901(2) 5407(1) 31(1) 
F(5) 9606(2) 3510(3) 4123(2) 44(1) 
N(1) 3293(3) 2092(3) 4115(2) 12(1) 
C(35) 5792(3) 3617(3) 1786(2) 15(1) 
C(22) 3046(3) 5347(3) 1805(2) 13(1) 
424 
 
F(8) -578(3) -488(3) 941(2) 74(1) 
C(9) 5296(3) 5362(3) 3403(2) 13(1) 
C(2) 4230(3) 1262(3) 4454(2) 17(1) 
C(16) 1291(3) 3663(3) 1583(2) 13(1) 
F(9) -1691(3) -237(4) -334(2) 87(1) 
C(23) 1558(3) 4624(3) 2867(2) 14(1) 
C(33) 4129(3) 2294(3) 1061(2) 14(1) 
C(7) 1699(3) 1020(3) 2281(2) 16(1) 
C(26) 4687(3) 2611(3) 1852(2) 12(1) 
C(30) 6846(3) 3171(3) 1270(2) 18(1) 
C(31) 6281(4) 2858(3) 481(2) 19(1) 
C(11) 7253(3) 6669(3) 3299(2) 17(1) 
C(15) 2297(3) 4229(3) 2161(2) 11(1) 
C(14) 4612(3) 6407(3) 3495(2) 11(1) 
C(13) 5229(3) 7577(3) 3476(2) 15(1) 
C(1) 2484(3) 2601(3) 4722(2) 17(1) 
C(21) 2095(3) 6323(3) 1596(2) 17(1) 
C(5) 912(4) -289(3) 3284(2) 21(1) 
C(17) 366(3) 4650(3) 1362(2) 16(1) 
C(6) 921(4) 20(3) 2524(2) 20(1) 
C(10) 6623(3) 5498(3) 3320(2) 13(1) 
C(32) 5194(4) 1842(3) 555(2) 17(1) 
C(29) 7385(4) 2023(4) 1617(2) 23(1) 
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C(20) 1388(4) 6715(3) 2305(2) 24(1) 
C(24) 627(3) 5597(3) 2643(2) 19(1) 
C(18) -346(3) 5047(4) 2064(2) 21(1) 
C(25) 1119(3) 5770(3) 1013(2) 18(1) 
C(4) 1677(3) 388(3) 3796(2) 18(1) 
C(3) 2460(3) 1390(3) 3556(2) 13(1) 
C(8) 2463(3) 1742(3) 2802(2) 14(1) 
C(27) 5235(4) 1445(3) 2199(2) 18(1) 
F(7) -224(4) 1600(3) 284(3) 113(2) 
C(12) 6558(3) 7697(3) 3379(2) 15(1) 
C(36) 7161(4) 7618(4) 1118(3) 34(1) 
C(34) 5725(4) 697(3) 899(2) 24(1) 
C(28) 6306(4) 1013(4) 1678(2) 23(1) 
______________________________________________________________________________  
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Solid-state structure of [2f][SbF6]·H2O with thermal ellipsoids rendered at the 50% probability 
level and with selected hydrogen atoms, one water molecule, and [SbF6]
- counterion omitted for 
clarity.  
Crystallographic Data for [2f][SbF6]·H2O.   
Identification code  JS-13 
CCDC Code 1835373 
Empirical formula  C34 H47 Au Cl F6 N O2 P Sb 
Formula weight  1000.86 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.5384(10) Å = 112.015(2)° 
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 b = 13.2116(13) Å = 105.708(2)° 
 c = 15.7777(11) Å  = 91.052(3)° 
Volume 1758.4(3) Å3 
Z 2 
Density (calculated) 1.890 Mg/m3 
Absorption coefficient 5.121 mm-1 
F(000) 980 
Crystal size 0.3 x 0.28 x 0.18 mm3 
Theta range for data collection 1.459 to 28.284°. 
Index ranges -11 ≤ h ≤ 12, -17 ≤ k ≤ 17, -18 ≤ l ≤ 21 
Reflections collected 31512 
Independent reflections 8736 [R(int) = 0.0381] 
Completeness to theta = 25.242° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5633 and 0.4270 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8736 / 0 / 438 
Goodness-of-fit on F2 1.024 
Final R indices [I > 2σ(I)] R1 = 0.0256, wR2 = 0.0516 
R indices (all data) R1 = 0.0337, wR2 = 0.0543 
Extinction coefficient n/a 
Largest diff. peak and hole 1.022 and -0.862 e.Å-3 
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 Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103) 
For [2f][SbF6]·H2O.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________  
Au(1) 8596(1) 4062(1) 2777(1) 11(1) 
Sb(1) 10000 5000 0 15(1) 
Sb(2) 10000 0 5000 22(1) 
Cl(1) 11133(1) 4665(1) 3506(1) 15(1) 
P(1) 6074(1) 3560(1) 2242(1) 12(1) 
F(1) 10141(4) 4357(3) 867(2) 81(1) 
F(2) 12018(3) 5138(2) 260(2) 64(1) 
F(3) 10179(3) 6378(2) 998(2) 51(1) 
F(4) 11012(3) -884(2) 4190(2) 49(1) 
F(5) 8253(3) -605(2) 3998(2) 50(1) 
F(6) 10222(3) 1120(2) 4585(2) 48(1) 
O(1) 10888(3) -417(2) 1248(2) 26(1) 
O(2) 11532(3) -1563(2) 2394(2) 33(1) 
N(1) 8118(3) 5775(2) 3277(2) 15(1) 
C(1) 9215(3) 2529(2) 2280(2) 14(1) 
C(2) 9654(3) 2231(3) 1454(2) 16(1) 
C(3) 10211(4) 1244(3) 1121(2) 18(1) 
C(4) 10337(4) 548(3) 1614(2) 19(1) 
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C(5) 9921(3) 859(3) 2445(2) 18(1) 
C(6) 9388(3) 1861(3) 2786(2) 15(1) 
C(7) 8916(4) 6355(3) 2854(3) 22(1) 
C(8) 8713(4) 6281(3) 4348(2) 21(1) 
C(9) 6531(4) 5863(3) 2991(2) 15(1) 
C(10) 6091(4) 6911(3) 3186(2) 17(1) 
C(11) 4612(4) 7020(3) 2965(2) 21(1) 
C(12) 3567(4) 6105(3) 2582(2) 18(1) 
C(13) 3998(4) 5071(3) 2388(2) 17(1) 
C(14) 5485(3) 4931(3) 2580(2) 14(1) 
C(15) 5526(3) 2895(2) 2984(2) 13(1) 
C(16) 6569(4) 3505(3) 4020(2) 17(1) 
C(17) 6215(4) 2992(3) 4681(2) 22(1) 
C(18) 4619(4) 3108(3) 4687(3) 25(1) 
C(19) 3590(4) 2492(3) 3674(3) 21(1) 
C(20) 3800(4) 1271(3) 3319(3) 23(1) 
C(21) 5388(4) 1171(3) 3306(2) 20(1) 
C(22) 5683(4) 1658(3) 2616(2) 16(1) 
C(23) 3926(4) 3011(3) 3014(3) 19(1) 
C(24) 6435(4) 1784(3) 4320(3) 23(1) 
C(25) 5286(3) 2848(2) 908(2) 13(1) 
C(26) 3584(3) 2599(3) 558(2) 18(1) 
C(27) 3048(4) 2058(3) -547(2) 21(1) 
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C(28) 3543(4) 2850(3) -945(3) 28(1) 
C(29) 5211(4) 3085(3) -619(2) 25(1) 
C(30) 5865(4) 2009(3) -965(2) 24(1) 
C(31) 5363(4) 1229(3) -564(2) 18(1) 
C(32) 5903(4) 1749(3) 533(2) 17(1) 
C(33) 5776(4) 3632(3) 488(2) 19(1) 
C(34) 3684(4) 980(3) -905(2) 21(1) 
_____________________________________________________________________________  
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Solid-state structure of [2g][SbF6] with thermal ellipsoids rendered at the 50% probability level 
and with hydrogen atoms, disorder, and [SbF6]
- counterion omitted for clarity. 
Crystal data and structure refinement for [2g][SbF6]. 
Identification code  JS-09 
CCDC Code 1835371 
Empirical formula  C35 H44 Au Cl0.95 F9 I0.05 N O P Sb 
Formula weight  1055.42 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.0238(6) Å = 106.082(2)° 
 b = 11.7115(7) Å = 106.450(2)° 
 c = 16.7522(11) Å  = 97.925(2)° 
Volume 1761.65(19) Å3 
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Z 2 
Density (calculated) 1.990 Mg/m3 
Absorption coefficient 5.166 mm-1 
F(000) 1028 
Crystal size 0.29 x 0.28 x 0.26 mm3 
Theta range for data collection 1.344 to 28.316°. 
Index ranges -13 ≤ h ≤ 13, -14 ≤ k ≤ 15, -21 ≤ l ≤ 22 
Reflections collected 30660 
Independent reflections 8761 [R(int) = 0.0353] 
Completeness to theta = 25.242° 100.0%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.5596 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8761 / 2 / 456 
Goodness-of-fit on F2 1.026 
Final R indices [I > 2σ(I)] R1 = 0.0267, wR2 = 0.0587 
R indices (all data) R1 = 0.0327, wR2 = 0.0611 
Extinction coefficient n/a 
Largest diff. peak and hole 2.624 and -0.785 e.Å-3 
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Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [2g][SbF6].  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________________
 x y z U(eq) 
_____________________________________________________________________________ 
Au(1) 6146(1) 5645(1) 7174(1) 10(1) 
Sb(1) 2359(1) -1787(1) 1095(1) 14(1) 
Cl(1) 8027(2) 5307(2) 6550(1) 10(1) 
P(1) 4358(1) 6222(1) 7717(1) 9(1) 
F(2) 1233(3) 226(2) 4611(2) 29(1) 
F(8) 1863(3) -1783(2) -77(2) 33(1) 
F(9) 3668(3) -274(2) 1457(2) 28(1) 
F(4) 918(3) -980(3) 1244(2) 35(1) 
F(7) 3774(3) -2607(3) 913(2) 38(1) 
F(3) 1732(3) -1167(2) 3677(2) 30(1) 
F(1) 1301(3) 446(3) 3399(2) 38(1) 
F(6) 1044(3) -3292(2) 704(2) 32(1) 
C(26) 3254(3) 5011(3) 7950(2) 10(1) 
F(5) 2888(3) -1761(3) 2259(2) 43(1) 
O(1) 3331(3) 497(3) 4410(2) 27(1) 
C(33) 4315(4) 4622(3) 8639(2) 12(1) 
C(23) 2125(4) 6138(3) 6218(2) 15(1) 
C(27) 2106(4) 5479(3) 8334(2) 13(1) 
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N(1) 7641(3) 7112(3) 8328(2) 14(1) 
C(12) 7262(4) 9179(3) 10352(2) 18(1) 
C(14) 4924(4) 7997(3) 9387(2) 12(1) 
C(28) 1317(4) 4453(3) 8561(2) 14(1) 
C(16) 3333(3) 7044(3) 7032(2) 9(1) 
C(32) 3504(4) 3617(3) 8869(2) 13(1) 
C(2) 5010(4) 4042(3) 6210(2) 13(1) 
C(34) 2475(4) 3879(3) 7114(2) 13(1) 
C(4) 3474(4) 2691(4) 4767(3) 22(1) 
C(13) 5801(4) 8877(3) 10180(2) 16(1) 
C(30) 1676(4) 2870(3) 7350(2) 15(1) 
C(35) 2388(4) 4097(3) 9249(2) 15(1) 
C(29) 558(4) 3339(3) 7731(2) 16(1) 
C(22) 1398(4) 6830(4) 5623(3) 21(1) 
C(18) 3656(4) 8444(4) 6149(3) 19(1) 
C(11) 7845(4) 8598(3) 9739(2) 17(1) 
C(10) 6967(4) 7709(3) 8949(2) 12(1) 
C(3) 4088(4) 3890(4) 5379(2) 17(1) 
C(011) 2484(5) 7516(4) 5338(3) 24(1) 
C(8) 8648(4) 6447(4) 8760(3) 22(1) 
C(17) 4421(4) 7754(3) 6732(3) 16(1) 
C(1) 1935(4) 23(4) 4034(2) 18(1) 
C(24) 2696(4) 7991(3) 7562(2) 14(1) 
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C(21) 738(4) 7744(4) 6150(3) 23(1) 
C(5) 3819(4) 1718(4) 5020(3) 22(1) 
C(31) 2752(4) 2501(3) 8030(2) 15(1) 
C(25) 1916(4) 8664(3) 6965(3) 17(1) 
C(19) 3003(4) 9363(3) 6678(3) 19(1) 
C(15) 5484(4) 7387(3) 8759(2) 11(1) 
C(6) 4733(4) 1855(4) 5831(3) 22(1) 
C(9) 8456(4) 8050(4) 8075(3) 21(1) 
C(7) 5344(4) 3021(4) 6431(3) 19(1) 
I(1) 8258(7) 5184(9) 6574(5) 27(2) 
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Solid-state structure of [2j][SbF6] with thermal ellipsoids rendered at the 50% probability level 
and with hydrogen atoms, disorder, and [SbF6]
- counterion omitted for clarity.  
Crystallographic Data for [2j][SbF6]. 
Identification code  JS-12 
CCDC Code  1835371 
Empirical formula  C34 H44 Au Br Cl0.77 F6 I0.23 N P Sb 
Formula weight  1066.78 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.1820(10) Å = 109.033(4)° 
 b = 11.4038(13) Å = 100.165(3)° 
 c = 16.3043(16) Å  = 100.426(4)° 
Volume 1702.7(3) Å3 
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Z 2 
Density (calculated) 2.081 Mg/m3 
Absorption coefficient 6.646 mm-1 
F(000) 1029 
Crystal size 0.26 x 0.24 x 0.18 mm3 
Theta range for data collection 1.926 to 28.275°. 
Index ranges -13 ≤ h ≤ 13, -14 ≤ k ≤ 15, -21 ≤ l ≤ 21 
Reflections collected 30650 
Independent reflections 8451 [R(int) = 0.0374] 
Completeness to theta = 25.242° 100.0%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.5487 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8451 / 2 / 418 
Goodness-of-fit on F2 1.028 
Final R indices [I > 2σ(I)] R1 = 0.0276, wR2 = 0.0582 
R indices (all data) R1 = 0.0348, wR2 = 0.0604 
Extinction coefficient n/a 
Largest diff. peak and hole 1.913 and -3.742 e.Å-3 
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 Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [2j][SbF6]. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________________
 x y z U(eq) 
_____________________________________________________________________________  
Au(1) 1103(1) 1550(1) 7182(1) 9(1) 
Sb(1) 1382(1) 6967(1) 8946(1) 12(1) 
Br(1) 1456(1) 3684(1) 3837(1) 30(1) 
P(1) 3370(1) 1458(1) 7651(1) 8(1) 
F(1) 2285(3) 8172(2) 8535(2) 25(1) 
F(2) 647(3) 5811(3) 7764(2) 32(1) 
F(3) 2930(3) 6303(2) 9026(2) 30(1) 
F(4) 497(3) 5794(2) 9376(2) 27(1) 
F(5) 2132(2) 8154(2) 10132(2) 23(1) 
F(6) -160(2) 7656(2) 8884(2) 22(1) 
N(1) 786(3) 1234(3) 8386(2) 12(1) 
C(1) -320(4) 25(4) 8158(3) 21(1) 
C(2) 312(4) 2383(4) 8881(3) 20(1) 
C(3) 2045(4) 1211(3) 8975(2) 11(1) 
C(4) 3299(4) 1341(3) 8731(2) 10(1) 
C(5) 4484(4) 1370(3) 9345(2) 12(1) 
C(6) 4412(4) 1277(4) 10164(2) 15(1) 
C(7) 3147(4) 1123(4) 10380(3) 16(1) 
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C(8) 1967(4) 1087(4) 9787(2) 14(1) 
C(9) 1281(4) 2111(4) 6130(2) 12(1) 
C(10) 1367(4) 1315(4) 5305(2) 12(1) 
C(11) 1432(4) 1796(4) 4623(3) 15(1) 
C(12) 1380(4) 3051(4) 4778(3) 18(1) 
C(13) 1240(4) 3833(4) 5582(3) 18(1) 
C(14) 1185(4) 3362(4) 6263(3) 15(1) 
C(15) 3649(4) -107(3) 6946(2) 10(1) 
C(16) 4731(4) -547(3) 7489(2) 13(1) 
C(17) 4888(4) -1848(3) 6887(3) 13(1) 
C(18) 3504(4) -2849(4) 6593(3) 16(1) 
C(19) 2412(4) -2440(4) 6051(3) 16(1) 
C(20) 2855(5) -2319(4) 5226(3) 21(1) 
C(21) 4242(4) -1321(4) 5528(3) 18(1) 
C(22) 2254(4) -1133(3) 6640(3) 12(1) 
C(23) 5337(4) -1728(4) 6066(3) 19(1) 
C(24) 4119(4) -3(4) 6118(2) 14(1) 
C(25) 4739(4) 2926(3) 7845(2) 10(1) 
C(26) 4626(4) 3268(4) 6991(2) 13(1) 
C(27) 5689(4) 4543(4) 7199(3) 15(1) 
C(28) 5411(4) 5616(4) 7947(3) 15(1) 
C(29) 5546(4) 5290(3) 8791(2) 13(1) 
C(30) 6999(4) 5149(4) 9088(3) 16(1) 
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C(31) 7274(4) 4078(4) 8334(3) 16(1) 
C(32) 6226(4) 2800(3) 8139(3) 13(1) 
C(33) 4475(4) 4039(3) 8600(2) 12(1) 
C(34) 7150(4) 4403(4) 7488(3) 17(1) 
I(1) -1468(1) 1453(1) 6680(1) 19(1) 
Cl(1) -1166(1) 1459 6725 19(1) 
______________________________________________________________________________ 
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Solid-state structure of [2r][SbF6] with thermal ellipsoids rendered at the 50% probability level 
and with hydrogen atoms, disorder, and [SbF6]
- counterion omitted for clarity.  
Crystallographic Data for [2r][SbF6]. 
Identification code  JS-17 
CCDC Code  1835366 
Empirical formula  C45 H49 Au Cl0.85 F6 I0.15 N O P Sb 
Formula weight  1132.70 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.0424(11) Å = 101.463(3)° 
 b = 12.0230(13) Å = 101.135(3)° 
 c = 19.663(2) Å = 100.103(3)° 
Volume 2225.8(4) Å3 
Z 2 
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Density (calculated) 1.690 Mg/m3 
Absorption coefficient 4.149 mm-1 
F(000) 1111 
Crystal size 0.25 x 0.22 x 0.18 mm3 
Theta range for data collection 1.773 to 26.452°. 
Index ranges -12 ≤ h ≤ 12, -15 ≤ k ≤ 15, -24 ≤ l ≤ 24 
Reflections collected 61519 
Independent reflections 9174 [R(int) = 0.0487] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.6465 and 0.5276 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9174 / 0 / 526 
Goodness-of-fit on F2 1.114 
Final R indices [I ≤ 2σ(I)] R1 = 0.0460, wR2 = 0.0956 
R indices (all data) R1 = 0.0624, wR2 = 0.1054 
Extinction coefficient n/a 
Largest diff. peak and hole 2.770 and -3.305 e.Å-3 
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Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) for 
[2r][SbF6].  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________  
 x y z U(eq) 
______________________________________________________________________________   
Au(1) 8747(1) 8127(1) 2346(1) 28(1) 
Sb(1) 8659(1) 2683(1) 819(1) 54(1) 
P(1) 6451(2) 8178(1) 1870(1) 17(1) 
Cl(1) 11102(3) 8142(3) 2743(3) 39(1) 
F(6) 7153(5) 3379(4) 666(3) 58(1) 
F(3) 8074(5) 1772(4) -108(3) 60(1) 
F(5) 9733(5) 3803(5) 500(3) 71(2) 
C(19) 5165(6) 6772(5) 1714(3) 21(1) 
F(2) 10188(7) 2025(9) 993(4) 132(4) 
O(1) 8334(7) 4433(4) 5181(3) 57(2) 
C(10) 5593(6) 9333(5) 3041(3) 22(1) 
C(29) 8585(6) 7911(5) 3334(4) 26(1) 
C(25) 2690(6) 5642(5) 1247(4) 28(2) 
N(1) 9124(6) 8318(5) 1318(3) 33(1) 
F(4) 7577(7) 1522(8) 1114(4) 116(3) 
C(8) 6625(7) 8400(5) 996(3) 27(1) 
C(26) 3666(6) 6845(5) 1394(4) 24(1) 
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C(9) 6024(6) 9523(5) 2354(3) 21(1) 
C(20) 5621(6) 5870(5) 1177(4) 24(1) 
C(24) 2739(7) 5250(6) 1944(4) 35(2) 
C(21) 4626(7) 4674(5) 1033(4) 28(2) 
C(16) 7392(6) 10480(5) 2543(3) 22(1) 
C(15) 7175(6) 11617(5) 2977(4) 25(1) 
C(27) 5209(7) 6372(5) 2411(3) 27(1) 
C(28) 3156(7) 4763(5) 713(4) 31(2) 
C(32) 8622(6) 7682(5) 4742(4) 28(1) 
C(30) 8688(6) 8862(5) 3878(4) 30(2) 
C(11) 5428(7) 10496(5) 3480(4) 31(2) 
C(39) 8451(8) 5404(6) 5061(4) 43(2) 
C(3) 7910(8) 8446(5) 818(4) 33(2) 
C(31) 8686(6) 8740(5) 4566(4) 28(1) 
C(34) 8756(7) 8489(6) 6047(4) 33(2) 
C(44) 8561(6) 6802(5) 3486(4) 31(2) 
C(22) 4683(7) 4289(5) 1727(4) 36(2) 
C(38) 8564(8) 6450(6) 5629(5) 42(2) 
C(33) 8649(7) 7551(6) 5473(4) 32(2) 
C(43) 8565(7) 5800(5) 2969(4) 32(2) 
C(7) 5496(7) 8497(5) 486(4) 30(2) 
C(14) 6004(7) 12027(5) 2529(4) 31(2) 
C(45) 8542(7) 6691(5) 4189(4) 30(2) 
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C(23) 4221(7) 5165(6) 2258(4) 34(2) 
C(18) 6793(7) 11411(5) 3662(4) 28(2) 
C(35) 8806(7) 8353(7) 6728(4) 38(2) 
C(40) 8472(8) 5570(6) 4342(4) 38(2) 
C(17) 4875(7) 9952(5) 1904(4) 28(1) 
C(42) 8487(8) 4736(6) 3125(4) 40(2) 
C(13) 4661(7) 11085(5) 2347(4) 34(2) 
C(6) 5642(10) 8650(6) -176(4) 44(2) 
C(12) 4274(7) 10898(6) 3037(4) 38(2) 
C(4) 8047(9) 8599(6) 150(4) 43(2) 
C(5) 6930(11) 8712(6) -340(4) 53(3) 
C(2) 10305(8) 9355(7) 1426(4) 47(2) 
C(41) 8437(8) 4627(6) 3807(4) 42(2) 
C(36) 8737(8) 7278(7) 6876(4) 45(2) 
F(1) 9258(7) 3616(12) 1740(3) 171(5) 
C(37) 8610(8) 6327(7) 6324(5) 45(2) 
C(1) 9561(8) 7223(6) 1016(5) 49(2) 
I(1) 11428(5) 8134(4) 3083(3) 36(2) 
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Solid-state structure of [2s][SbF6]2 with thermal ellipsoids rendered at the 50% probability level 
and with hydrogen atoms, one co-crystallized DCM molecule and two [SbF6]
- counterions omitted 
for clarity.  
Crystallographic Data for [2s][SbF6]2·DCM. 
Identification code  JS-03 
CCDC Code 1835365 
Empirical formula  C64 H88 Au2 Cl6 F12 N2 P2 Sb2 
Formula weight  2025.43 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pccn 
Unit cell dimensions a = 20.8838(10) Å = 90° 
 b = 17.9885(10) Å = 90° 
 c = 18.4736(10) Å = 90° 
Volume 6939.9(6) Å3 
Z 4 
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Density (calculated) 1.939 Mg/m3 
Absorption coefficient 5.336 mm-1 
F(000) 3944 
Crystal size 0.22 x 0.08 x 0.05 mm3 
Theta range for data collection 1.857 to 24.998°. 
Index ranges -24 ≤ h ≤ 24, -21 ≤ k ≤ 21, -21 ≤ l ≤ 21 
Reflections collected 36322 
Independent reflections 6107 [R(int) = 0.1193] 
Completeness to theta = 24.998° 99.9% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.4798 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6107 / 0 / 396 
Goodness-of-fit on F2 1.059 
Final R indices [I > σ(I)] R1 = 0.0468, wR2 = 0.1034 
R indices (all data) R1 = 0.0913, wR2 = 0.1292 
Extinction coefficient n/a 
Largest diff. peak and hole 2.319 and -2.320 e.Å-3 
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Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) for 
[2s][SbF6]2.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
Au(1) 2084(1) 5662(1) 4609(1) 18(1) 
Sb(1) 3955(1) 3336(1) 3471(1) 27(1) 
Cl(1) 1940(1) 6015(1) 3399(1) 27(1) 
P(1) 2190(1) 5276(1) 5803(1) 18(1) 
Cl(3) 5138(1) 2465(2) 523(2) 49(1) 
Cl(2) 4936(2) 4028(2) 835(2) 58(1) 
F(2) 3431(3) 3244(3) 4286(3) 30(1) 
F(6) 3227(3) 3496(4) 2901(3) 44(2) 
F(5) 4476(3) 3436(4) 2652(3) 48(2) 
F(1) 4011(3) 4360(3) 3638(3) 46(2) 
F(4) 3887(3) 2315(3) 3295(4) 48(2) 
F(3) 4666(3) 3165(4) 4065(4) 50(2) 
N(1) 1760(4) 4539(5) 4385(4) 25(2) 
C(30) 2346(5) 6740(5) 4739(5) 21(2) 
C(28) 1955(4) 6579(5) 6623(5) 21(2) 
C(32) 3136(5) 7723(6) 4726(5) 22(2) 
C(3) 1742(5) 4038(5) 5038(5) 20(2) 
C(31) 2985(5) 6982(6) 4704(5) 23(2) 
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C(23) 1481(5) 7052(6) 7056(5) 26(2) 
C(27) 377(5) 6040(6) 7094(5) 28(2) 
C(4) 1600(5) 3300(6) 4949(6) 26(2) 
C(19) 1641(4) 5819(5) 6404(5) 17(2) 
C(8) 1876(4) 4345(5) 5708(5) 20(2) 
C(26) 1030(5) 5976(6) 5963(5) 25(2) 
C(7) 1822(5) 3858(6) 6307(5) 24(2) 
C(24) 883(5) 7177(5) 6597(6) 28(3) 
C(2) 2216(5) 4219(6) 3823(5) 27(3) 
C(25) 557(5) 6437(6) 6411(6) 28(2) 
C(14) 4212(5) 5295(6) 6983(5) 26(2) 
C(20) 1451(5) 5402(6) 7106(5) 27(3) 
C(21) 983(5) 5894(6) 7555(6) 30(3) 
C(6) 1672(5) 3126(6) 6211(6) 28(3) 
C(17) 3142(5) 4686(6) 6761(5) 27(2) 
C(22) 1296(5) 6637(6) 7741(6) 34(3) 
C(1) 1107(4) 4566(5) 4070(6) 25(2) 
C(15) 4125(5) 5747(6) 6296(5) 26(2) 
C(9) 3050(4) 5142(5) 6056(5) 22(2) 
C(5) 1560(5) 2843(6) 5549(6) 31(3) 
C(29) 4401(5) 5326(7) 5649(5) 34(3) 
C(10) 3355(5) 4712(7) 5413(6) 34(3) 
C(18) 3861(5) 4550(6) 6906(6) 28(3) 
450 
 
C(11) 4070(5) 4582(7) 5570(6) 36(3) 
C(16) 3397(5) 5884(6) 6167(6) 26(2) 
C(33) 5175(6) 3166(6) 1186(6) 40(3) 
C(12) 4147(5) 4129(6) 6261(6) 40(3) 
_____________________________________________________________________________ 
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